Tun yaushe ne waɗannan alamun suka kasance?
Kuma duk wani ciwo mai tsanani dole ne a bi da shi a wannan hanyar musamman a shekarunka.
Kuma tare da
Hakanan za a gwada yawan cholesterol da kuma karfin jini.
Shin kana jin hakan yanzu?
Kuma yanzu kana da ciwon hanta?
Kuma duk da haka, shin kana jin wahalar numfashi?
Za ka iya gaya mini abin da za ka iya gani a cikin wannan?
Kuma yaya girmanka zai kasance?
Ina kuma yin gasa.
Kuma ina jin zafi da kuma damuwa.
Kuma a yau na ji zafi sosai a kirji.
Kuma shin wannan ne lokacin da za ku ji rauni?
Shin yana cutar da ciwon kirjinka?
Kuma ina jin ɗan ɗanɗano.
Kuma ina so in gaya maka inda ciwon kirji yake.
Kuma suna da su.
Kuma da cutar sukari.
Kuma ka san abin da yake ji kamar na ji kamar na ji kamar na so in yi zurfi.
Kuma ka san mutane suna ci gaba da yin mini ba'a.
Shin kana da ciwon hanta a yanzu?
Kuma ka ce wannan kamar wani matsa lamba ne a kirjinka.
Shin wani a cikin iyalinka yana da ciwon zuciya, ciwon zuciya, ciwon zuciya, yawan mai, ko kuma hawan jini?
Kana jin zafi ko kuma alamun ciwon jijiyoyinka?
Akwai wani a cikinku da yake da irin wannan rashin lafiya?
Shin kana da wasu alamun cutar?
Shin kana jin cewa kana shan numfashi?
Shin har yanzu kana da ciwon hanta?
Domin wannan lokaci ne na mura.
Amma ba za mu damu da ciwon kirji ba domin yana iya zama tushen cututtukan zuciya.
Amma abin da ya fi muhimmanci a yanzu shi ne ciwon kirji.
Amma ina numfashi sosai.
Amma na san mutane da yawa suna yin min ba'a.
Amma dole ne mu ɗauki kowane irin ciwo da tsanani.
Amma yanzu kana numfashi sosai, ko ba haka ba?
Na manta da shi gaba ɗaya saboda wannan ciwon kirji.
Kana jin kamar wani yana yi maka barawo?
Shin har yanzu kana jin wuya ka numfasa?
Shin suna da irin wannan alamun?
Shin kana da wani rashin lafiya na kullum kamar hawan jini ko kuma wasu cututtuka irin wannan?
Shin akwai wata cuta ta likita da ke tattare da wasu cututtuka masu tsanani kamar ciwon sukari?
Shin kana fama da ciwon kirji?
Kana da hawan jini?
Shin kana da matsalar numfashi?
Ka san alamun cutar?
Ka ga wannan hoton?
Ka sha ruwa sosai a yau
Duk da haka, ina yin gwajin sukari.
Alamun ta sun yi daidai da na kaina.
Yaya zafin jiki yake?
Yaya karfin jini kake da shi?
Idan ka ci gaba da yin hakan
Idan zafin jiki ya wuce digiri na biyu na Fahrenheit
Idan kana ganin alamun ka ko kuma matsalarka sun inganta
Yana da ɗanɗano mai ɗanɗano.
Kuma yana da ɗan ɗan ɗanɗano.
Na ɗanɗana na jiya.
Ina da ciwo mai tsanani a cikin kirji.
Ina kuma shan numfashi sosai.
Zan aika maka da hoto.
Ina jin zafi a cikin kirji a yau.
A yau, ina da ɗan ƙanshi da ɗan ƙanshi.
Ina ganin yana da mura.
Ina ganin yana da mura mai sauƙi.
Kana jin kamar wani mai nauyi ne ya hau kan ƙirjinka?
Na soma mamaki, kuma a lokaci guda na ji kamar na yi.
Ina jin zafi a tsakiyar kirji.
Matsin lamba yana kama da ciwon kirji.
Yana cikin ƙirjina.
Yana tsakiyar dutse.
Yana tsakiyar sashin.
Ina jin zafi a kirji.
Na damu sosai game da wannan ciwon da aka yi a cikin ƙwai.
Ina so ka bayyana irin ciwon da nake yi a zuciyata.
Alal misali, hawan jini ko kuma sukari.
Dama kamar tsakiyar kirji
Yanzu za ka iya samun takaparin a kan taya.
Maryamu, ka yi kwanaki da yawa kana da wannan alamar.
Yanzu ka ce kana da ciwon hanta.
A wasu lokatai ina fama da ciwon hanci.
Shin, akwai wasu alamun bayyanar cututtuka a gare ku, banda ciwon?
Ko kuwa wani yana zaune a kirjinka?
Kamar dai tsokoki, da ciwon kai, da kuma ciwon hanci.
A tsakiyar ƙirjina
Ka nuna mini inda nake shan wahala a wannan hoton.
Domin yana da takalma.
Kana ganin wasu daga cikin waɗannan alamun suna iya kasancewa cikin ciki?
Shin yaranku suna da irin waɗannan alamun?
Ka gaya mini game da ciwon zuciyarka.
Yana tashi ne kawai da daddare.
Na ɗanɗana a cikin kwanaki biyu da suka gabata.
Ya fara tashi ne kawai a daren jiya.
Ni ne Dr. Porter na asibitin gaggawa na Cibiyar Triad.
Za ka iya gaya mini game da ciwon kirji?
Na ji zafi a gabashin kirji.
Na ji zafi sosai a kirji.
Da kyau, lokacin da nake da wannan ciwon a kirji.
Wane irin ciwo kake da shi a zuciyarka?
Yaushe ne ya fara ciwon kirji?
A wace yanki ne kake da ciwon kirji?
{Sashe na biyu}
Kana jin zafi a kirjinka?
Na kamu da ciwon sukari kuma na kamu da shi.
Ka ce kana da ciwon hanci.
Saurin kamuwa da cutar COVID-19 a cikin EU/Yurofan Tattalin Arziki da Birtaniya, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Yanayin da ya yi daidai da na COVID-19 a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai da Birtaniya ya tabbatar da cewa, duk da cewa matakan sun bambanta daga ƙasa zuwa ƙasa, COVID-19 ya sami ci gaba mai sauri a duk ƙasashe.
A cewar kwarewar Italiya, kasashen, asibitoci da cibiyoyin kula da gaggawa na bukatar kara kasancewa a shirye don magance yawan mutanen da ke kamuwa da cutar COVID-19 da ke bukatar kulawa ta musamman.
A ranar 31 ga watan Disamba na 2019, an sanar da jerin abubuwan da suka faru na girgizar kasa da ba a san dalilinsa ba a birnin Wuhan, lardin Hubei, kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta kasar Sin ta bayyana dalilin cutar da ake kira Coronavirus, wanda yanzu ake kira Coronavirus, cuta ta 2 na cutar sankarar cuta ta huhu, 2-SARS-CoV.
Tun daga wannan lokacin, cutar ta kamuwa da cuta ta 2-SARS-CoV ta zama sananne da cutar coronavirus COVID-19.
Shaidar ta nuna cewa har zuwa yau, kashi 80% na mutanen da ke fama da COVID-19 suna da wani abu mai sauƙi, wato kamuwa da cutar huhu ba tare da kamuwa da cutar huhu ba ko kuma suna da cutar huhu, kuma yawancin suna warkewa.
Kashi 14% na waɗanda suka kamu da COVID-19 suna bukatar a kwantar da su a asibiti, kuma kashi 6% na sauran marasa lafiya suna bukatar a yi musu asibiti sosai.
Yawan mutuwar mutane da ke fama da cutar COVID-19 a cikin gidajen da ke barci ya kai kusan kashi 4 cikin 100.
A cikin wannan binciken, za mu tantance yanayin kamuwa da cutar COVID-19 a kowace ƙasa ta EU/Yankin Tattalin Arzikin Turai (EU/EEA) da kuma Birtaniya kuma mu kwatanta shi da yanayin lardin Hubei na kasar Sin.
Muna kuma kwatanta yawan mutanen da ke dauke da cutar COVID-19 a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai da Birtaniya da na Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Cutar COVID-19 a cikin EU / Yankin Tattalin Arzikin Turai da Birtaniya
Bayan China, COVID-19 ya ci gaba da bunkasa a wurare dabam-dabam kuma ya sami karuwar cutar a sauran ƙasashe a duniya.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana cutar COVID-19 a matsayin annoba ta duniya.
A ranar 5 ga watan Maris, a cewar Eurosurveillance 2020, Spiteri da abokansa sun ba da rahoton farkon kamuwa da cutar COVID-19 a Turai, a cewar WHO.
A cikin ƙasashen EU/Yankin Tattalin Arzikin Turai, an samu mutum uku na farko da aka tabbatar da cutar a ranar 24 ga Janairu, 2020, a cikin mutanen da suka dawo daga Wuhan, lardin Hobei, China.
A ranar 15 ga Maris, 2020, an samu kamuwa da cutar COVID-19 a duk ƙasashen EU 30/Yankin Tattalin Arzikin Turai da Birtaniya, wanda ya haifar da adadin kamuwa da cutar 39,768 da suka shafi mutuwar 1,727 a tsakanin 31 ga Disamba, 2019 a Italiya kadai.
Samun yawan masu kamuwa da cutar da kuma yawan kamuwa da cutar COVID-19
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana samun adadin adadin adadin shari'o'in COVID-19 a duk ƙasashe a duniya daga kafofin na hukuma kamar Ma'aikatun Kiwon Lafiya na ƙasashe, hukumomin kiwon lafiya na yanki da WHO, kuma ana sabunta su a kowace rana da karfe 8:00 na safe.
An yi amfani da wannan bayanan ne don tantance yanayin COVID-19 a cikin EU da Birtaniya da kuma kwatanta su da Italiya.
A matsayin mai hana ci gaban COVID-19 a cikin al'amuran da suka shafi cutar, mun yi nazarin rage yawan kamuwa da cutar COVID-19 na kwanaki 14 don yin la'akari da yanayin COVID-19 a kowace ƙasa ta EU da Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma gabatar da adadin wadanda suka kamu da cutar a kowace kasa da aka samu a karfe 8:00 na safe na ranar 15 ga watan Maris, idan aka kwatanta da wadanda aka samu a Italiya a cikin watan 31 ga watan Janairu zuwa 15 ga watan Maris.
Hanyar COVID-19 a cikin EU da Birtaniya
Matsakaicin yawan kamuwa da cutar COVID-19 na kwanaki 14 a cikin EU da Birtaniya sun kasance daidai da na lardin Hubei a China (Figure 1.
A cikin EU da Birtaniya gaba ɗaya, yawan kamuwa da cutar COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu, kuma ya sami ci gaba mai yawa a ranar 28 ga Fabrairu, 2020.
Wannan ya fi yawaita ne saboda yawan masu kamuwa da cutar a Italiya, amma sauran kasashen EU da Birtaniya sun nuna irin wannan karuwar yawan kamuwa da cutar COVID-19 da ke dauke da sinadarai.
Shafin 2 ya nuna yawan adadin kamuwa da cutar COVID-19 a cikin EU da Birtaniya idan aka kwatanta da Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Wannan ya nuna cewa a karfe 8:00 na safe na ranar 15 ga watan Maris, adadin mutanen da suka kamu da cutar a wasu kasashe 15 na EU da Birtaniya ya yi daidai da adadin mutanen da suka kamu da cutar a Italiya a makonni 3 ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin mutanen da suka kamu da cutar COVID-19 a cikin EU da Birtaniya suna ƙaruwa cikin sauri.
Bayanan da aka samu na yawan kamuwa da cutar COVID-19 sun nuna cewa wannan kamuwa da cutar tana ci gaba da sauri a duk ƙasashe.
Wannan ya faru ne duk da cewa ƙasashe ba sa cikin yanayi iri ɗaya a cikin yanayin amsawar lafiyar jama'a ta ƙasa, kuma akwai bambance-bambance a cikin ma'anar yanayin da kuma hanyoyin yin gwaji don tabbatar da kamuwa da COVID-19.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da ke fama da cutar ta COVID-19 a Italiya sun bayyana halin da ake ciki cewa kusan kashi 10 cikin 100 na mutanen da ke fama da cutar COVID-19 suna bukatar kulawa ta ICU.
Bayanai na kwancewar marasa lafiya na COVID-19 a asibitoci da cibiyoyin kulawa mai tsanani a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai yanzu suna cikin kashi 6% da 1% na shari'o'in (ba a bayyana bayanai ba).
Duk da haka, dole ne a tattara wannan bayanan a cikin tsari don kammala bayanan kulawa na yanzu wanda ke mai da hankali kan yawan adadin shari'o'in da aka bayar da rahoton da kuma yawan mutuwar.
Wani bincike da aka gudanar a watan Nuwamba na 2010 ya nuna bambanci mai yawa a cikin yawan wuraren da ake samun wuraren kulawa da ICU da kuma cibiyoyin kula da lafiya a Turai, inda a Jamus wannan adadi ya kai 29.2 da kuma a Portugal 4.2 a kowace mutum 100,000.
Wannan yana nuna cewa ƙasashe na iya samun ƙasa da ƙasa ko kuma mafi yawan albarkatu idan aka kwatanta da Italiya (wurin yin asibiti na ICU da na ICU na 12.5 ga kowane mutane 100,000 a watan Nuwamba na 2020).
Yanayin da aka tsara game da yadda ake kula da lafiyar jiki, tare da ƙididdigar kowace ƙasa a cikin EU da UK game da yaduwar yanayin COVID-19 da ke da alaƙa da haɗarin sama da 90% na karuwar ƙarfin kwanciyar hankali, ya bayyana a cikin sabuntawar ECDC ta shida na COVID-19 Rapid Risk Assessment.
Tun da yake akwai cututtuka a cikin EU da Birtaniya, kuma asibitoci da cibiyoyin kulawa da gaggawa suna kula da yawan jama'a a wani yanki, ya fi kyau a karɓi bayanai game da cututtuka da wuraren kulawa da gaggawa daga cikin ƙididdigar ƙididdigar yanki na matakin 2 (NUTS).
Kwarewar Italiya da kuma halin da ake ciki a wasu ƙasashe sun nuna cewa COVID-19 yana yaduwa cikin sauri a cikin ƙasashen EU da Birtaniya.
Kasashe, asibitoci da kuma cibiyoyin kula da gaggawa na bukatar su shirya kansu don yanayin ci gaba da watsa cutar SARS-CoV-2 a cikin al'umma da kuma karuwar adadin masu kamuwa da COVID-19 da ke bukatar kulawa ta kiwon lafiya da kuma a wasu lokuta, kamar yadda ake yi a yanzu a yankunan da aka kamu da su na Italiya.
A cikin sabon kimantaccen hadarin ECDC, an kuma bukaci a yi aiki da hanzari a cikin gaggawa, a yi amfani da shi don rage yaduwar cutar ta coronavirus 2-SARS-COV, tare da sauya tsarin daga dakatarwar zuwa jinkiri, saboda a yayin da ake ganin an yi saurin karuwa a yawan adadin masu kamuwa da cutar, ba za a samu cikakken lokaci ba ga masu yanke shawara da asibitoci don fahimtar, daidaitawa da daidaitawa da kuma amsawa idan ya yiwu.
Ana yin kimantawa na gaggawa da kuma matakan kiwon lafiya na jama'a don daidaita tasirin cutar.
Yanzu akwai wani karamin dama ga kasashen da za su iya yin kokarin rage yaduwar cutar ta coronavirus 2-SARS-CoV da kuma kara rage matsin lamba a kan bangaren kiwon lafiya.
Idan hakan ya gaza, tsarin kula da lafiyar sauran kasashen EU zai shawo kan yawan marasa lafiya da ke cikin ICU a cikin kwanaki ko makonni masu zuwa.
Cutar Coronavirus (COVID-19), wanda ya haifar da cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar sankara ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta ta ta ta hanyar cutar ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta
Kamar yadda yake da irin wannan cutar, wato, SARS-CoV, wanda ya yi sanadiyar kamuwa da dubban mutane a shekara ta 2003, sabon SARS-CoV-2 na iya kamuwa da cutar ta hanyar cutar kumburi kuma ta hanyar irin wannan tsari, ya haifar da bayyanar irin wannan alamar.
Ana samun cututtuka masu tsanani da kuma mutuwar COVID-19 a ƙasa da SARS, amma ana samun karuwar kamuwa da cutar kuma yana shafar tsofaffi da maza fiye da matasa da mata.
Wannan labarin ya ba da amsa ga yawan adadin wallafe-wallafen da ke tattare da wannan sabon cuta, yana ba da cikakken bayani game da yadda ake saurin ci gaba da bincike.
Muna tattauna muhimman abubuwan da ke tattare da ilimin halittu, ilimin halayyar mutum, ilimin ƙwayoyin cuta, ganewa, magani, tsinkaya da rigakafin cutar.
Ko da yake har yanzu akwai wasu tambayoyi da za a iya amsawa, muna fatan wannan kimantawa za ta taimaka wajen fahimtar da kuma hana wannan cuta mai tsanani.
Bikin bazara na 25 ga Janairu, 2020 ya zama abin tunawa da tunawa ga jama'ar kasar Sin saboda sun kasance a gida a duk lokacin hutunsu na makonni bayan barkewar cutar.
Wannan kwayar cutar tana kama da cutar coronavirus (CoV) wadda ta haifar da cutar sankarar hanta ta hanyar numfashi (SARS) a shekara ta 2003; saboda haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta sake masa suna coronavirus SARS-CoV-2 kuma ta sake masa suna COVID-19.
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma ta bazu cikin sauri a duk faɗin kasar da kuma wasu kasashe 50 a duniya.
A ranar 2 ga Maris, 2020, cutar ta samu kamuwa da cutar COVID-19 guda 80,000, wanda ya kai 40,000 da suka warke kuma fiye da 3,000 suka mutu.
WHO ta yi gargadin cewa COVID-19 "abokin gaba na 1" ne kuma ya fi ta'addanci ƙarfi.
A cikin kasa da watanni biyu, an wallafa fiye da 200 na labarai game da COVID-19 da suka shafi ganewar asali, ganewar asali, ganewar asali, ganewar asali da kuma maganin cutar, bayan an fara gano cutar a ranar 7 ga Janairu, 2020, kuma sun gano tsarin kwayoyin halitta na cutar a cikin marasa lafiya da yawa.
Wannan kimantawa na ƙoƙarin sauƙaƙe yanayin bincike a cikin wannan sabon yanayin da sauri a cikin yanayin ci gaba.
A duk lokacin da COVID-19 ya fara, muna ƙoƙarin kwatanta shi da SARS da sauran cututtukan coronavirus da kuma ciwon huhu na Gabas ta Tsakiya (MERS, 2012 generalization).
Za mu kuma tattauna abin da muka sani game da rigakafin cutar da kuma yadda za a yi hasashen ta, da kuma wasu tambayoyi masu gaggawa da ba a amsa su ba.
Ana amfani da kwayar cutar coronavirus a cikin al'ada a matsayin cutar ta mutum, kuma tana haifar da kusan kashi 15% na zazzabi na kowa 4.
Duk da haka, a cikin wannan karni, mun fuskanci kamuwa da cutar coronavirus sau biyu, wato SARS-CoV da MERS-CoV, wanda ya haifar da barkewar cutar a China a 2003 da kuma Saudiyya a 2012, kuma da wuri-wuri ya bazu a ƙasashe da yawa a duniya, inda ya sami mummunan kamuwa da cutar da mutuwar.
Wannan yana nufin cewa COVID-19 na yanzu shine kamuwa da cutar coronavirus ta uku a tarihin ɗan adam.
An kuma nuna a cikin Figure 1.1, an fara sanar da cutar ta numfashi da ba a bayyana asalinta ba daga Wuhan a ranar 31 ga Disamba, 2019 da Hukumar Lafiya ta kasar Sin.
Bayan kwana bakwai, an gano jerin kwayoyin cutar coronavirus.
An yi rahoton mutuwar farko a Wuhan a ranar 15 ga Janairu, 2020.
A lokacin, an yi gaggawa a birane, larduna da ƙasashe masu kewaye da shi.
A ranar 20 ga watan Janairu, an sanar da kamuwa da cutar a cikin ma'aikatan kiwon lafiya, kuma an nuna cewa cutar tana da ikon watsawa daga mutum zuwa mutum.
A ranar 23 ga Janairu, an killace birnin Wuhan kuma an dakatar da dukkan sassan sufuri na jama'a.
A ranar 24 ga watan Disamba, wani bincike na farko na likita ya bayyana cewa daga cikin mutane 41 da suka kamu da cutar, mutane 21 ne kawai suka samu damar kai tsaye zuwa kasuwar abincin teku, kuma a wannan yanayin, an gano farkon farkon cutar daga tushen dabba da ba a sani ba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya ta bayyana cewa akwai gaggawa a duniya.
A lokacin da aka ba da rahoton, cutar ta riga ta bazu a duk faɗin ƙasar Sin da kuma kusan ƙasashe 50 a duniya. (Fig. 2.2)
Saboda yanayin yana ci gaba da sauri, za a iya buɗewa zuwa ga ƙarshen lokaci da kuma zurfin haɗakarwa.
A ranar 11 ga Fabrairu, 2020, an gudanar da bincike mai zurfi a kan marasa lafiya 8,866 wanda ya nuna cewa mutane 4,021 sun kamu da COVID-19 kuma an sake yin sabon hoto a cikin binciken (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya shafi mutane na kowane zamani, amma mafi yawan mutane suna tsakanin shekaru 30 zuwa 65.
Kimanin rabin (47.7%) na waɗanda suka kamu da cutar sun fi shekaru 50, kaɗan ne daga cikinsu sun fi shekaru 20 da haihuwa, kuma 14 ne kawai suka fi shekaru 10 da haihuwa.
Yawan kamuwa da cutar SARS-CoV-2 a cikin maza ya fi girma (0.31/100,000) fiye da mata (0.27/100,000).
Ana samun ci gaba a cikin yanayin COVID-19 a gaba ɗaya a Hobie da yankunan da ke kewaye da shi.
COVID-19 yana ɗaukar matsakaici na kwanaki 5 (9-2) kafin a gano mutum.
A matsakaici, tsawon lokacin kamuwa da cutar ya kai kwanaki 4.8 (7.2-3.0).
Yana kashe mutum a matsakaici a cikin 9.5 (13-4.8) kwanaki.
Farkon fararen hali (R0) na cutar ya kasance 3.77 (95% CI:3.51-4.05), kuma daidaitaccen fararen hali ya kasance R0 4.82-2.32.
Yawan kamuwa da cutar ya karu sosai kafin 23 ga watan Disamba, wanda ya yi daidai da yawan zirga-zirga da sufuri kafin bikin bazara na kasar Sin.
Yawan mutuwar a cikin wadanda aka tabbatar da cutar ya kai 1.44% (95% CI:1.10-1.86%) da kuma adadin mutuwar da aka daidaita a cikin dukan waɗanda aka kamu da cutar ya kai 3.06% (95% CI:2.02-4.59%).
Babban dalilai uku na haɗarin COVID-19 sune jinsi, shekaru sama da 60 da kuma kamuwa da cutar huhu.
Kwayar cutar korona ita ce babbar, ƙwayoyin cuta mai ƙunshe da RNA mai ƙunshe da ƙwayar cuta.
Ana iya rarraba wannan kwayar cutar zuwa nau'i hudu, wato alpha, beta, gamma da delta. Ana iya kamuwa da kwayar cutar ta Alpha da beta.
A cikin SARS-CoV da MERS-CoV, glycoprotein S (S) yana aiki tare da mai karɓar angiotensin 2 (ACE2) da dipeptide peptide 4 (DPP4) mai karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar
An saki RNA na kwayar cutar a cikin cytoplasm; bayan an sake yin kwayar cutar, RNA na kwayoyin halitta tare da glycoproteins da nucleosaccharide proteins na kwayar cutar suna samar da ƙwayoyin cuta na kwayar cutar wanda ke haɗuwa da membrane na plasma don hana kwayar cutar.
An bayyana jerin farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 wani sabon nau'in coronavirus ne wanda ya ƙunshi kashi 99.98% na ƙididdigar kwayoyin halitta tsakanin 10 da aka tattara daga babban wurin da cutar ta fara a kasuwar abincin teku ta Wuhan.
Kwayar cutar SARS-CoV-2 ta kasance mai kama da SARS-CoV zuwa MERS-CoV.
Ta hanyar microscopy na watsa lantarki, an gano ƙwayoyin cuta na SARS-CoV-2 a cikin sassan ultraviolet na murfin iska na mutum.
An gano ACE2 na mutum a matsayin mai karɓa don SARS-Cov-2 da SARS-CoV.
Koyaya, SARS-CoV-2 ya fi rauni fiye da SARS-CoV fiye da ACE2 na mutum, wanda shine dalilin da ya sa cutar ta haifar da cutar ta SARS-CoV-2 ta zama ƙasa da haɗari ga waɗanda suka kamu da cutar fiye da waɗanda suka kamu da SARS-CoV.
Hakanan SARS-CoV-2 zai iya samar da sabon kwayar cutar da aka yi wa lambar ta orf3b da kuma kwayar cutar da aka yi wa lambar ta orf8.
SARS-CoV-2 orf3b na coronavirus na iya taka rawa wajen kamuwa da cutar ta hanyar hana shi bayyana IFNβ; a wannan yanayin, orf8 ba shi da wani aikin da aka sani.
A ranar 18 ga Fabrairu, 2020, Zeus da abokan aiki sun ba da rahoton cikakken tsarin cryo-EM na ACE2 na mutum a cikin maganin A 2.9 a hade tare da amino acid B0AT1.
Sun gano cewa wannan mahaɗin yana da nau'i biyu na budewa da rufewa, kamar dimer da aka tattara kuma mahaɗin ACE2-B0AT1 na iya haɗa sunadarai S guda biyu, yana ba da shaida don ganowa da kuma hana cutar coronavirus.
B0AT1 na iya zama maganin gwaji don maganin cutar SARS-CoV-2 don hana cutar.
Makarantar farko da na tsakiya
An gano cewa SARS-CoV da MERS-CoV sun fito ne daga kwayar cutar kumfa, kuma an kamu da su daga cats da kuma tsuntsaye zuwa mutane.
Ta hanyar kwatanta ilimin halittu na SARS-CoV-2 da sauran ƙwayoyin cuta, an gano cewa kwayar cutar ta kasance asalin kwayar cutar SARS-CoV-2 saboda sabon kwayar cutar ta kasance 96% kama da sauran kwayar cutar SARS-CoV-2 da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, yadda kwayoyin halitta na tsakiya ke taimakawa kwayar cutar ta tsallaka shinge na nau'in da kuma watsawa zuwa mutum ba a gano ba kuma hanyar watsawa ta ci gaba da bukatar bayani.
G. da abokan aiki, Marianne, sun bayyana cewa cutar tana watsawa daga kwayar cutar zuwa mutum wanda ke haifar da haɗuwa da irin wannan furotin na S.
A cewar wani bincike, masu bincike a Guangzhou, China, sun bayyana cewa pangolin - dabbobin da ke da nono mai cin nama kuma ana amfani da shi sosai a cikin maganin gargajiya na kasar Sin - na iya zama babban kwayar cutar coronavirus ta SARS-CoV-2 saboda akwai 99% na kwayoyin halitta na kwayar cutar da aka gano a cikin pangolin tare da SARS-CoV-2.
Duk da haka, bambancin 1% na kwayoyin halitta tsakanin ƙwayoyin cuta biyu har yanzu bambanci ne mai girma, saboda haka, ana sa ran samun ƙarin shaida don samun sakamako mai ban mamaki. (Figure 33.)
Har yanzu ba a gano cikakkiyar siffar jiki da sinadarai na SARS-CoV-2 ba.
Kwayoyin cutar SARS-CoV da MERS-CoV a yanayin rashin ƙarfi na iya rayuwa har tsawon awanni 48 a cikin yanayin bushe har zuwa kwanaki 5 a zafin jiki ƙasa da 20 ° C da kuma yawan danshi na 40%-50%.
Kwayar cutar SARS-CoV-2 na iya samun irin wannan fasalin.
An ruwaito cewa SARS-CoV-2 yana da saurin kamuwa da cutar sama da zafi mai zafi da zafin jiki na 56 °C zuwa 30 °C; ƙwayoyin cuta, 75% ethanol, chlorine idan sun ƙunshi maganin rigakafi, peroic acid, chlorophore, da sauran masu ƙona mai, ban da chlorhexide, na iya kashe cutar yadda ya kamata.
Mutane ba su da kariya ga cutar SARS-CoV-2 kuma suna iya kamuwa da sabon cutar.
A halin yanzu, babu cikakken bincike game da yadda mutum zai iya jure wa cutar SARS-CoV-2.
Saboda haka, za mu iya yin magana ne kawai game da binciken da aka yi a baya game da cutar coronavirus, musamman SARS-CoV da MERS-CoV (Fig. 4).
A kullum, bayan kamuwa da cutar ta kai hari a kan kwayoyinta, ana fara gano ta ta hanyar tsarin rigakafin kwayoyinta ta hanyar masu karɓar ganewar asali (PRRs) ciki har da masu karɓar nau'in C, masu karɓar nau'in Toll (TLR), masu karɓar nau'in NOD, da masu karɓar nau'in RIG-I (RLR).
Ta hanyar hanyoyi daban-daban, cutar ta bayyana abubuwan da ke haifar da kamuwa da cuta, haɓakar ƙwayoyin cuta na dendritic da kuma samar da Interferon Type I (IFNs) wanda ke iyakance yaduwar cutar da kuma hanzarta fasfocin macrocytotic antibacterial na cutar.
A lokaci guda kuma, furotin na SARS-CoV na N na taimakawa kwayar cutar ta tsere daga amsawar rigakafi.
Nan ba da daɗewa ba, za a iya samun amsa mai kyau ta rigakafi ta hanyar yin fushi da cutar.
T lymphoma na irin wannan halitta, wanda ke da CD4+CD8+T, yana da muhimmiyar rawa wajen samar da kwayar halitta.
CD4 + T yana sa kwayar cutar ta B ta yi amfani da kwayoyin cutar don samar da maganin rigakafi na musamman, kuma CD8 + T tana kashe kwayar cutar ta kai tsaye.
Kwayoyin T masu taimako suna taimakawa wajen samar da cytokines kafin kamuwa da cuta, wato, ƙwayoyin rigakafi.
Hakanan, coronavirus na iya hana ayyukan T cell ta hanyar kashe T cells.
Hakanan ana buƙatar rigakafin ruwa ga ƙarin abubuwa kamar C3a da C5a da antibodies don magance kamuwa da cutar.
Alal misali, maganin rigakafi da aka karɓa daga marasa lafiya da suka warke yana kunna cutar MERS-CoV.
A gefe guda, tsarin rigakafi na jiki yana haifar da yawan radicals na kyauta wanda zai iya haifar da lalacewar jiki da sauran tsarin, kuma a mafi munin yanayin, zai haifar da rashin aiki da yawa har ma da mutuwa.
Kwayar cutar korona ta SARS-CoV-2 da ke kamuwa da kwayar cutar ta hanyar kwayar halitta, yana iya kamuwa da tsofaffi da mata masu juna biyu.
A yawancin lokaci, mutanen da ke fama da cutar ta kwayar cuta ko kuma tsarin rigakafi na jiki suna da haɗari mafi girma na kamuwa da cutar fiye da sauran mutane.
A cewar wani bincike da aka yi a Wuhan, wanda ya nuna cewa an yi bincike a kan mutane 425 da suka fara kamuwa da cutar, lokacin da za a yi kamuwa da cutar SARS-CoV-2 yana da kwanaki 1-14 kuma yawanci kwanaki 3-7.
A wani lokaci kuma, wani bincike a kan mutane 1,099 ya nuna cewa an samu matsakaicin bayyanar kwanaki 3 da kuma tsakanin kwanaki 0 zuwa 24.
Binciken da aka yi kwanan nan, da kuma wanda aka ambata a sama, ya nuna cewa an samu kwanaki 4.8 (7.2-3.0) na bayyanar cutar a cikin alƙaluma 8,866 na masu kamuwa da cutar.
Yana da muhimmanci ga hukumomin kiwon lafiya su tsara lokacin da za a yi amfani da shi wajen yin keɓewa bisa ga ainihin lokacin da cutar ta fara, don haka a hana kamuwa da cutar daga wanda ba shi da wata alama zuwa wani.
A matsayin al'ada, mutanen da suka kamu da cutar ko kuma suka sami wasu marasa lafiya, yawanci suna bukatar a yi musu killace na kwanaki 14.
Shin dole ne a tsawaita lokacin keɓewa zuwa kwanaki 24?
Yana da mahimmanci a cikin bayyanar cututtuka na farko da na farko na COVID-19 wanda zai iya faruwa a kan kansa ko tare da wasu alamomi kamar tari, rashin numfashi, ciwon tsoka, haushi, ciwon kai, kumburi, narkewar hanci, ciwon kirji, ciwon ciki, ciwon zuciya, da kuma ciwon hanci.
Wasu mutane sun kamu da rashin numfashi da rashin iskar oxygen a cikin jini mako guda bayan bayyanar cutar.
A cikin yanayin da ya fi tsanani, cutar tana ci gaba da sauri zuwa rashin numfashi, rashin karfin jini da kuma cututtukan jiki, ciwon sukari da kuma rashin lafiyar jini.
Masu fama da cututtukan cutar da ke nuna ciwon huhu da kuma ciwon huhu da ke da ciwon huhu da kuma ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da kuma ciwon huhu da ke da ciwon huhu da ke da ciwon huhu da ke da kuma ciwon huhu da ke da ke da ciwon huhu da ke da ciwon huhu da ke da kuma ciwon.
Wani bincike na alƙaluma a ƙarshen Disamba 2019 ya nuna cewa kashi 98% na marasa lafiya sun sami ciwon kumburi, 76% na rashin ƙarfi, 55% na rashin numfashi, 3% na rashin ƙarfi, kuma 8% na bukatar na'urar numfashi.
Binciken da aka yi kwanan nan game da wani nau'i na iyali da kuma nau'i na canja wuri a cikin mutum marar alamun sun nuna irin wannan sakamakon.
A cikin kwatancen, wani binciken da aka gudanar a shekara ta 2012 ya nuna cewa masu dauke da cutar MERS-CoV sun sha wahala daga rashin numfashi a matsayin babban alamar (98%) har zuwa (47%), kumburi mai bushe (5%) a matsayin babban alama.
Koyaya, kashi 80% na waɗanda suka kamu da cutar sun bukaci numfashi, wanda ya fi yawan waɗanda suka kamu da COVID-19 girma, kuma hakan ya dace da ƙarin mutuwar MERS daga COVID-19.
An kuma lura da ciwon ciki (26%) da kuma kumburi (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, an lura cewa har zuwa (100% -99%), kumburi mai bushe (75% -29%), rashin numfashi (42% -40%), ciwon ciki (25% - 20), da kumburi (25% - 13) sune manyan alamun bayyanar cututtuka kuma kusan 20% -14% na waɗanda suka kamu da cutar suna buƙatar numfashi na hannu.
A ranar 14 ga Fabrairu, adadin mutuwar COVID-19 ya kai kashi 2% yayin da adadin masu kamuwa da cutar ya kai 66,576 a duniya.
A kwatanta, yawan mutuwar da ake samu daga SARS ya kai 10% daga cikin 8,096 da aka tabbatar da cutar a watan Nuwamba na 2002.
Don MERS, a cewar wani bincike na alƙaluma a watan Yuni na 2012, yawan mutuwar ya kai 37% daga cikin 2,494 da aka tabbatar.
Wani binciken da aka yi a baya ya nuna cewa R0 na SARS-CoV-2 ya kasance 6.47, wato, wani matsakaici na dogara (CI) na kashi 95% zuwa 7.23-5.71, yayin da R0 na SARS-CoV ya kasance tsakanin 2 zuwa 4 kawai.
Ana kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV ta hanyar alamun bayyanar cututtuka, yawan mutuwa, da kuma R0 ko a cikin Table 1.1.
Halin da aka nuna a sama ya nuna cewa SARS-CoV-2 yana da mafi kyawun yaduwar cutar fiye da MERS-CoV da SARS-CoV, amma yana da ƙasa da kisa.
Saboda haka, sarrafa cutar coronavirus ta SARS-CoV-2 ya fi rikitarwa fiye da MERS-CoV da SARS-CoV.
Ana fara da igiyoyi a cikin gida ɗaya ko kuma a cikin taro ɗaya ko kayan aiki na sufuri, kamar jirgin ruwa.
Mutane da yawa suna da haɗuwa da marasa lafiya na musamman ko kuma waɗanda suka riga sun yi tafiya a Wuhan ko wasu yankuna masu cutar a cikin makonni biyu kafin su kamu da cutar.
Bugu da ƙari, an bayar da rahoton cewa mutane za su iya ɗaukar cutar ba tare da wata alama ba har tsawon makonni biyu, kuma marasa lafiya da suka warke daga asibiti za su iya ɗaukar cutar a sake, wanda hakan yana ba da gargadi ga tsawaita lokacin keɓewa.
A cikin marasa lafiya, yawan kwayoyin halitta na waje (musamman lymph nodes) yana da kyau ko kuma ya ragu a farkon lokaci.
Alal misali, wani mai cutar lymphocytes mai ƙarancin jini < 4x109/L yana da adadin lymphoma mai suna < 1x109/L, kuma an lura da karuwa a cikin matakan aminotransferase aspartate da viriemia a cikin marasa lafiya 1,099 na COVID-19.
Yawan ƙwayar cuta, hanta da kuma ƙwayar cuta a cikin jini ya karu a wasu marasa lafiya, kuma sun sami karuwar furotin C da kuma jini na jini a cikin yawancin marasa lafiya.
A cikin marasa lafiya masu cutar, matakan D-dimer, wanda shine samfurin fibrin da ke cikin jini, ya karu kuma adadin lymphoma ya ragu sosai.
An lura da rashin daidaituwa a cikin hasken rana na kirji a cikin yawancin marasa lafiya na COVID-19 kuma yana nunawa a cikin inuwa mai launin toka a ɓoye ko duhu kamar gilashin iska a cikin huhu.
Mutane da yawa suna nuna rashin lafiyar huhu, lalacewar huhu, da kuma cututtukan numfashi mai tsanani (ARDS).
Lokacin da ARDS ta faru, kamuwa da cuta mara kyau, tarin ruwa, da ci gaba da ƙwayoyin cuta, ana iya yin musayar gas.
Rashin amfani da irin 1 da 2 na pennyoacytes yana rage yawan sulfate da kuma ƙara yawan abubuwan da ke cikin jini, don haka rage ƙarfin huhu don faɗaɗa, kuma yana ƙara haɗarin bugun jini.
Saboda haka, yawan hasken da aka yi wa mai haƙuri zai nuna cewa cutar ta yi muni kuma zai fi ɓoyewa.
A ranar 18 ga Fabrairu, 2020, bincike na farko na ilimin cututtuka na COVID-19 ya nuna cewa kashe ƙwayoyin cuta, samar da hyaline membrane, da kuma satar lymph nodes, da kuma kwayoyin cuta a cikin huhu na marasa lafiya da suka mutu saboda cutar, daidai yake da kamuwa da cutar kamuwa da cuta da cutar ta ARDS da kuma na marasa lafiya na SARS da MERS.
An yi amfani da RNA na SARS-CoV-2 ta hanyar hanyar hanyar RT-PCR (reverse polymerase chain transcription) a matsayin babban mataki na gano COVID-19.
Ko da yake sakamakon karuwar farashin ƙididdigar ƙarya, wanda zai iya saurin yaduwar, an fara amfani da alamun likita don gano cutar a China a ranar 13 ga Fabrairu, 2020 (saboda RT-PCR ba a amince da shi ba).
Akwai kuma irin wannan yanayin da aka samu na gano SARS.
Saboda haka, haɗuwa da cututtuka, alamun likita, gwaje-gwaje na gwaji, da kuma binciken bincike na bukatar a samu ganewar asali da kuma magani mai kyau.
A ranar 14 ga Fabrairu, 2020, kungiyar Feng Zhang ta bayyana yarjejeniyar amfani da fasaha ta SHERLOCK ko CRISPR don gano kwayar cutar SARS-CoV-2, wanda ke gano RNA mai amfani na SARS-CoV-2 a cikin 20x10-18mol/L zuwa 200x10-18mol/L (10-100 kwafi ga kowane microlitre da aka fitar) tare da karɓar kwayar cutar a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai kyau ba.
Muna fatan wannan fasaha ta kasance sabuwar kuma idan aka tabbatar da ita, za ta iya yin karin samfurori na likita da sauƙi da sauƙi.
Idan ba a samu sabon kwayar cutar ba, masu kula da lafiya za su iya ba da kulawa ga marasa lafiya na COVID-19, tare da yin amfani da maganin da aka yi amfani da shi a baya ga sauran marasa lafiya na coronavirus kamar SARS-CoV da MERS-CoV da sauran cututtukan cutar.
Wadannan magunguna sun hada da magungunan riga-kafi da ake amfani da su a yanzu, magungunan ɓoye, masu tayar da rigakafi, steroids, maganin warkewar marasa lafiya, magungunan Sin, da kuma taimakon tunani.
An kuma ba da shawarar yin amfani da maganin plasma ga marasa lafiya da suka warke.
Kamfanonin magunguna suna gasa don samar da maganin rigakafi da allurar rigakafi ga cutar.
Kwayar cutar SARS-CoV-2 tana kai hari ne ga tsarin numfashi kuma, a mafi ƙarancin hali, tana iya kai hari ga gabobin da ke dauke da ACE2, kamar su tsarin hanji da koda.
Bugu da ƙari, rashin aiki da rashin ƙarfi na tsarin numfashi suna da babbar barazana ga marasa lafiya da kuma manyan abubuwan da ke haifar da mutuwar marasa lafiya.
Saboda haka, taimakon numfashi yana da muhimmanci wajen sauƙaƙe bayyanar cututtuka da kuma ceton rayukan marasa lafiya, wanda ya ƙunshi maganin oxygen gaba ɗaya, maganin oxygen-free, air conditioning, air conditioning, air conditioning, mechanical air conditioning, dangane da tsanani da kuma tsanani na cutar.
Ga marasa lafiya da ke da alamun cutar kumburi na numfashi, dole ne a yi musu maganin oxygenation-extra-membrane oxygenation (ECMO), wani fasaha na gyaran zuciya da numfashi don magance mummunar cutar kumburi na numfashi ko zuciya.
Bugu da ƙari, kula da daidaiton lantarki, hanawa da kuma magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
An kuma gano cewa cutar cytokine ta haifar da sakamako mai yawa na tsarin rigakafi na marasa lafiya na SARS da MERS.
Cytokine cuta wani nau'i ne na amsawa ga tsarin kamuwa da cuta wanda aka yi ta hanyar sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Wadannan cytokines suna tilasta wa ƙwayoyin rigakafi su samar da babban adadin radicals na kyauta wanda shine babban dalilin ARDS da kuma rashin aiki na gabobin jiki.
Ƙarfafa tsarin rigakafi don magance cututtukan cytokine, musamman a cikin marasa lafiya masu ɓoye.
Ana amfani da corticosteroids da toshilizomab, da kuma anti-IL6 monoclonal antigen, don magance cutar cytokine.
Sauran magungunan maganin rigakafi don magance cutar cytokine sun hada da rage tsarin garkuwar jiki ga T-cell, IFN-γ, IL-1 da TNF-cell, da kuma hana JAK; Blinatomab; cytokine-signing activator4; da kuma activating HDAC.
Ana amfani da steroids, a matsayin masu karfafa tsarin rigakafi, don magance SARS don rage yawan cutar.
Bugu da ƙari, steroids ba su da amfani ga cutar SARS da COVID-19 idan aka sha su a cikin abinci mai yawa.
Maimakon haka, zai iya haifar da sakamako masu illa, musamman ƙwayoyin cuta, wanda zai iya shafar ganewar asali.
Bugu da ƙari, an ba da shawarar yin amfani da gajeren lokaci na corticosteroids a cikin ƙananan zuwa matsakaiciyar abinci don amfani ga marasa lafiya na COVID-19 da ke da rashin lafiya.
A lokacin rubuce-rubuce, babu wani magani da ya tabbatar da tasirin cutar.
Duk da haka, an yi amfani da ƙwayar cuta ta Rhymdesvir, wanda yake da ƙwayar cuta mai ƙwayoyin cuta, wajen nuna tasirin cutar COVID-19 a cikin wani mai haƙuri a Amurka.
Remdesvir ne sabon maganin kashe kwayoyin cutar da Gilead ta fara samarwa don magance cututtukan da suka haifar da kwayar cutar Ebola da kuma cutar Malburg.
Daga bisani, Remdesvir ya kuma nuna tasirinsa na hana kwayar RNA guda ɗaya, ciki har da SARS da MERS.
A cewar Amman, Gilead ta ba da wannan tsari don gudanar da gwajin cutar coronavirus SARS-CoV-2 ga China kuma sakamakon ya kasance mai sa ran gaske.
Bugu da ƙari, ana ba da shawarar baricetinub, alpha interferon, lopinavir/ritonavir, da ribavirin, a matsayin magani mai mahimmanci ga marasa lafiya da ke da alamun cututtukan cututtukan huhu.
Ƙarƙashin zuciya, ƙwayar zuciya, ƙyar zuciya, ƙwayar jijiya, da sauran sakamako masu illa na iya faruwa bayan amfani da maganin Lupinavir/Ritonavir.
Dole ne a lura da yadda waɗannan magunguna suke hulɗa da sauran magunguna a cikin marasa lafiya.
Plasma na marasa lafiya da kuma samar da maganin rigakafi
Tattara jinin marasa lafiya da suka tsira daga cutar da kuma amfani da shi don magance marasa lafiya da ke fama da irin wannan cuta ko kuma don kare lafiyar mutane daga kamuwa da cutar yana da dogon lokaci.
A gaskiya ma, marasa lafiya da suka warke suna da yawan maganin rigakafi don magance cututtukan da ke cikin jini.
Magungunan antigen sune immunoglobins (lg) da ake samarwa ta hanyar lymphoma na nau'in Β don yaki da pathogens da sauran dalilai na waje da gano kwayoyin da ba su da kyau a cikin pathogen kuma su kawar da su kai tsaye.
A wannan hanyar, an karɓi plasma daga cikin mutanen da suka warke daga cutar COVID-19 zuwa cikin jini na mutane 10 da suka kamu da cutar.
Alamun sun warke bayan awanni 24, kuma sun sami sauƙi daga kamuwa da cuta da kuma cutar, kuma sun sami ingantaccen oxygen a cikin jini.
Duk da haka, ana buƙatar tabbaci da bayani don bayar da shawarar tsari da amfani a kan babban sikelin kafin ci gaban waɗannan magunguna na musamman.
Bugu da ƙari, idan aka yi la'akari da tasirin maganin, dole ne a yi la'akari da wasu lalacewar da ke tattare da plasma.
Alal misali, maganin rigakafi na iya kara yawan maganin rigakafi da kuma haifar da cututtukan cytokine wanda zai iya zama mai haɗari ga rayuwa.
Ana samun ƙarancin maganin rigakafi a cikin jini, kuma ana bukatar plasma sosai don kula da marasa lafiya.
Samun da kuma samar da makamai masu amfani da makamai masu guba da za su iya magance cutar ta duniya yana da wuyar gaske.
Saboda haka, ware B-cell daga marasa lafiya da suka warke da kuma gano tsarin kwayoyin su da kuma sanya maganin rigakafi mai tasiri, ko kuma bincika maganin rigakafi da ke shafar furotin na kwayar cutar, yana da muhimmanci sosai.
Idan aka yi haka, za mu iya samar da maganin rigakafi cikin sauƙi.
TCM an yi amfani da ita wajen magance cututtuka daban-daban a kasar Sin tun shekaru dubbai.
Duk da haka, tasirinsa ya dogara ne akan haɗuwa da abubuwa da yawa a cikin lissafi wanda ya bambanta bisa ga ganewar asali na TCM.
Yawancin sinadarai masu tasiri sun kasance ba a sani ba ko kuma ba a sani ba saboda samarwa da tabbatar da su a cikin wannan nau'i ko cakuda mai dacewa yana da wuya.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin maye gurbin magani ga marasa lafiya waɗanda alamun su na da sauƙi zuwa matsakaici ko waɗanda ke cikin farkon yanayin cutar da kuma warkewa.
Alal misali, maganin Shu Feng Jie Du da Lian Hua Qing Wen sun yi tasiri wajen magance COVID-19.
An samu mafi yawan adadin marasa lafiya da aka yi amfani da su wajen magance cutar COVID-19 a larduna da dama a kasar Sin inda kashi 87% na marasa lafiya suka samu magani daga TCM, ciki har da a Gansu (63.7%), Ningxia (50%), da kuma Hunan (50%), yayin da a lardin Hubei na TCM aka yi amfani da su ne kawai ga kashi 30% na marasa lafiya da suka kamu da cutar COVID-19, kuma an samu mafi ƙarancin adadin warkewa (13%).
Duk da haka, wannan ƙananan kwatanta ne, saboda yawancin wasu dalilai masu tasiri kamar yawan marasa lafiya da kuma tsanani na cutar dole ne a yi la'akari da su a cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli ZHang da abokan aikinsa sun gudanar da wani bincike game da kwatanta maganin maganin yamma (WM) kawai.
Sun gano cewa tsawon lokacin da ake bukata don warkewar zafin jiki, ɓacewar bayyanar cututtuka, da kuma bukatar asibiti a cikin WM+TCM ya ragu sosai fiye da na WM kadai.
Mafi mahimmanci, ƙarancin ci gaban cututtuka (daga mai sauƙi zuwa mai tsanani) a cikin WM+TCM ya kasance ƙasa da na WM kawai (7.4% da 46.2%), kuma mutuwar a cikin WM+TCM ya kasance ƙasa da na WM kawai (8.8% da 39%).
Bugu da ƙari, ƙarfin TCM da tsaro har yanzu suna fuskantar gwaji mai kyau a kan sikelin da kuma cibiyoyin da yawa.
Bayyana tsarin aiki da kuma bayanin abubuwan da ke cikin maganin TCM ko kuma abubuwan da ke ciki zai zama da ban sha'awa idan ya yiwu.
Marasa lafiya da ake zargin suna da cutar COVID-19 ko kuma an tabbatar da cutar suna fuskantar babban tsoro na cututtukan da ke haifar da mutuwa ko kuma annobar annoba, kuma waɗanda aka keɓe suna fuskantar rashin jin daɗi, rashin hankali, da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar ta, hypoxia da kuma kumburi, da kuma sakamako masu illa na miyagun ƙwayoyi, misali rashin barci daga amfani da corticosteroids, na iya haifar da damuwa da rashin jin daɗi.
A farkon farkon barkewar cutar SARS, an bayyana yawan cututtukan hankali ciki har da ciwon ciki, damuwa, tashin hankali, tashin hankali, alamun hauka, rashin hankali, har ma da kashe kansa.
Kula da cutar da kuma tilasta yin keɓewa, a matsayin wani ɓangare na amsawar lafiyar jama'a ga COVID-19, na iya sa mutane su ƙara damuwa da yin laifi game da tasirin cutar, keɓewa, da kuma cutar a kan iyalansu da abokai.
Saboda haka, ana bukatar a samar da kulawar lafiyar kwakwalwa ga marasa lafiya da ke fama da COVID-19, wadanda ake zargi da su da kuma wadanda suka kamu da su, da kuma ga jama'a.
Dole ne a haɗa da goyon bayan ilimin halayyar mutum, samar da ƙungiyoyin kula da lafiyar hankali na fannoni da yawa, sadarwa mai kyau da kuma cikakken bayani game da sabuntawa na cutar SARS-CoV-2, shirye-shiryen magani da amfani da na'urorin lantarki, da kuma tsarin gudanarwa na ƙwararru don hana mutane samun kusanci.
Ana buƙatar allurar rigakafi mai tasiri don katse sarkar watsawa daga dabbobi da mutane masu cutar zuwa ƙwayoyin cuta na farko kuma galibi ana amfani da su wajen yin maganin rigakafin cutar don sarrafa cututtukan da ke tattare da sababbin ƙwayoyin cuta.
An yi ƙoƙari don samar da allurar rigakafi bisa ga furotin S don samar da rigakafin kare lafiyar lokaci mai tsawo da / ko kariya ga SARS-CoV.
An yi bincike kan alluran da aka rage na SARS a cikin samfurin dabba.
Bugu da ƙari, ba a gano tasirin in vivo na waɗannan masu neman allurar rigakafi a kan tsarin shekaru guda ɗaya da kuma tsarin yaki da cutar ta mutuwa da kariya daga yaduwar kwayar cutar ta mutum-dabba kafin a fara binciken asibiti ba.
Wannan na iya kasancewa saboda SARS ta ɓace shekaru 17 da suka gabata kuma babu wani labari daga wannan lokacin.
A akasin haka, ana samun karuwar cutar MERS a Gabas ta Tsakiya kuma ana samun karuwarta a wasu yankuna saboda ci gaba da samun albarkatun da mutane da dabbobi ke da su a yankin.
An kirkiro dabarun MERS ta hanyar amfani da kwayar cuta, plasmids na DNA, masu ɗaukar kwayar cuta, nanomomachines, ƙwayoyin cuta na kwayar cuta, da kuma wasu sassan furotin na recombinant, wasu daga cikinsu an yi su ne don kimantawa a cikin dabbobi.
Samar da ingantaccen kwayar cutar SARS-CoV-2 ga marasa lafiya yana da gaggawa kuma yana da muhimmanci wajen sarrafa cutar.
Bugu da ƙari, yin nasara a kan wannan matsalar yana da matukar wuya saboda tsawon lokacin da ake bukata don yin allurar rigakafi (kimanin 18mgs) da kuma canjin yanayin cutar coronavirus.
A matsayin sabon cuta, COVID-19 ya fara nuna kansa a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya za su iya warkewa ba tare da cutar ba.
Koyaya, kamar SARS da MERS COVID-19 yana haifar da rashin lafiya da mutuwa mai yawa a cikin ɓoyayyen yanayi.
Saboda haka, samar da samfurin hasashen cutar na cutar yana da muhimmanci ga hukumomin kiwon lafiya su fi dacewa da ayyukan su, musamman a wuraren da akwai iyakancewar albarkatu.
Bisa ga binciken asibiti da aka bayar, waɗannan dalilai na iya shafar ko kuma suna da alaƙa da hasashen marasa lafiya na COVID-19 (Table:
Shekara: Shekara ita ce mafi muhimmanci wajen warkewa daga SARS kamar yadda yake ga COVID-19.
COVID-19 ya fi faruwa a cikin shekaru 65 zuwa 30 kuma a cikin wani bincike wanda ya shafi mutane 8,866, 47.7% na marasa lafiya sun fi shekaru 50 kamar yadda aka ambata a sama.
Marasa lafiya da ke bukatar kulawa ta musamman sun fi fuskantar wasu cututtuka kuma sun fi tsufa fiye da sauran (a matsakaiciyar shekaru 66 zuwa 51), kuma hakan ya nuna cewa shekaru suna da tasiri sosai a sakamakon cutar COVID-19.
Jima'i: Cutar SARS-Cov-2 tana cutar da maza fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka riga aka bayyana.
Rashin sauran cututtuka: Marasa lafiya da ke fama da cutar COVID-19 da ke bukatar kulawa mai zurfi suna da mafi yawan cututtukan zuciya ko kuma cututtukan zuciya.
Har ila yau, bugun zuciya ya zama babban dalilin mutuwa a cikin marasa lafiya na SARS.
An ruwaito cewa SARS-CoV-2 na iya zama mai ƙuntatawa tare da ACE2 mai kyau wanda zai iya haifar da bugun jini a cikin marasa lafiya na COVID-19.
Ya kamata a ce shekaru da kuma cututtukan asali suna da alaƙa da juna kuma suna iya haɗuwa.
Sakamakon gwaji na musamman: matakan C-type-responsive protein (CRP) a cikin jini na nuna mummunan kamuwa da cuta ko lalacewar tsoka kuma yana da wani dalili na ɓoye na cutar, amsa ga magani, da kuma warkewa ta ƙarshe.
An kuma yi shawarar cewa akwai alaƙa tsakanin matakin CRP da tsanani da kuma hasashen COVID-19.
Bugu da ƙari, karuwa a cikin lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan enzymes suna samuwa a wurare da dama na jiki, musamman a zuciya da jijiyoyi, kuma suna saki a lokacin lalacewar tsoka.
Saboda haka, waɗannan su ne alamun rashin lafiyar zuciya da jijiyoyi.
Babban alamun asibiti: Domin a yi la'akari da sakamakon da kuma rikitarwa na COVID-19, dole ne a yi la'akari da cutar ta hanta da kuma ci gaban alamun asibiti na ɗan lokaci tare da sauran matsalolin.
Amfani da steroids: Kamar yadda aka ambata a baya, steroids suna ƙarfafa tsarin tsarin jiki kuma ana amfani da su a matsayin magani mai taimako don cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Saboda yawan abincin da ake amfani da shi a cikin cututtukan SARS, yawancin waɗanda suka tsira sun sami mutuwar ƙashin ƙashi da rashin jini tare da rashin ƙarfi da kuma mummunan rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da abinci mai ƙarancin steroid kuma a takaice a cikin marasa lafiya na COVID-19.
Matsalolin da suka shafi damuwa: A lokacin da COVID-19 ya barke, yawancin marasa lafiya suna fuskantar matsanancin damuwa saboda sun sha wahala daga dogon lokaci na keɓewa da rashin tabbas da kuma mutuwar dangi da abokai.
Dole ne a ba da kulawa ta hankali da kuma taimako na dogon lokaci ga waɗannan marasa lafiya don taimaka musu su shawo kan damuwa kuma su koma ga rayuwarsu ta yau da kullum.
Bisa ga binciken da aka yi, COVID-19 yana da nau'i daban-daban na watsawa idan aka kwatanta da SARS.
Baya ga sake dawowa a cikin ƙananan huhu, SARS-CoV-2 na iya sake dawowa cikin tasiri a cikin ƙananan huhu kuma yana nuna alamun haske ko rashin bayyanar a farkon lokacin kamuwa da cuta, kamar sauran cututtukan coronavirus waɗanda ke haifar da zazzabi na yau da kullun.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokacin da suka kamu da cutar ko kuma lokacin da ba su kamu da cutar ba a lokacin aikin yau da kullum suna iya haifar da ƙalubale mai yawa don sarrafa cutar.
Duk da haka, SARS-CoV ana iya watsa shi yayin da mutum yake da cutar a ɓoye, yayin da mafi yawan watsawa ba a fara yi ba.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS tsanani kuma tana da wuyar sarrafawa.
A halin yanzu, ana yin ƙoƙari sosai don dakatar da yaduwar SARS-CoV-2 a kasar Sin, ciki har da rufe Wuhan da garuruwan da ke kewaye da shi da kuma sanya dukkan mutane cikin keɓewa.
Duk da haka, waɗannan ayyukan sun yi mummunan lahani ga tattalin arziki da sauran sassan ƙasar, amma adadin sababbin cututtuka na raguwa, yana nuna raguwar annobar.
Mafi kyawun ƙididdigar shine cewa cutar za ta ƙare a watan Maris kuma za ta rage tsawon watanni 4 zuwa 3.
Duk da haka, wasu masana ba su da kyakkyawan fata.
Paul Hunter da abokan aikinsa sun kiyasta cewa COVID-19, wanda ya fi SARS yawa, ba zai ƙare ba a shekarar 2020.
Ira Longini da abokan aikinsa sun yi wani samfurin da ya nuna cewa cutar SARS-CoV-2 za ta iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wani rukuni na Kanada ya bayyana cewa an gano cutar SARS-CoV-2 a wurare biyu na tsakiyar turbinate da kuma ƙwayar ƙwayar cuta na marasa lafiya da suka warke makonni 2 da suka gabata kuma suka bar asibiti, wanda ke nuna cewa sabon kwayar cutar za ta iya zama wani abu mai kama da kumburi.
A lokaci guda kuma, a yayin da adadin sabbin kamuwa da cutar ke raguwa, alamun alamun cutar sun bayyana a kasar Sin, kuma hakan na nuna cewa dabarun da ake amfani da su yanzu na iya yin tasiri.
Da farko an yi hasashen cewa cutar Ebola za ta iya kaiwa mutane miliyan ɗaya zuwa kamuwa da cutar kuma ta kashe mutane miliyan biyar.
Ko da yake, tare da keɓewa da kuma ɓoyewa, cutar ta ƙare a cikin iko.
Yana yiwuwa, kamar SARS-CoV, SARS-CoV-2 ya zama mai rauni a cikin kamuwa da cuta kuma a ƙarshe ya ɓace ko ya zama ƙarancin cutar da ke cikin mutum.
Ana kwatanta yawan kamuwa da cutar COVID-19 da SARS da MERS a ƙasa (Fig. 5).
SARS-CoV-2 ana iya watsa shi ta hanyar kwayar cuta, kuma yana iya zama ta hanyar kai tsaye zuwa abubuwa masu ƙazanta da cutar.
Ana samun wannan kwayar a cikin ƙura, wanda ke ba da damar samun damar watsa cutar daga ƙura zuwa baki.
Wani sabon bincike ya nuna cewa akwai mutane 138 da suka kamu da cutar, inda kashi 41 cikin 100 na waɗanda suka kamu da cutar suka kamu da cutar a asibiti, inda 17 daga cikinsu sun kamu da cutar a baya kuma 40 daga cikinsu ma'aikatan kiwon lafiya ne.
Saboda haka, ana bukatar a yi tsaro sosai don kare mutane, musamman ma ma'aikatan kiwon lafiya, masu bada tallafi, 'yan uwa, abokan aiki, har ma da masu sa ido a kan titi da suka yi hulɗa da marasa lafiya da kuma wadanda suka kamu.
Hanyar farko da za a iya amfani da ita don rage haɗarin kamuwa da cuta ita ce yin amfani da abin rufe fuska; yin amfani da masks na tiyata da kuma N95 respiratory masks (ƙungiyoyi na 1860) zai taimaka wajen hana yaduwar ƙwayoyin cuta.
Masks na fuska na tiyata yana hana a canja wurin saukad da daga mutum mai cutar ta hanyar iska ko kuma a haɗa su da fuskokin kwayoyin daga inda za a iya watsa su zuwa wasu.
Duk da haka, kawai N95 mask (suna lamba 1860) zai iya karewa daga numfashin ƙananan ƙwayoyin cuta daga 10 zuwa 80 nanometers, kuma kawai 5% na ƙwayoyin cuta za su iya yaduwa gaba ɗaya; SARS-CoV-2 ya yi kama da SARS-CoV a cikin girmansa kuma yana da kimanin 85 nanometers.
Saboda ƙwayoyin cuta na iya yaduwa ko da an saka masks biyar na tiyata a kai a kai, masu ba da kula da lafiya da ke da damar kai tsaye ga marasa lafiya dole ne su yi amfani da N95 (ƙungiyoyi na 1860) maimakon masks na tiyata.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya dole ne su sa kayan rufi masu kyau don rage yawan kamuwa da cutar.
Hakanan ƙwayoyin cuta na iya kamuwa da mutum ta hanyar ido.
A watan Janairun 2020, wani likita ya kamu da SARS-CoV-2 ta hanyar yin amfani da abin rufe fuska na N95; mai yiwuwa cutar ta shiga jikinsa ta hanyar kamuwa da cutar ido.
Saboda haka, ma'aikatan kiwon lafiya suna bukatar su yi amfani da takalmin fuska mai haske da kuma tabarau yayin da suke aiki tare da marasa lafiya.
A wuraren da mutane ke da cutar, an ba da shawarar kowa ya wanke kansa da sabulu fiye da dā, ya zauna a gida don yin keɓewa, kuma ya rage hulɗa da mutanen da za su iya kamuwa da cutar.
Ƙafa uku ne wuri mai kyau don nisantar da mutum daga mai ciwo.
Waɗannan ayyuka suna da tasiri sosai wajen rage haɗarin kamuwa da cutar da kuma hana yaduwar cutar.
Ko da yake SARS-2 ya zo a matsayin sabon cutar ga mutanen duniya, akwai kamanceceniya da SARS wanda aka gano a ranar 7/1/2020 ya kasance babban abin da ya haifar da canjin (China) dangane da zurfin ilimin da aka samu game da yaduwar SARS a 2003.
Ko da yake, har zuwa 19 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta Duniya ba ta ba da tabbaci ga masu bincike ba cewa cutar tana da iyakanceccen yaduwar mutum zuwa mutum, kuma babu matsala a hana cutar.
Wannan saƙon ya sa mutane suka ji tsoro kuma suka yi rawar jiki, musamman ma a lokacin da dukan ƙasar ke shirin bikin bazara, lokacin da aka rasa damar da za a iya sarrafawa da kuma hana cutar a cikin mafi ƙarancin yanayi a birnin Wuhan.
Hukumomin kula da marasa lafiya a kasar Sin na iya karɓar wannan darasi kuma su ci gaba da inganta su a nan gaba.
Alal misali, hukumomi da cibiyoyi za su (1) zama masu hankali wajen yin sanarwa ta jama'a, domin kowace kalma da za su yi wa al'umma za ta iya canja shawarwari da halayensu; (2) su kasance masu saurin fahimta da kuma amsawa ga sanarwa na rashin daidaito, fiye da yadda za su jira rahotanni na likita da na hukuma; (3) su kasance masu tsauri wajen hanawa da kuma sarrafa cutar a farkon lokaci fiye da yadda za su sa mutane su ji daɗi; da kuma (4) su yi aiki sosai da kuma yin aiki da horo don ƙara wayar da kan jama'a game da cututtuka da kuma tsarin amsawa da kuma ingantacciyar hanyar amsawa.
Cutar coronavirus-19 ta samo asali ne daga wani sabon cutar SARS-CoV-2 da aka fara a watan Disamba na 2019.
A cikin kasa da watanni biyu, an yi amfani da shi a duk faɗin China da kuma ƙasashe kusan 50 a duniya, a daidai lokacin da aka rubuta wannan.
Saboda cutar tana kama da SARS-CoV-2 kuma alamun sun yi kama da na SARS-CoV-2, yaduwar cutar ta haifar da yiwuwar SARS ya dawo.
Koyaya, akwai wasu bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda sune manyan bambance-bambance a cikin hanawa da iyakance cutar da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa, maza fiye da mata, kuma yana da yawan kamuwa da cuta da mutuwa a cikin tsofaffi fiye da matasa.
SARS ya fi mutuwa fiye da COVID-19 (10.91% vs. 1.44%).
Marasa lafiya na COVID-19 suna kamuwa da cutar ko da ba su da wata alama, yayin da marasa lafiya na SARS suna kamuwa da cutar yayin da suke amfani da ita, wanda ke haifar da matsala da kwanciyar hankali da yawa don hanawa da kuma iyakance yaduwar COVID-19 kamar yadda yake a SARS.
Wannan ya bayyana dalilin da ya sa SARS-CoV-2 ke yaduwa da sauri fiye da SARS-CoV-2 a duniya.
Gwajin RNA na yau da kullum na SARS-CoV-2 na iya zama mara kyau ga wasu marasa lafiya na COVID-19.
A gefe guda kuma, marasa lafiya da suka warke za su iya samun cutar.
Wadannan binciken sun kara hadarin yaduwar cutar a hanyar ban mamaki.
Tare da ci gaba mai sauri a bincike kan COVID-19, an warware wasu matsaloli masu yawa, kamar haka:
Daga ina cutar SARS-CoV ta fito?
Ko da yake kashi 96% na jinin da ake da shi tsakanin SARS-CoV-2 da SARS-CoV-2 kamar cutar sankara, ba za a iya cewa SARS-CoV-2 ya fito ne daga cutar sankara ba.
Wane dabba ne ya kasance mai matsakaici wajen watsa kwayar cutar daga kwayar halitta, wato, kwayar cutar kamshashin daji zuwa mutum?
Ba tare da amsa tambayoyin #1 da 2 ba, ba za mu iya dakatar da tasirin watsawar ba, kuma za a iya samun yaduwar cutar a duk lokacin da ta taso.
Ko da yake bincike na kwayoyin halitta da kuma gwajin sinadarai sun nuna cewa SARS-CoV-2 yana haɗuwa da (ACE2), ta yaya cutar ta shiga cikin kwayoyin iska kuma ta haifar da canji da ke tattare da cutar?
Shin kwayar cutar tana haɗuwa da ƙwayoyin halitta masu alaƙa da ACE2 a wasu gabobin jiki?
Idan ba a ba da amsoshin waɗannan tambayoyin ba, ba za mu iya gano cutar da sauri ba kuma mu sami magani mai kyau.
Har yaushe cutar za ta kasance?
Ta yaya kwayar cutar ta samo asali daga kwayoyin halitta yayin da ake watsawa tsakanin mutane?
Shin zai zama annoba ta duniya, kamar SARS mai hallaka ko kuma za a kira ta mura?
Yana da muhimmanci kuma yana da muhimmanci, kuma yana iya ɗaukar lokaci don bincika waɗannan tambayoyin da ke sama da kuma wasu tambayoyi.
Ko da yake, duk abin da martani da amsa suka bukaci, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu koma ga rayuwa ta yau da kullum.
Hanyar da ke da alaƙa da dabbobi a cikin kwayar cutar coronavirus
Canjin da aka yi ya yi wa kwayar cutar korona da kuma kwayoyinta, har da mutane, iko na dubban shekaru.
Kafin 2003, an san cewa akwai kwayoyin cutar coronavirus guda biyu da ke haifar da cututtuka masu sauƙi, kamar ciwon kai da kuma rashin lafiya na yau da kullum.
Yaduwar cututtukan cututtukan numfashi, wanda aka sani da SARS da kuma cututtukan cututtukan numfashi na Gabas ta Tsakiya, wanda aka sani da MERS, ya nuna cewa kamuwa da wani nau'in HCoV na iya zama mai haɗari da kuma haɗari ga rayuwa.
Haɗuwa da SARS-CoV-2 a tsakiyar kasar Sin a ƙarshen 2019 ya sake nuna cutar coronavirus kuma ya haifar da kyakkyawan sakamako na watsawa, amma ya rage yawan kamuwa da cutar idan aka kwatanta da SARS-CoV-2 na yau da kullum.
HCoV yana gudana daga dabba zuwa mutum, kuma fahimtar tushen da ke da alaƙa da dabba na HCoVs na iya zama da amfani.
Yawancin nau'ikan HCoVs sun fito ne daga aljanu, yayin da ba su da cutar.
An san ƙwayoyin halitta na HCoV na matsakaici.
Gano dabbobi masu cutarwa yana taimakawa wajen hana cututtukan mutum.
Binciken da aka yi game da cutar korona a cikin dabbobi na iya kawo muhimman bayanai game da cutar korona a cikin mutane.
A cikin wannan bincike, za mu ba da cikakken bayani game da nau'ikan 7 na coronavirus, tare da nazarin tarihin gano su da kuma tushen da ke tattare da dabbobi da kuma rarraba su tsakanin jinsuna.
Abu mafi muhimmanci shi ne, muna iya sanin nau'ikan kwayar cutar ta coronavirus kuma mu gane bambance-bambance a cikin yanayin ci gabanta da kuma tsarin kwayoyinta.
A wannan lokacin ne aka gano cutar coronavirus (COVID-19) a halin yanzu.
Duk da haka, bukatun kwayoyin halitta na iya canzawa kuma yana taimakawa wajen ci gaban cutar a cikin yanayin rashin lafiyar da aka gano.
Nau'in kwayar cutar corona, (CoVs), na cikin iyalin coronaviridae, wanda ya ƙunshi nau'in kwayar cutar RNA mai ƙwayoyin cuta guda ɗaya da kuma mai ƙwayoyin cuta masu ƙwayoyin cuta.
Wadannan kwayoyin sun shiga cikin manyan kwayoyin 26 zuwa 32 kilobes na RNA da ake kira "CoVs", saboda suna da siffar kambi a cikin cikakken bayani.
A asali, nau'ikan kwayar cutar korona suna da kwayoyin da ba a sarrafa su ba kuma suna da irin wannan hanawa.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna da manyan manyan manyan fayiloli biyu (ORF1a da ORF1b), wanda aka fassara zuwa: pp1a da pp1ab.
Abubuwan da ke cikin furotin na musamman sun fi amfani da furotin na 16 wanda ba a tsara shi ba, wanda aka ƙayyade a matsayin nsp1~16.
Ragowar kwayoyin halitta na da ORFs don gina jiki, wanda ya ƙunshi S-shaped, E-shaped, M-shaped, da N-nuclear.
Wasu sunadarai na asali sun canza su ta hanyar asali na nau'ikan CoVs.
Bisa ga wannan tsari na furotin, kwayar cutar ta corona ta rarraba zuwa nau'i hudu, alpha-coronavirus, beta-coronavirus, gamma-coronavirus, da delta-coronavirus, ciki har da beta-coronavirus wanda shine mafi yawan adadin kwayar cutar corona kuma an rarraba shi zuwa nau'i hudu (C, B, A, da D).
Shaidar da aka samu a cikin halittu sun nuna cewa tsuntsaye da kuma tsuntsaye suna yin aiki iri ɗaya na asalin kwayoyin halitta na yawancin alpha-virus da beta-virus, yayin da tsuntsaye sune tushen tushen gamma-virus da delta-virus.
A cikin dubban shekaru, nau'ikan coronavirus sun ci gaba da wucewa ta hanyar shinge tsakanin nau'ikan su kuma sun zama cututtukan mutum.
A halin yanzu, an gano nau'ikan HCoV guda bakwai na mutum.
Wannan ya hada da HCoV-229E da HCoV2NL63 alpha-coronavirus.
Sauran 5 na beta-viruses sun hada da: HCoV-OC43, HCoV-HKU1, SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-2 da kuma SARS-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun cututtuka masu matsakaici, kamar ciwon kai da kumburi na yau da kullun da/ko kumburi.
A akasin haka, SARS-CoV, MERS-CoV, da SARS-CoV-2 da aka gano su ne masu cutar da yawa, suna haifar da matsalolin numfashi a cikin yawancin marasa lafiya kuma suna iya haifar da alamun cutar numfashi mai tsanani (ARDS) da kuma bayyanar cutar kumburi.
An gano farkon kamuwa da cutar HCoV-229E, B814, daga cikin waɗanda ke da matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin
Tun daga wannan lokacin, an samu ƙarin bayani ta hanyar bincike mai zurfi game da HCoV-229E da HCoV-OC43, duka biyu suna haifar da bayyanar cututtuka na ɗan gajeren lokaci.
Hakika, an yarda da shi sosai cewa kamuwa da nau'in kwayar cutar coronavirus yana da sauƙi har zuwa yaduwar SARS.
Cutar SARS ta 2003 ta kasance daya daga cikin cututtukan da suka fi muni a tarihi, ta yi sanadiyar kamuwa da mutane fiye da 8,000, kuma yawan mutuwar ya kai kusan 10%.
Shekaru 10 bayan haka, "alamu na cutar numfashi a Gabas ta Tsakiya ta haifar da babban annoba a yankin Larabawa tare da yaduwar cutar a duniya.
Kwayar cutar coronavirus 2019, (2019-nCoV), wanda aka sake suna SARS-CoV-2, shine tushen ci gaba da cutar COVID-19, wanda ya kashe mutane 3,120 kuma ya kamu da fiye da 91,000 har zuwa 3 ga Maris, 2020.
Ya yi kararrawa kuma dole ne duniya ta shirya don cutar SARS-CoV-2 mai zuwa.
Dukkanin nau'ikan HCoVs guda bakwai suna da tushe na dabba a cikin bats, beraye ko dabbobi.
Akwai shaidu da dama da suka goyi bayan ci gaban asalin dukkanin nau'ikan cutar sankara ta HCoVs, wanda ƙwayoyin cuta ba su da kyau kuma ba su da lafiya, amma suna da bambancin halittar jini.
Cutar COVID-19 ta 2019 ta kawo manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga kasar Sin da kuma duniya.
Bayanin da ke tattare da dabbobi na HCoVs na samar da wani tsari na fahimtar tarihin halitta, ikon gudanarwa, da kuma abubuwan da ke sa jinsunan su tashi da kuma canzawa.
Wannan zai iya zama jagora da kuma ingantaccen tsari ga dabbobi masu dauke da kwayoyin halitta, masu matsakaici da masu karfafawa na SARS-CoV-2 tare da taimako mai mahimmanci don hana yaduwar cutar a nan gaba.
A cikin wannan bincike, za mu ba da cikakken bayani game da yanayin da ke tattare da dabbobi, canjin tsakanin jinsuna, da kuma yanayin da ke tattare da cutar korona ta H.
Musamman, za mu gano kuma mu tattauna game da wani nau'i na kwayar cutar coronavirus, wadda ba ta da cutar a cikin ƙwayoyinta, amma bayan an canja shi zuwa sabon ƙwayoyin, ta zama mai cutar.
Ba ma magana game da ci gaban cutar coronavirus, wanda yawan kamuwa da ita yana da alaƙa da raguwar kamuwa da ita.
An kuma bayyana sakamakon ci gaba da yaduwar SARS-CoV-2 a cikin rahoton.
An san nau'ikan CoVs na dabba tun daga ƙarshen shekarun 1930.
Kafin a ware masu kamuwa da cutar B814 HCoV-229E daga waɗanda suka kamu da cutar a cikin numfashi, an ware nau'ikan COVID-19 daga cikin mutane da yawa, ciki har da tsuntsaye, beraye, shanu, alade, cats da karnuka.
A cikin 'yan shekarun da suka gabata, an gano nau'ikan cutar coronavirus guda bakwai.
Takaitaccen tarihin gano cutar korona a cikin jerin sunayen duniya, (Table 1) zai ba da bayani da kuma jagora.
An fara gano mutum na farko da ya kamu da cutar HCoV-229E a shekara ta 1966 daga waɗanda ke fama da cutar ta numfashi, kuma daga bisani ya ci gaba da girma a cikin ƙwayoyin huhu na WI-38.
Masu kamuwa da cutar HCoV-229E sun nuna alamun bayyanar cututtuka na yau da kullum, wato ciwon kai, ciwon hanci, gajiya da kumburi, tare da tsufa da aka gani a cikin 10 zuwa 20% na masu kamuwa da cutar.
Daga baya a 1967, an cire HCov-OC43 daga tushe da kuma hanyar wucewa a cikin kwakwalwar dabbobin da ke shan madara.
Alamomin da bayyanar cututtuka na HCov-OC43 sun kasance daidai da na HCoV-229E, wanda ya warke daga alamomin waɗanda ke fama da cututtukan numfashi masu tsanani, kamar su mura A da rhinovirus.
HCoV-229E da HCoV-OC43 suna rarraba a duniya, suna kaiwa a cikin hunturu a cikin sanyi.
Yawanci, rayuwar waɗannan ƙwayoyin cuta ba ta wuce mako guda ba, wanda ke biyo bayan kusan makonni biyu na rashin lafiya.
Wani bincike na masu ba da gudummawa ya nuna cewa mutane masu lafiya sun kamu da cutar HCoV-229E mai ci gaba da sanyi.
Wasu marasa lafiya da ke da rashin ƙarfi ne kawai ke fama da cutar ta narkewa.
SARS wanda aka fi sani da cutar sankarar kwayoyin halitta, an fara rubuta shi sosai cewa HCoV shine tushen cutar a cikin rayuwar ɗan adam kuma SARS-CoV shine mai haifar da kamuwa da cuta, HCoV na uku da aka gano.
An fara samun SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta haifar da kamuwa da cutar ta 8096 wanda ya haifar da mutuwar 774 a cikin ƙasashe da nahiyoyi.
Duk da cewa cutar tana yaduwa cikin sauri, ana sa ran cewa kowace cuta za ta karu zuwa biyu na biyu, kuma za a yi rayuwarta na kwanaki 4 zuwa 7 kuma za ta sami mafi yawan kamuwa da cutar a rana ta 10 na kamuwa da cutar.
Masu cutar SARS-CoV suna da ciwon kai da ciwon kai da kuma ciwon kai da ke nuna rashin fahimta da kuma rashin fahimta, sannan kuma rashin fahimta da kokain da kuma rashin tausayi suna biyo baya a matsayin alamun ƙarshe.
Lymphonia, wanda ke haifar da rashin nasarar gwajin hanta da kuma karuwar nitrogen a cikin uria, yana haifar da rashin lafiyar SARS.
Ana samun ciwon huhu da kuma bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Kimanin kashi 20 zuwa 30% na marasa lafiya za su bukaci kulawa mai tsanani da kuma taimakon hannu.
Duk da tsarin da ke ƙasa, gabobin jiki da yawa, ciki har da tsarin narkewa, hanta da koda suna fuskantar matsaloli masu tsanani da ke tattare da ƙwayoyin cytokine wanda zai iya zama sanadin mutuwa ga marasa lafiya masu rashin ƙarfi.
An fara gano cutar ne daga binciken da aka yi na farfado da huhu na wani dangi mai cutar da ya zo Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai wajen gudanar da bincike kan cutar HCoV.
An gano HCoV-NL63 daga jariri mai watanni bakwai a Netherlands a ƙarshen 2004.
Da farko an gano cewa yana da yawa a cikin yara da manya da kuma marasa lafiya da ke da rashin ƙarfi da kuma cututtukan cututtuka.
Rashin ƙwayar cuta da kuma ciwon ido mai ruwan kasa da kuma ciwon hanci da kuma ciwon daji na cutar HCoV-NL63 ne ke haifar da cutar.
Wani bincike na daban ya nuna cewa an samo wannan kwayar cutar ne daga wani jariri mai watanni 8 da haihuwa a Netherlands da ke fama da cutar kumburi.
Ko da yake an gano shi a Netherlands, amma a gaskiya ya bazu a duniya.
HCoV-NL63 ana hasashen zai kai kusan kashi 4.7% na kamuwa da cutar a cikin mutane, wanda ya kai ga ƙaruwar cutar a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar kurma, wanda aka fi sani da kumburi.
A wannan shekarar, an gano HCoV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi asibiti a Hong Kong saboda kumburi da kumburi.
Duk da haka, an gano cutar huhu da kuma cutar kumburi da aka samu daga al'umma da HCoV-HKU1 da ke da alaƙa da kamuwa da cutar ta raƙuman ruwa.
An gano HCoV-NL63, HCoV-229E, HCoV-OC43, da HCoV-HKU1 a duniya kuma suna haifar da cututtukan cututtukan huhu.
Dukkanin nau'ikan HCoVs hudu da aka samu daga al'umma sun kasance masu kyau ga mutane kuma suna da ƙananan yiwuwar canzawa kuma su zama manyan masu haifar da cututtuka, ko da yake abubuwan da suka faru sun faru ne saboda dalilai marasa kyau kamar yadda aka gano a cikin wasu lokuta na cutar HCoV-NL63 da aka gano kwanan nan da ke haifar da cutar huhu mai tsanani a China.
A gaba ɗaya, yayin da waɗannan HCoVs suka sami damar shiga cikin jikin mutum kuma su sami nasarar warkewa a cikin jikin mutum, suna da ƙarancin kisa ko kuma suna haifar da cututtuka.
An fara gano cutar MERs-CoV a Saudiyya a shekarar 2012 a cikin huhu na wani mutum mai shekaru 60 da haihuwa wanda ya kamu da cutar kumburi mai tsanani da kuma fama da cutar koda.
Yayin da yawancin lokuta da aka tabbatar da gwaji a cikin dakin gwaje-gwaje a Gabas ta Tsakiya, yanayin yanayi da ke faruwa yana haifar da kusanci da yawa a cikin ƙasashen Turai da Tunisia.
A shekarar 2015, an sake samun wani kamuwa da cutar a Koriya ta Kudu inda aka samu mutum 186 da suka kamu da cutar.
Ana iya bambanta bayyanar cututtukan MERS da SARS ta hanyar ci gaban ciwon huhu.
Ba kamar SARS ba, yawancin marasa lafiya na MERS suna fama da ciwon hanta na hanta, wanda ke ware MERS daga abubuwan da ke haifar da cutar HCoV.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun tsarin jijiyoyin jiki, ciki har da kumburi da kuma kumburi.
A ranar 14 ga Fabrairu, 2020, an samu fiye da 2,500 na lokuta da aka tabbatar da gwaji tare da yawan mutuwar 34% na MERS-CoV, wanda shine ɗayan cututtukan da suka fi cutar da ɗan adam ya sani.
A cikin rabin watan Disamba na 2019, an gano cewa akwai wasu cututtukan huhu da suka shafi kamuwa da cutar SARS-CoV-2 da aka yi wa gwaji a Wuhan, lardin Hubei, China.
Hukumar lafiya ta duniya ta ce cutar kumburi mai saurin tashi da SARS-CoV-2 ta haifar da wata babbar matsalar kiwon lafiya a duniya da ake kira COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 9,053 a duniya, wanda ya kai mutuwar 3.4.
Shaidu sun ce yawan mutuwar a birnin Hubei, China, ya kai kashi 4.2 cikin dari, yayin da a kasashen waje ya kai kashi 1.2 cikin dari.
SARS-CoV-2 kamar SARS-CoV da MERS-CoV suna haifar da kamuwa da cututtukan huhu ta hanyar shan cocaine da kuma numfashi.
Wasu marasa lafiya suna fama da cutar haihuwa.
Ciwon huhu yana ɗaya daga cikin alamun cututtuka masu tsanani kuma yana iya girma da sauri kuma ya zama daidai da numfashi.
Ko da yake SARS-CoV-2 da SARS-CoV-2 suna da kusanci sosai saboda tsayin daka na 82% na jerin kwayoyin halitta, suna haɗuwa a cikin kwayoyin halitta daban-daban.
Ana ganin cewa SARS-CoV-2 ba shi da sanadin rashin lafiya amma yana da yawa fiye da SARS-CoV-2 da kuma COVID-19.
Rahotanni sun nuna cewa SARS-CoV-2 ba shi da alamomi kuma yana iya taimakawa wajen yaduwar cutar a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran cututtuka shida, za a iya ganin kamanceceniya da bambance-bambance da ke da muhimmanci.
Na farko, rayuwar HCoV da kuma tsawon rayuwarsa suna da nasaba sosai.
A wannan yanayin, SARS-CoV-2 yana cikin jerin sunayen HCoVs shida.
Na biyu, alamun cutar COVID-19 suna tsakanin SARS-CoV da HCoVs hudu da aka karɓa daga al'umma (misali HCoV-229E da HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, masu kamuwa da cutar SARS-CoV-2 suna nuna alamun da ake samu a cikin HCoVs, ciki har da rashin bayyanar cututtuka, ko da bayyanar cututtuka.
A gefe guda kuma, ana iya ganin karamin rukuni na mutanen da ke fama da COVID-19 a cikin waɗanda ke fama da cutar SARS-CoV-2, ko da yake adadin ya yi ƙasa da haka.
Na uku, SARS-CoV-2 ya nuna alamun da ke tattare da HCoVs da kuma SARS-CoV da aka samu daga al'umma.
A gefe guda, karuwar SARS-CoV-2 ya yi yawa kamar yadda ake karɓar HCoVs a cikin al'umma.
A gefe guda kuma, an yi tambaya ko SARS-CoV-2 zai rage yawan kamuwa da cutar bayan an kai ta mutum kamar yadda aka yi a SARS-CoV da Mars-CoV.
A ƙarshe, ana iya gano abu iri ɗaya kamar HCoVs da SARS-CoV-2 a cikin samfurin ƙazanta.
Ko an samu karuwar cutar ta SARS-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV
Har ila yau, akwai tabbaci cewa SARS-2 zai iya tasowa a cikin yanayi kamar yadda HCoVs ke tasowa a cikin al'umma.
Maganar cutar SARS-CoV-2 da ke iya kamuwa da cutar da kuma ci gaba da yaduwa bayan kamuwa da ita a cikin mutum zai shafi maganin cutar COVID-19 a yanzu.
HCoVs guda huɗu da aka samu a cikin al'umma suna haifar da bayyanar cututtuka na matsakaici wanda mutum ya saba da shi sosai.
A wani ɓangaren kuma, yana iya zama gaskiya cewa mutane sun yi aiki sosai tare da waɗannan nau'ikan HCoVs guda huɗu.
A wata ma'anar, za a iya cewa sun tsira daga cutar HCoV.
HCoVs da ke haifar da cutar a cikin mutane sun ɓace kuma mutane da suka kamu da cutar sun ɓace.
Don haka, dole ne HCoVs su ƙaru a cikin mutane kuma su kai matakin da zai ba da damar ci gaba da daidaitawa da ƙwarewa wanda ke ba da damar ƙin ƙwayoyin cuta.
Ƙarin yaduwar SARS-CoV-2 yana saurin kamuwa da cutar ta hanyar saurin kamuwa da cutar ta hanyar saurin kamuwa da cutar ta hanyar saurin kamuwa da cutar ta hanyar saurin daidaitawa da mutane.
Idan an daidaita shi da kyau, za a iya hana shi kaiwa mutane da wuya ta hanyar rigakafi ko wasu hanyoyin hana kamuwa da cuta.
A cikin shekaru da yawa, an yi amfani da nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'an na nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'u na nau'ikan nau'u na nau'ikan nau'u na nau'ikan nau'u na nau'u na nau'u na nau'u.
Wadannan ƙwayoyin ba sa bukatar wani ajiyar sigina.
Akasin haka, saboda rashin lafiyar SARS-CoV da MERS-CoV, ba a daidaita su da mutum ba kuma ba a ci gaba da watsa su zuwa mutum ba.
Suna bukatar su ci gaba da rayuwa kuma su koma gida don neman yaduwar da ake nufi da mutane, wanda zai iya kasancewa ta hanyar matsakaici ko fiye da haka, da kuma karuwar kwayoyin halitta.
Halayen SARS-CoV-2 sun yi kama da SARS-CoV da MERS-CoV da kuma nau'ikan HCoV guda huɗu da aka samo daga al'umma.
Yawan kamuwa da cutar yana kama da HCoV da ke kamuwa da cutar a cikin al'umma a halin yanzu.
Koyaya, HCoVs da aka karɓa ta hanyar al'umma sun fi haifar da rashin lafiya.
Ya rage a lura ko zai iya daidaita kansa da mutum kuma ya bazu cikin jikin mutum ba tare da ajiya ko ƙwayoyin halitta ba.
Kafin mu tattauna asalin HCoV, bari mu tattauna game da dabi'un da ke faruwa da kuma halaye na HCoV, da kuma yanayin da ake samu da kuma yadda ake girma.
Wani halittun zai iya haifar da ci gaban kwayoyin HCoV idan ya shiga cikin wani abu na gaba da ke kusa da shi, kuma zai iya musayar homologs a matakin sarkar nucleotide.
Tsohon kwayar cutar yana daidaitawa da kyau kuma ba a mayar da su zuwa kwayar ba.
Bugu da ƙari, ƙwayoyin cuta suna yin amfani da HCoV a kai a kai kuma na dogon lokaci.
A lokuta biyu, kwayoyin halitta suna da halayyar kamuwa da cutar, kuma suna da halayyar halitta don HCoV ko kuma don haihuwar cutar.
A akasin haka, idan HCoV ya bayyana kansa a matsayin mai ƙarancin ƙwayoyin cuta kafin ko kusa da lokacin da ya bayyana kansa ga mutum, to, ba zai dace da sabon ƙwayoyin cuta ba kuma zai iya haifar da cutar.
Wadannan kwayoyin salts na iya zama tushen rayuwa mai amfani wajen kamuwa da cutar a cikin mutane kuma suna taimakawa wajen karuwar kwayoyin salts ta hanyar hana cutar ta karuwa a cikin lokaci sannan kuma ta wuce zuwa mutane don karuwar cutar.
HCoV na iya shiga cikin hanyar da aka rufe ta hanyar kamuwa da cutar idan ba za a iya samun damar watsa shi a cikin kwayoyin halitta ba.
HCoV, a akasin haka, zai iya daidaita kansa da kwayoyin halitta masu ƙanƙara kuma zai iya samun wuri na dogon lokaci.
A wannan yanayin, ƙwayoyin gishiri na tsakiya sun zama ƙwayoyin gishiri na halitta.
Bayanai na Downstream zuwa Downstream suna nuna wani abu game da SARS da ke da alaƙa da tarihin rayuwa.
Nazarin yawan mutane ya nuna cewa masu amfani da maganin rigakafi da kuma cutar LGG sun fi yawa fiye da yadda suke a cikin al'umma.
Masks na katunan daji (Pugma larvae) da kuma karnuka masu gudu da ke zaune a cikin kasuwanni masu tasowa sun fara bayyana cewa su ne ke watsa SARS-CoV-2 kamar yadda suke da ƙwayar cuta da ke tattare da SARS-CoV-2 a cikin gida.
Wannan ya ba da tabbacin cewa babu wani labari na SARS a kasuwa bayan an kawar da dukan Pygmy larvae.
Ko da yake an gano cewa Pugma larvae ne na daji ko kuma na gonaki da ba su da wata dangantaka da rikice-rikice na kasuwa, wannan ya ba da shawarar cewa Pugma larvae suna da iyaka ga girma na jinsin amma ba a cikin sars Cove ba.
Wannan ya nuna cewa kashi 80% na kwayoyin halitta daban-daban sun samu maganin SARS-CoV a cikin kasuwar Guangzhou, kuma idan akwai nau'ikan kwayoyin halitta masu yawa na ƙananan dabbobi masu shayarwa, suna aiki a matsayin matsakaici don hana karuwar kwayoyin SARS-CoV.
Dukkanin su suna ganin cewa su ne ƙarshen SARS-CoV.
Abin da ya bambanta da wannan binciken shi ne cewa an rufe yanayin kwayoyin halitta na SARS-CoV da ke da alaƙa da cutar sankarar COV, kalmar SARS ta fito ne daga cutar sankarar HKU3 (SARSr-RH-BatCoV HKU3) da ke cikin cutar sankarar Hiroshu a China.
Wannan kwayar cutar tana da kyau ga maganin SARS-CoV-3 da kuma SARSr-RH-BatCoV HKU3 gene.
Wannan da sauran ƙwayoyin cuta na Cove suna da kashi 88-92% na jerin daidaito na nucleotide tare da SARS-CoV.
Wannan binciken ya gabatar da wani sabon ra'ayi na cewa kwayoyin cuta na aljanu suna haifar da cututtukan mutum.
An gano wasu nau'ikan SARS kamar CoVs (SL-CoVs) a cikin bats, amma guda ɗaya da aka sani da WIV1 ne kawai za a iya rarraba shi a matsayin kwayar cutar mai rai.
Anjin angiotensin mai canza enzyme 2 (ACE2) wanda aka sani da mai karɓar SARS coronavirus.
WIV1 an cire shi daga samfurin ƙwayoyin cuta na bat wanda ya nuna cewa ACE2 na bat da kuma cat Pygmy yana amfani da larvae da mutane a matsayin mai karɓa don shigar da kwayar halitta.
Mafi muhimmanci a gare su shi ne, maganin warkar da cutar SARS zai iya hana aikin WIV1.
A wannan yanayin, WIV1 ya nuna kusancin dangantaka da SARS a cikin aljanu, yana nuna kashi 95% na nucleotides a cikin jerin simulation.
Amma saboda yawan daidaito tsakanin waɗannan ƙwayoyin, yawancin mutane sun yarda cewa WIV1 ba shine ainihin mahaifa na SARS-CoV ba kuma ƙwayoyin cuta ba su da ainihin ajiyar kwayoyin cutar SARS-CoV.
An gano kwayoyin halitta na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
CoV-HKU4 na cutar kumburi da MERS-CoV suna amfana daga karɓar kwayar cutar guda, cutar kwayar cutar (DPP4) don shigar da kwayar.
RNA mai ƙarancin ƙwayoyin cuta RNA mai ƙarancin ƙwayoyin cuta a cikin Mars-Cov da ke kusa da tarihin rayuwa fiye da na coronavirus na Black Sabbath wanda aka samo a Turai da Afirka.
A yanzu haka, babu wani Mars-Cove da za a iya ganowa a cikin duniyar Asabar.
Mars-Cov da kuma makamantansu suna da alaƙa da Cov-HKU25 kuma suna da kusan kashi 87 cikin ɗari na jerin abubuwan da ke cikin su.
Ko da yake, ba za a iya barin makãho na ranar Asabar ba don samun wani ɗakin Mars-Covet mai sauri.
A gefe guda kuma, nazarin da aka yi a Gabas ta Tsakiya ya nuna cewa dabbobi masu ƙarancin ƙwayar cuta suna da ƙwayoyin cuta na musamman na Mars-Cov, kamar yadda suke da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun
An gano ainihin kwayar cutar Mass-Covid kuma an bambanta ta daga kwayar cutar guda ɗaya da za a iya ɗauka ta hanyar numfashi, har ma da nuna cewa waɗannan kwayar cutar suna aiki ne a matsayin sashin salula na SARS-Covid.
An kuma lura cewa a yawancin lokaci bayyanar cututtuka ba su da matsakaici amma an lura da yaduwar cutar a cikin yanayin da ke tattare da kamuwa da cutar Mars-Cov.
An lura cewa, ƙwayoyin cuta masu kamuwa da cutar suna fitar da cutar ba kawai ta hanyar numfashi ba amma ta hanyar ƙwayoyin cuta, wanda shine hanyar da cutar ke yadawa ga ƙwayoyin cuta.
Ko da yake, akwai wasu cats da suka tsira tun lokacin da aka samu yawancin lokuta na Mars kuma ba su da wata hulɗa da dabbobi da suka riga sun nuna alamun cutar, tushen ya kasance mutum-zuwa-mutum ko kuma hanyar da za a iya ɗaukar ƙananan dabbobi marasa ƙima da Mars-Covey.
SARS-CoV-2 yana da kashi 96.2 cikin dari na nucleides da aka haɗa tare da COV-RaTG13 mai karɓa daga Rhinolavus mai karɓa.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, daidaita bambancin tsakanin SARS-CoV-2 da RaTG13 yana da kyau ga dangantaka ta iyali.
Kamar yadda ya ce, ba za a iya samun makamai masu makanta ba a SARS-CoV-2 har sai an gano wasu makamai masu makamai masu makamai a nan gaba.
A cikin matakan da suka gabata, ana ganin cewa za a sayar da kwayoyin halitta na SARS-CoV-2 tsakanin masu cin ganyayyaki na dutse ko a kashe su a cikin kantin sayar da abincin teku na Wuhan, tare da farkon yanayin da COVID-19 ya goyi bayan, wanda ke haifar da cikakken yanayin watsawa daga dabba zuwa mutum.
Wasu daga cikin binciken da suka yi game da tsarin tsarin halittu (wanda ya shafi kwayoyin halitta) sun nuna cewa akwai rukuni na madarar da ke cikin ƙananan kwayoyin halitta, wanda aka sani da pangolin (Mins Javanika), kuma yana iya zama daga cikin juwellar da ke da alaƙa da SARS-CoV-2.
Kwayoyin Cove na samar da sababbin kwayoyin cuta 85-92% na daidaitattun nucleotides tare da SARS-CoV-2.
Ko da yake suna da alaƙa da RATG13 a cikin kashi 90 cikin dari na sanannun matakan nucleotide.
Sun sanya shekaru biyu na shekaru biyu don tarin SARS-CoV-2 a matsayin kwayar cutar a cikin itacen halittar, wanda ya fi yawa ya ba da babban mai karɓa (RBD) tare da SARS-CoV-2, tare da kashi 97 cikin ɗari na amino acid mai ƙarancin ƙarfi.
A akasin haka, RBD na SARS-CoV-2 da RaTG13 sun bambanta sosai, ko da yake akwai mafi girma a cikin daidaitattun kwayoyin halitta.
Binciken da aka yi a baya kan cutar pangolin ya kuma nuna cewa kamuwa da kwayar cutar ta DNA daga samfurori na huhu, wanda ya bayyana a matsayin na SARS-CoV-2.
Wannan binciken ya ƙunshi hanyoyi daban-daban da kuma mutum ya lura da gina jiki na mutum wanda ya kama kashi 86.3 cikin dari na dukan ƙwayar cuta na kwayar cuta.
Ba za mu iya yin watsi da cewa pangolin yana da kyau a cikin kwayoyin cutar SARS-CoV-2.
Duk da haka, babu wata hujja da ta kasance don gano asalin asalin cutar SARS-CoV-2 ta penguin duk da cewa akwai SARS-CoV-2 da penguin SARS-CoV-2 masu kama da Covas.
Duk da haka, nisa tsakanin SARS-CoV-2 da RaTG13 ya fi ƙasa da tsakanin SARS-CoV-2 da penguin SARS-CoV-2 na COVs.
Ana iya samun ci gaban SARS-CoV-2 a cikin aljanu, penguins da sauran nau'ikan masu shayarwa ta hanyar rarraba.
Tare da mafi girman daidaituwa na jerin da aka samu a RBDs tsakanin SARS-CoV-2 da penguins, SARS-CoV-2 yana da alaƙa da beta-CoV, SARS-CoV-2 da RaTG13 suna samar da mafi girman ƙwayar jini-zilla na jerin daidaituwa.
An yi imani da cewa an yi la'akari da cewa babban daidaituwa tsakanin RBDs na penguin SARS-CoV-2 da ke da alaƙa da beta SARS-CoV-2 da SARS-CoV-2 an ƙaddara su ne don daidaitaccen zaɓi-ci gaba.
A-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-a-
A matsayin wata ci gaba mai karfi, haɗin kai yana da yawa a tsakanin beta-Coves.
Hukumar tantancewa ta kasance a waje da yankin Zenotic na SARS-CoV-2.
A gefe guda, an kuma gwada manyan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Tarihin juyin halitta ya nuna cewa HCoV-NL63 da HCOv-229E sun samo asali ne daga cutar coronavirus, lokacin da aka gano HCoV-OC43 da HCoV-HKU1 a cikin dabbobi masu cutar.
An gano cewa an gano cutar coronavirus mai suna ARCoV.2 (Coronoblastoma) a Arewacin Amirka a cikin wani nau'in cutar coronavirus wanda ke da alaƙa da HCoV-NL63.
A gefe guda, HCo-229E ya kasance na ɗan lokaci yana da alaƙa da wani ƙwayoyin cuta na Cove, mai suna Hyposydorus/Humans/19/2008.
A bayyane yake, sabon bayani game da asalin cutar da ake kira HCoV an taƙaita shi a cikin tsari na farko da na biyu.
Binciken tarihin ci gaba ya nuna yawan watsawar HCoVs a cikin tarihi.
Lokacin da HCo-OC43 ya wuce daga kwayoyin halitta zuwa mutane don kamuwa da cutar ta hanyar gida a cikin 1890s, an lura da cutar ta numfashi mai tsanani.
Tarihin watsa HCoV-229E a cikin iska bai bayyana ba
Alpha-Covus bats suna da dangantaka mai kyau da HCO-229E da aka gano.
Daga cikinsu akwai alpinus Cove-Alpa.
Wasu dalilan da ke nuna cewa cutar tana iya kaiwa mutum kai tsaye daga kwayar cutar zuwa kwayar cutar.
Na farko, mutane ba alpacas ba (dabba kamar tumaki amma dabbobin da suka fi girma) suna iya yin hulɗa da gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, HCoV-229E yana da alaƙa da cutar sankarar ƙwayoyin cuta ta cutar kumfa daban-daban kuma ba zai iya zama cuta a cikin kumfa ba, yayin da ƙwayar alpha-coronavirus ke haifar da yaduwar cutar numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, alpha-coronavirus na alphabets ba a samu a cikin dabbobi masu rai ba.
Saboda haka, ba za a iya yin watsi da yiwuwar cewa alpins HCoV-299E da ke da alaƙa da alpha-coronavirus sun kamu da cutar daga mutane ba.
A gaskiya ma, sunadarai sune tushen kai tsaye na cututtukan cututtukan mutum kamar raspberry, Ebola, na'ura mai cutar kwayar cuta, da kuma ƙwayoyin cuta.
Saboda haka, ba abin mamaki ba ne cewa a ranar Asabar mai makaho, ana iya watsa cutar korona -229E kai tsaye zuwa ga mutane.
A gefe guda kuma yayin da alpha-coronavirus na cutar sankara ke aiki a matsayin wani rukuni na kwayoyin halitta na cutar sankara H-299E, alpins da algae na iya aiki a matsayin tsakiya na salula na salula wanda ke watsa ƙwayoyin cuta zuwa mutane. Kamar yadda yake a cikin yanayin MERS-COV.
MERS-KOV ya zama mafi kyawun samfurin don watsawa daga nau'in halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar hali
An gano asalin cutar MERS-COV daga ƙwayoyin cuta a farkon ganowa da kuma karfafawa ta hanyar binciken da aka samu.
A bayyane yake cewa Black Saturday yana da wadataccen kwayar cutar da ke haifar da sauyawar kwayoyin halitta daga kashi zuwa kashi da kuma watsa su tsakanin jinsuna.
Tsufa, da kuma yawan ƙwayar cuta, da kuma haɗuwa da kusancin ƙarfin tashi na iya haifar da waɗannan yanayin don yin ƙwayoyin cuta su zama "motsawar cutar".
A yau, an san MERS-COV a matsayin cutar kwayar cuta guda ɗaya na shekaru da yawa.
Wannan ya dace da yanayin da aka canza daga tantanin halitta na tsakiya zuwa tantanin halitta na halitta da kuma ajiyar tantanin halitta.
MERS-COV yana haifar da cututtuka masu ƙarancin gaske, wanda ke haifar da ƙananan canjin DNA a cikin waɗannan dabbobi.
Cutar da aka yi wa mutane ta zama abin da ya faru, mutane sun zama matattu na MERS-COV, lokacin da ba za a iya ci gaba da watsawa ba.
Ba kamar yadda tsuntsaye suke yi wajen watsa MERS-COV ba, bangolin sun bambanta, idan akwai wani abu, da yadda SARS-COV-2 ke watsawa.
A musamman, beta-cove penguins suna da matukar cutarwa ga penguins.
A ƙarshe, za su iya zama matattu na SARS-CoV-related beta-CoV-related cell types, kamar yadda ciwon ciwon daji yake a cikin SARS-CoV-like condition.
Akwai yiwuwar cewa za a iya watsa SARS-CoV-2 daga dabba zuwa mutum ko kuma a gano su a cikin bincike na gaba.
Na farko, ƙwayoyin cuta na iya ɗaukar wani kwayar cutar SARS-CoV-2 da ke da alaƙa da cutar wanda ya yi kama da SARS-CoV-2.
Mutane suna iya raba yanayin da suke rayuwa tare da tsuntsaye ta hanyar sayar da nama ko kuma sayar da gawayi.
Na biyu, penguins na iya zama cibiyar haɓakar kwayoyin halitta na sabon SARS-CoV-2 da aka gano yana da alaƙa da cutar.
Mutane sun kamu da ƙwayoyin cuta daga cin nama da kuma farauta.
Duk waɗannan dabbobi masu shayarwa, musamman dabbobin gida, na iya zama masu saurin kamuwa da SARS-CoV-2.
Ana yin bincike a kan dabbobi da kuma dabbobi don gano maganin.
Na uku, kamar yadda aka ambata a sama, ana iya samun sake haɗuwa da daidaita SARS-CoV-2 a cikin nau'in halittu na uku waɗanda suka sami haɗuwa da tsuntsaye da penguins.
Ana ci gaba da bincike kan asalin SARS-CoV-2.
Baya ga nau'ikan dabbobi masu ƙwayoyin salula, akwai manyan dalilai guda uku a cikin ƙwayoyin cuta waɗanda suke da mahimmanci don sauƙaƙe ƙetare iyakar kwayoyin.
A farko dai, matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsaka
Idan aka kwatanta da wasu kwayoyin RNA, ana ƙididdige ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigarƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙ
Coven yana da hujja-ta hanyar karanta Exoribon class (wanda ke ƙone RNA), cire kowane sakamako daga cikin ƙwayoyin cuta ya canza sosai kuma yana raunana da kuma kashewa ko kuma ba ya aiki.
Musamman, an san nucleotides masu rarrafe a matsayin masu karɓar kwayar cutar ta hanyar hana shiga cikin kwayar cutar ta waje da RNA mai dogara da RNA mai karɓar enzymes.
Remedivair yana daya daga cikin maganin rigakafin SARS-CoV-2 da ake gwadawa a cikin dakin gwaje-gwaje.
Duk da haka, matsakaicin adadin masu cutar COVID-19 ya ninka na ƙwayoyin halitta kusan sau miliyan.
Bugu da ƙari, yawancin lokuta, matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsaka
Idan aka kwatanta da SARS-CoV-2 wanda ke da matsakaicin matsakaicin tsalle fiye da SARS-CoV-2 wanda ke da ƙananan matsakaicin tsalle, ana ba da shawarar cewa a sami mafi girman matakin daidaitawa.
An yi zaton cewa ta daidaita da wani kwayar halitta da ke kusa da mutum.
Amma ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da sayen guda ɗaya.
A ka'idar, wani ɓangare na daban wanda ke haifar da motsi na kwayoyin halitta don samar da allurar rigakafi da riga-kafi na SARS-CoV-2 wani ɓangare ne mara aiki.
Na biyu, babban RNA na kwayar cutar korona yana ba da ƙarin ƙwayoyin halitta don daidaitawa daga kwayar halitta don tsallewa da sake haɗuwa, har ma da ƙarin yiwuwar ci gaba da kasancewa a cikin juna. Wannan yana da amfani ga haɗuwa da sabon kwayar cutar yayin da yanayin ya inganta.
Wannan yana da nasaba da karatun karatun da aka yi na musamman da kuma yadda furotin ke aiki a kan rubutun lambar a ƙarshen sashi na uku na genome.
Na uku, COVIDs suna canzawa a cikin tsari na bazuwar yayin rarraba RNA ta hanyar 'sashin zaɓi-sakewa-sakewa' na musamman.
A cikin kwayar halitta da ke aiki a matsayin kewayawa, lokacin da take tattara RNA mai kwakwalwa, sau da yawa ana yin tsalle-tsalle a cikin ɓoye.
RNAs masu tsayi da kuma subgenomic suna iya haɗuwa don samar da sabon COVID.
An gano hujjojin phylogenetic game da yanayin sake haɗuwa a cikin HCOV-HKU1 da HCOV-OC43, kamar su kwayar cutar dabba kamar SL-COV da COV-HKU9.
An haɗa kwayoyin cuta-virus a cikin haɗuwa da yaduwar.
Tare da dalilai uku na kamuwa da cutar da aka ambata a sama, haɗuwa da kwayar cutar ta hanyar kwayar halitta wani dalili ne na tasiri ga yaduwarsu tsakanin halittu.
A nan, an dauki tsarin SARS-CoV a matsayin misali mai kyau, wanda kuma ya nuna hujja ga zaɓin mai kyau ta hanyar aikin watsa.
Ganin nazarin kwatankwacin rarrabuwa tsakanin mutane da kuma SARS-CoV-2 ciwon, an yi tunanin SARS-CoV zai iya samun kwarewa mai sauri a cikin kwayoyin halitta daban-daban, musamman tare da tsalle-tsalle a cikin RBD na S-protein.
A yawancin lokaci, RBD na furotin S na COVID yana haɗuwa da fitowar sel kuma yana zaɓaɓɓu ta hanyar amsawar antigen.
A SARS-CoV, RBD yana da yawa a kan amino acid 318 zuwa 510 a kan S1. wanda ya haɗu da ACE2 na mutum kamar yadda ake amfani da shi don shigar da kwayar cutar.
SARS-CoV RBD na iya gano ƙwayoyin ACE2 na dabbobi daban-daban, ciki har da bats, ciwit, mice, da kuma karnuka na raccoon, yana hana watsa ƙwayoyin cuta.
A gaskiya ma, an gano amino acid 6 kawai da suka bambanta da na mutum da na ciwon kansa daga RBD kuma 4 daga cikinsu sun kasance masu daidaitawa a kan masu karɓa-daidaitacce don hulɗa da mai karɓa na ACE2.
Civit SARS-CoV-2 yana da tsalle-tsalle a cikin K479N da S487T na RBD, wanda zai iya ƙara daidaitaccen aiki na protein Spike tare da mai karɓar ACE2 na mutum.
A wasu kalmomi, maye gurbin waɗannan amino acid guda biyu yana da mahimmanci ga dacewa da kwayar cutar ga mutane.
An yarda cewa SARS-CoV-2 yana da haɗin kai tare da fitowar tantanin halitta iri ɗaya da SARS-CoV.
Kashi 30 cikin dari na bambancin SARS-CoV-2 da SARS-CoV-1 suna cikin S1 na S-protein wanda ke da haɗin haɗin S-protein tare da ACE2 na mutum wanda ya canza.
A gaskiya, binciken EM ya nuna cewa daidaito na wannan mahaɗin ya fi na mutum ACE2 da S ARS-KOVS kashi 10 zuwa 20 fiye da na mutum.
Dole ne kuma a tantance ko za a nemi wani kwayar cutar don watsa SARS-CoV-2.
Abin mamaki, cutar NL63 tana haɗuwa da ACE2 amma tare da wani ɓangare daban na S.
Akwai sauran masu karɓar kwayar cutar H, kamar ƙwayar cuta ta N na aminopepidase don kwayar cutar H 229E, da kuma 9-O na cilic acid don kwayar cutar H-OC43.
Wannan zai iya zama dalilin nasarar da aka samu na daukar CoVs a cikin mutane bayan an samu wannan yaduwar tsakanin jinsunan da aka samu daga dabbobi da suka kamu da cutar.
Duk da haka, ana iya sarrafa sakamakon da ake samu daga kwayar cutar zuwa wasu kwayoyin halitta don dalilai masu zaman kansu.
Yaduwar kwayoyin halitta tsakanin mutane da kuma inda kwayoyin halitta na coronavirus suke, kamar su bats, dabbobi masu rarrafe da kuma dabbobi masu rarrafe, na iya zama cikas ga watsawar rana.
Ana buƙatar kwayar cutar ta kamu da cutar ta hanyar ɗaukar nauyin ƙwayoyin halitta da kuma kawar da ƙuntataccen ƙwayoyin halitta, don samun nasarar watsawa tsakanin rana.
A wannan yanayin, ana gano da kuma bayyana muhimman magungunan sunadarai na yankin da cutar take ciki.
An tsara kwayoyin halitta da yawa da ba su da kyau don samar da tushen tushen tushen kansa da ƙuntataccen kwayar cutar SARS-CoV-2 ta amfani da fasahar fasaha ta CRISPR.
Haɗuwa da cutar coronavirus: Komawa wurin da aka fara
Bambancin da bambancin da ke cikin kwayar cutar coronavirus na ba da dama ga haɗuwa da HCoVs.
Saboda haka, ƙwayar cuta ta coronavirus tana yin aiki iri ɗaya da CoVs.
Duk da haka, saurin juyawa da kuma tsara kwayoyin halittar mutum na iya taimakawa wajen ci gaban kwayar cutar ta coronavirus kuma suna aiki a matsayin matakai biyu masu muhimmanci a cikin wannan tsari.
Alal misali, samun ko rasa kwayar da ke cike da furotin yana da ikon sarrafa samfurin da aka yi amfani da shi.
Daga cikin kwayoyin SARS-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-
An gano cewa cutar ta SARS-CoV-2 ta mutu ne a cikin abubuwa daban-daban a farkon annobar.
Wannan shi ne rashin haske da kuma duhu, ORF8 ya rabu zuwa ORF8a da ORF8b kuma an bar shi ya zama canji wanda ke inganta musayar kwayoyin halitta.
Bugu da ƙari, SARS-CoV-2 yana da tarihin da ya dace da ƙwayar cutar alpha da gamma, wanda ya ƙunshi ƙarin yankin mai daidaitawa a cikin RNA-related RNA polymers.
An gano wuraren da aka tsara a cikin nsp9, mafi yawan nsp10, da kuma wani ɓangare na nsp14.
Hakazalika, an nuna cewa cutar sankarar kwayar cutar ta coronavirus ta samu irin wannan daidaitawa a lokuta daban-daban, kamar yadda ta faru a Saudiyya.
Baya ga SARS-CoV-2 da MS-CoV-2 da aka lura da su, an lura da daidaitawa a cikin kwayar cutar coronavirus, wanda aka tsara a cikin kwayoyin cutar coronavirus da ba a rarraba su tare da sauran dabbobi na coronavirus.
Ya kamata a lura cewa ganewar asali na iya haifar da canje-canje masu yawa da ba a so, wanda zai iya haifar da yaduwar cutar a cikin wani yanki da aka tsara, kamar tsarin rigakafi.
Misali na irin wannan sakamako shine cikakken asarar ORF4 na farkon coronavirus-229 E, wanda ke haifar da ɓarna da kuma ɓarna na 2-nucleotide.
Duk da yake ana iya lura da ORF4 marar lalacewa a cikin sunadarai da kuma cutar houster da ke da alaƙa da HCoV-229E, ƙwayar alpha ta COVID-19 tana nuna wani abu mai cike da nucleotide, sakamakon haka yana da tsayayya.
A ƙarshe, ƙwayar cutar ta coronavirus ta samo asali ne daga kwayoyinta.
Ba a gano bayyanar cututtuka ba, ko kuma bayyanar cututtuka masu sauƙi da kuma marasa ƙarfi a lokacin da ake kamuwa da cutar coronavirus, wanda ke nuna cewa an watsa shi tsakanin coronavirus da cutar ta cutar.
An gano cewa sunadarai sun dace da cutar coronavirus a zahiri da kuma a zahiri.
Alal misali, rashin aikin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar coronavirus.
Bugu da ƙari, yana da kisan kai na halitta na ƙwayar cuta, wanda ya rage yawan ƙwayar cuta ta NKG2/CD94 da kuma rashin daidaituwa na ƙananan ƙananan ƙananan I.
Bugu da ƙari, yawan adadin oxygen da ke cikin maganin (ROS), wanda ya bayyana a cikin yawan adadin ƙwayar cuta na ƙwayar cuta, zai iya rage haɓakar da kuma sake dawo da kwayar cuta ta coronavirus kuma ya shafi enzyme acoribonucleosis, don haka haifar da ƙarancin ƙarancin ƙwayar cuta, wanda ke da ƙarancin kamuwa da cutar yayin da ta shiga cikin sabon kwayar cuta.
Sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Saboda haka, ba zato ba tsammani ne cewa nau'ikan cututtukan corona guda uku sun haɗu a cikin shekaru biyu da suka gabata.
Coronaviruses ba irin wannan cuta ba ce kuma suna haifar da alamun bayyanar cututtuka a cikin kwayoyin halitta kamar kumburi da kuma kumburi.
Suna ƙara amfani da su kuma suna riƙe da su ba tare da amsa mai ƙarfi na ƙwayoyin cuta ba.
Asirin abin da ya sa ake riƙe da su kuma ba su da wata alama a cikinsu yana nan, kuma abin da ke sa mutum ya kamu da cutar.
Alamomin da ke da tsanani suna faruwa ne saboda amsa mai ƙarfi da kuma aiki na tsarin rigakafi da kuma yawan adadin furotin, kuma idan tsarin rigakafi ya yi ƙarfi, cutar huhu za ta ƙara tsanani.
A akasin haka, masu karɓar cutar da ake ganowa, masu amsawa da kuma tsarin rigakafi, sun bambanta da karuwa da kuma hana CoV.
Irin wannan dabarun hana rigakafin na iya samun sakamako mai kyau na cutar ta SARS-CoV-2.
Wannan ƙwayoyin sunadarai suna da karfinsu na ƙwayoyin cuta, wanda ke da ƙarfi sosai a cikin bats.
Saboda haka, gudanar da furotin da aka cire daga kwayoyin halitta, aƙalla a cikin matakai na SARS-CoV-2 a cikin mutum, zai kasance da amfani.
Duk da haka, aikin NLRP3 mai karuwa, ba shi da cikakkiyar aiki a cikin aljanu.
A bayyane yake cewa, kasancewa da furotin mai yawa NLRP3 tare da MCC950 na iya zama da amfani wajen magance cutar korona.
Haɗuwa da SARS-CoV-2 ya haifar da sabon tsari, wanda ya haifar da SARS-CoV-2 da MS-CoV-2 .
Yayin da aka gano beta-virus na 95% na nucleotide hadewa da SARS-CoV-2 an gano beta-virus, ana kuma gano beta-virus na 96% na nucleotide hadewa da SARS-CoV-2.
Yayin da aka gano dabbobi masu rai da kuma wasu dabbobin da ke kasuwa da ke dauke da cutar SARS-CoV-2 mai kama da cutar, ba a gano wani wuri mai sauri da kuma gaggawa na SARS-CoV-2 ba.
An gano haɗin beta-virus na coronavirus a cikin dabba na pangolin tare da SARS-CoV-2, wanda ke nuna cewa bangolin zai iya aiki a matsayin matsakaiciyar kwayar halitta, ko kuma (beta-virus) na pangolin zai iya samar da wani yanki na kwayoyin halitta na SARS-CoV-2 na ƙarshe.
Ko da yake tambayoyi sun kasance, babu wata hujja cewa SARS-CoV-2 ya kasance na mutum, ko dai da gangan ko ta hanyar hadari.
An gano cutar korona ne sakamakon yaduwar cutar SARS-CoV-2.
Binciken cutar korona a cikin kwari da sauran dabbobi ya canza ra'ayoyinmu da ra'ayoyinmu game da muhimmancin kwayoyin halitta da kuma yadda dabbobi ke watsa kwayar cutar korona zuwa mutane.
Shaidar da aka samu ta nuna cewa SARS-CoV-2, MS-CoV-2 da SARS-CoV-2 sun ƙunshi kwayoyin cuta na aljanu kuma an watsa su zuwa mutane ta hanyar kwayoyin halitta.
Kamar yadda kamuwa da cutar SARS-CoV-2 ta samo asali daga hulɗar da ke tsakanin mutane da dabbobi a cikin kasuwanni, rufe kasuwanni da kashe 'yan kasuwa na iya kawo ƙarshen cutar SARS.
Saboda wannan dalili, dole ne a kawar da dabba daga kasuwa, don hana watsawa da ke da alaƙa da dabba, kuma wannan ya faru ne saboda gano asalin da kuma abubuwan da ke cikin beta-virus na coronavirus da ke da alaƙa da SARS-CoV-2.
Koyaya, ko kuma yadda za a iya watsa SARS-CoV-2 zuwa mutane ta hanyar pangolin da sauran dabbobi masu shayarwa zai kasance a cikin gwajin da za a yi a nan gaba.
A gefe guda kuma, cutar korona ta MERS ta kasance a duniya na dogon lokaci.
Wadannan tsuntsaye suna da amfani wajen sufuri, saboda su ne tushen dabbobin da ke samar da nama, madara, fata da abinci ga mazauna yankin.
Sun fi yawa a Gabas ta Tsakiya da Afirka.
Saboda haka, ba za a iya yin hadaya da dukan dabbobi ba don sarrafa Mars, kamar yadda aka yi a kasuwannin dabbobi na kasar Sin, don hana yaduwar SARS-CoV-2 da SARS-CoV-2 ba.
Don hana yaduwar cutar, dole ne a yi kokari a duniya don samar da ingantaccen tsarin cutar coronavirus ta cutar ta Mars, tare da matakan hana kamuwa da cutar.
Duk da yake ba za mu iya kawar da cutar ba, sabon nau'in kwayoyin halitta zai iya zama sanadin yaduwar.
Ana samun tarin cututtukan coronavirus na dabba a yankin dutse.
Musamman, ƙwayar cuta ta coronavirus, wadda ta ƙunshi dabba, ta bambanta.
Akwai damar da za a iya samun kwayar cutar ta dabbobi ta ci gaba da kuma daidaitawa, don haka haɗuwa da sababbin kwayar cutar zai iya zama da yawa kuma/ko kuma ya fi kisa ga mutane a nan gaba.
Dole ne a hana al'adun cin dabbobi a wasu yankunan kasar Sin don rage rashin dangantaka tsakanin mutane da dabbobi.
Tare da cutar SARS, MERS da kuma coronavirus, ana bukatar ingantaccen shiri da shirin amsawa.
A gaskiya ma, ƙwayoyin cuta da yawa sun wanzu a duniyar nan na dogon lokaci.
Za su zauna a cikin gidajensu na musamman, har sai an sami damar yaduwa.
Ko da yake tsuntsaye suna da halaye masu yawa da ke taimakawa wajen yaduwar cutar, ana iya rage yiwuwar kamuwa da cutar da kuma dangantaka da tsuntsaye da sauran dabbobi idan aka koya wa mutane su guje wa su.
Ana buƙatar ci gaba da kula da dabbobi masu shayarwa don samun kyakkyawar fahimtar yanayin CoVs da ƙwayoyin halitta, wanda ke tabbatar da fa'idodi a cikin hana dabbobi daga mutum zuwa mutum da kuma ci gaba da yaduwarsu.
A ƙarshe, hanya mafi inganci don hana dabbobi kamuwa da cutar ita ce ta nisantar mutane daga wuraren da dabbobi masu dauke da cutar suke zama.
Wasu daga cikin abubuwan da ke cikin dabba na SARS-CoV-2 har yanzu ba su bayyana ba.
Da farko, idan ƙuƙwalwa ta iya canja wurin cutar SARS-CoV-2 zuwa pangolin, zai dace a bincika ko a wane yanayi ne ƙuƙwalwa da pangolin suke da irin wannan yanayin.
Na biyu, idan ana ganin cewa bats suna taka muhimmiyar rawa wajen isar da su kai tsaye zuwa ga mutane, to, ya kamata a yi la'akari da yadda mutane ke hulɗa da bats.
Na uku, idan dabba mai shayarwa ta uku tana aiki a matsayin mai ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙ
A ƙarshe, saboda yawancin masu shayarwa suna ɗaukar dabbobi na gida, suna iya kasancewa a shirye don SARS-CoV-2, dole ne a lura da gwaji.
Idan sun kasance ƙwari, pangolin ko wasu dabbobi masu shayarwa, ana sa ran za a iya gano SARS-CoV-2 ko kuma irin wannan ƙwayar cuta a cikin yanayin ƙwayoyin halitta a nan gaba.
Ana ci gaba da nazarin yadda SARS-CoV-2 ke tasowa a cikin dabbobi, tare da ƙoƙarin kawar da cutar coronavirus a cikin mutane.
Ana buƙatar sabunta ma'aunin COVID-19 na "matsalolin da ake zargi" da "matsalolin da aka tabbatar".
A ranar 6 ga watan Fabrairun 2020, ƙungiyarmu ta wallafa wani jagora mai sauri don ganowa da kuma magance cutar coronavirus ta 2019 (2019-nCoV), wanda ya ba da gogewarmu kuma ya nuna ƙalubalen da muke fuskanta a duniya.
Koyaya, cutar korona ta 2019 (COVID-19) sabuwar cuta ce, kuma sanarwa da iliminmu suna ƙaruwa a hankali bisa ga binciken da ake samu a kan bincike da kuma kwarewar aikin asibiti; saboda haka, ana sabunta hanyoyin ganewa da magani akai-akai.
A cikin wannan rubutun, mun amsa wata tambaya game da jagorarmu da kuma samar da sabon sa hannu don "halayen da ake zargi" da "halayen da aka tabbatar" bisa ga sabon sa hannu da kuma maganin COVID-19 (Sashe na 7) da kwamitin kula da lafiyar kasar Jamhuriyar Sin ya fitar.
A watan Disamba na 2019, an kamu da sabon coronavirus 2019 (2019-nCoV), wanda yanzu ana kiransa COVID-2019 da kuma SARS-CoV-2 (Covid-19).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba ta duniya.
Don taimakawa yaki da SARS-CoV-2, ƙungiyarmu ta gabatar da jagorar shawarwari kan gaggawa da aka buga a kan layi a cikin Military Medical Research a ranar 6 ga Fabrairu, 2020.
Tun lokacin da aka buga shi, ya sami karbuwa sosai.
lura Ko da yake COVID-19 sabon cuta ne, sanarwa da iliminmu na karuwa ne bisa ga binciken da ake samu a kan bincike da kuma kwarewar aikin asibiti; saboda haka, ana sabunta hanyoyin ganewa da kuma magance su kullum.
Alal misali, jagororin bincike da magani na COVID-19 da kwamitin kula da lafiyar kasar Sin ya wallafa (http://www.nhc.gov.cn/), sun wallafa a cikin jimlar nau'i bakwai daga 16 ga Janairu zuwa 3 ga Maris, 2020, tare da wasu sassan da aka gyara sosai.
Yanzu, jagororinmu sun zo ne daga wani bayani daga Zhou et al., wanda ya ba da shawara mai sauƙi game da yadda za su yi la'akari da kwarewarsu ta asibiti.
Ayyukan su sun ba da sabon tabbaci ga ƙa'idodinmu kuma sun nuna cewa akwai tabbaci game da wannan annoba ta duniya.
Muna goyon bayan kuma muna godiya da aikin da suka yi.
Duk da haka, aikin su na bukatar sabuntawa bisa ga sabon tsarin ganewa da kuma maganin COVID-19 (Matsalar gwaji ta bakwai) da kuma sabon bincike.
A cewar Fassarar 7 (Maris 3, 2020), don tabbatar da cewa wani mutum mai cutar ya kamu da cutar dole ne ya haɗa kowane ɗayan nau'ikan alamun cututtuka na musamman tare da nau'ikan alamun asibiti guda biyu don gudanar da bincike mai zurfi, ko kuma dole ne ya ƙunshi nau'ikan alamun asibiti guda uku idan babu tarihin cutar a fili:
Tarihin kamuwa da cutar: (1) Tarihin tafiya ko zama a birnin Wuhan da yankunan da ke kewaye da shi, ko wasu al'ummomin da aka ruwaito cewa akwai COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (2) Tarihin kamuwa da cutar SARS-CoV-2 (ta hanyar gwajin cutar nucleic acid mai kyau); (3) Tarihin kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamu a cikin makaman da ta kamuwa da ta kamuwa da ta kamuwa da ta kamuwa da ta kamuwa da ta kamuwa da ta kamu a cikin makaman da ke ke ke ke ke ke ke ke ke ke ke ke ke ke kewaye da kewaye da ke kewaye da kewaye da ke kewaye da kewaye da ke kewaye da ke ke kewaye da kewaye da ke ke kewaye da kewaye
Alamar asibiti: (1) har zuwa da/ko alamun cutar numfashi; (2) tare da halaye na musamman na cutar COVID-19; (3) saboda yawan ƙwayoyin fari da ke nuna yawan al'ada, raguwa, ko raguwar yawan lymphocytes a farkon matakin.
Dole ne a gano wani tabbataccen hali bisa ga wani abu da ake zargi da cutar ko kuma wata hujja ta sararin samaniya kamar haka: (1) gwajin PCR na ainihi na SARS-CoV-2 mai kyau; (2) cikakken kwayar halitta na kwayar cutar da ke nuna asalin sabon kwayar cutar; (3) tabbatacce ga IgM antigen da IgG antigen ga SARS-CoV-2 a cikin gwajin magani; ko kuma canji a cikin IgG na SARS-CoV-2 mai kyau ga tabbatacce, ko kuma yawan kwayoyin cutar ya karu sau da yawa a lokacin da aka warke.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihi don nucleic acid a cikin numfashi ko samfurin jini zuwa kashi na biyu (18 ga Janairu, 2020) da kashi na uku (22 ga Janairu, 2020).
An ƙara gano cutar a cikin samfurin jini a shafi na huɗu (27 ga Janairu, 2020) da shafi na biyar (8 ga Fabrairu, 2020); sannan an ƙara shaidar cutar a shafi na bakwai.
Waɗannan gyare-gyare sun kasance bisa ci gaba da aikin da masu bincike suka yi na neman wani kit na gano nucleic acid don saurin ganewa, tare da samfurori na numfashi wanda ya haɗa da samfurin jini, wanda ya kara samun samfurori daban-daban, kuma ya tallafa wa samun sakamako mai kyau na maganin rigakafi na musamman zuwa ga sigogi masu tabbacin.
Duk da haka, akwai ƙarin hujjoji da za su nuna cewa muna sane da cututtukan da ba su da alamun bayyanar cututtuka.
Saboda haka, ya kamata a sabunta tsarin Zhou et al., domin sun lissafa mutumin da ba shi da alamun asibiti a matsayin "ƙarancin haɗari".
Hakanan, ana buƙatar ƙarin bincike game da tsarin ƙididdigar aikin asibiti da bincike.
A sakamakon haka, muna fatan samun ƙarin hujjoji kai tsaye kuma muna roƙon masu karatu su ba da ra'ayinsu.
Don sanya alamar "Halin da ake zargi" da "Halin da aka tabbatar", muna ba da shawarar bin sawun kuma bi sabon jagororin da aka ba su a ƙasashensu.
Kuma ƙungiyarmu za ta sabunta jagororinmu na ba da taimako a kan kari.
Bangladesh ta samu sabbin mutane biyar da suka mutu sakamakon COVID-19, wanda ya kai matsakaicin adadin a kowace rana
A Duniyar Bangladesh, an tabbatar da cewa an samu wasu mutane biyar da suka mutu sakamakon cutar COVID-19 a wannan rana.
Wannan shi ne adadin mutuwar da aka samu a cikin rana daya daga cutar.
A jiya, Hukumar Kula da Cututtuka da Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton adadin mutane da suka kamu da cutar, inda akwai mutane 114 da suka kamu da cutar da kuma mutane 33 da suka warke daga cutar.
An samu mutuwar mutane 17.
A wani bayani da aka yi a shafin yanar gizo, mai gudanar da IEDCR, Mista Mirza Sabrina Flora ya ce, mutane hudu ne suka mutu, wata mace kuma.
A cewar Dr. Mirzdar, akwai mutane biyu da suka kai shekaru 60, biyu da ke tsakanin shekaru 51 zuwa 60 da kuma daya mai shekaru 41 zuwa 50.
Ya kuma ce wadanda aka kashe su mazauna Dhaka ne.
Hukumar lafiya ta duniya (WHO) ta bayyana COVID-19 a matsayin annoba a duniya a ranar 11 ga Maris.
Wani jami'in lafiya ya shaida wa kamfanin dillancin labarai na Anadolu, wani jami'in yada labarai na gida, cewa daya daga cikin wadanda suka mutu shi ne Jalal Sa'afur Rahman, darektan kwamitin yaki da cin hanci da rashawa na Bangladesh, wanda ake kula da shi a asibitin Kuwait Matri.
A wani sakon da aka wallafa a shafin yanar gizo a ranar Asabar, Ministan Sufuri da Hanyoyi, Abdullahi Qadar ya ce za a jinkirta zirga-zirgar jama'a fiye da yadda aka tsara, har zuwa wannan Asabar.
An fara dakatar da zirga-zirgar jama'a a ranar 26 ga Maris kuma an shirya ta a ranar Asabar, 4 ga Afrilu.
Ana ci gaba da isar da kayayyakin da ake bukata - magani, man fetur da abinci.
An samu kamuwa da cutar COVID-19 ta farko a Bangladesh a ranar 8 ga watan Maris, a cikin mutane biyu da suka dawo daga Italiya tare da matar wani daga cikinsu.
A ranar 19 ga Maris, waɗannan mutane uku sun warke.
SARS-CoV-2 ya kai kamuwa da cutar miliyan daya a duniya
A ranar Alhamis, jimlar adadin mutane da suka kamu da cutar SARS-CoV-2 ta wuce miliyan daya a duniya, in ji bayanan jami'ar Johns Hopkins.
Akalla mutane 52,000 ne suka mutu sakamakon cutar COVID-19, wadda ke da nasaba da cutar korona.
Wannan canji mai muhimmanci ya faru a ranar da Malawi ta sanar da kamuwa da cutar korona ta farko da kuma Zambiya ta sanar da mutuwar farko da ta shafi cutar.
A ranar Alhamis, Koriya ta Arewa ta ce tana daya daga cikin kasashe da ba su da cutar korona.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da suka kamu da cutar, wanda ya kai mutum 79,332 a cikin sa'o'i 24 kafin 10 na safe na tsakiyar Turai (0800 UTC) na 4 ga Afrilu.
A Amurka, an samu karin mutane 244,000 da suka kamu da cutar korona, wanda ya shafi mutuwar akalla 5,900.
CBS ta ba da rahoton cewa, a ranar Laraba, fiye da 1,000 na mutane sun mutu a Amurka sakamakon kamuwa da cutar coronavirus, sakamakon binciken da aka yi daga Jami'ar Johns Hopkins.
A duniya, ƙasashe sun sanar da matakan gaggawa don hana cutar yaduwa.
A ranar Alhamis, Sargi Sobyanin, gwamnan Moscow, ya kara tsawon lokacin zama a gidansa har zuwa 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya bayyana cewa za a biya ma'aikatan Rasha albashi ba tare da sun shiga aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta amince da tsawaita dokar ta baci ta kwana 15; an amince da kuri'un 215 a matsayin a, 10 a matsayin a, kuma an amince da kuri'un daya a matsayin a.
Saudiyya ta kara wa birnin Makka da Madina dokar hana zirga-zirga na tsawon yini; a baya, an hana zirga-zirga daga karfe 3 na rana zuwa 6 na safe.
Thailand ta shirya aiwatar da dokar hana zirga-zirga tsakanin 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike Madden, ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa 1 ga Mayu.
Shaguna a Ostiraliya suna rage yawan kayan wanka a kowace ma'amala
A ranar Asabar da yammacin ranar Asabar, kantin sayar da kayayyaki na Australiya, Wolverines & Coles, ya rage yawan sayen kayan wanka zuwa fakiti biyu da ɗaya a kowace ma'amala a duk shagunan da ke cikin ƙasa.
A ranar Litinin, ALDI ta kuma sanya dokar hana amfani da fakiti guda daya.
An sanya waɗannan ƙuntatawa a matsayin saƙo a ƙofofin da kuma shafin Facebook na jerin.
An ce masu sayarwa suna sayen abubuwa da yawa saboda tsoron COVID-19 fiye da yadda mutane ke buƙatar yin amfani da kai.
A ranar Laraba, Wolversees ta rage sayen gidajen wanka don kawowa gidaje kawai don kunshin daya a kowace bukata.
Wannan canjin ya biyo bayan wani sabon ƙuntatawa na hudu-package da Wolverhampton da Coles suka sanar a ranar 4 da 5 ga Maris.
Koles, a cikin wata sanarwa ta 8 ga Maris, ya bayyana cewa, da ikon da aka yi na iyakancewar kunshin hudu, "har yanzu yawancin shagunan suna sayar da kayayyaki a cikin sa'a daya", kuma ya kira bukatar "ba zato ba tsammani", yayin da ALDI, a cikin wani sakon Facebook a ranar Talata, ya kira ta "ba zato ba tsammani".
A makon da ya gabata, masu sayarwa sun yi nasara a "sakewa mai kaifi", a cewar mai magana da yawun Wolverhampton.
A makon da ya gabata, kantin sayar da kayayyaki na Costco a Canberra ya sauya adadin da aka ba su zuwa fakiti biyu.
Don daidaita ƙarancin, Coles ya nemi ƙarin fakiti daga masu samarwa kuma ya ƙara yawan lokutan isarwa, Wollers ya nemi ƙarin kayan aiki, yayin da ALDI ta ba da umarnin kayan don samun damar zuwa ranar Laraba.
Russell Zimmerman, babban jami'in hukumar sayar da kaya ta Australiya, ya ce masu sayar da kaya suna ƙoƙarin ƙara yawan kaya, amma ƙuntatawar da hukumar ke yi a kan lokacin da za a kawo manyan motoci yana sa aikin ya yi wuya.
Ya yi hasashen cewa farashin samarwa zai karu, saboda masu samarwa suna ƙoƙari su cika buƙata, kuma tare da ƙananan masu sana'a.
A ranar Talata, ALDI ta sanar da cewa bayan an gabatar da kayan aikin, wasu shagunan ba za su iya ba da kyauta ta musamman a ranar Laraba ba.
A wani rahoto da News.com.au ta wallafa, Dr. Gary Mortaimer, masanin sayar da kayayyaki a jami'ar Queensland ta fasaha, ya ce, shaguna suna cike da kayayyaki a kowace dare.
Ya ce, toilet cleanse yana da girma, wanda ke haifar da ƙananan kayan aiki a cikin adadi, kuma, lokacin da aka sayar, yana sa ɗakunan ajiya su zama marasa komai, yana sa ya zama da wuya a ji cewa an rasa su.
Rahasiyel Zimmerman ya ruwaito cewa Coles da Wolverine suna da ra'ayin cewa idan akwai yawan kayan da za a iya amfani da su a kan ɗakunan ajiya, idan za a iya sayen kayayyaki kamar toilet cleaners da cleaning, kuma a cikin killace, to, za a iya rage tsoro.
Kamfanin kera kayan wanka mai amfani da kayan kwalliya mai suna Who Gives a Crap ya ce a ranar Laraba an rasa kayan.
Kimberly-Clark, wanda ke da Cleenex toilet clinic da kuma Solaris paper wanda ke da Sorbent, ya tabbatar da cewa sun yi aiki 24/7 don kare wadata, a cewar wani rahoto daga News.com.au.
Domain.com, wani shafin yanar gizon gidaje, ya ruwaito cewa wasu masu sayar da gidajen gidajen gidaje na gidajen gidaje sun ba da kyauta ga masu samar da kayan aikin gidaje na farko a Melbourne, lokacin da aka yi ƙananan ƙari saboda masu sayar da gidaje suna da lokaci mai yawa a lokacin hutun karshen mako na hutun ma'aikata.
Labarin ranar Alhamis na NT News, jaridar jaridar Darwin, ta ba da shafuka takwas don a yanke su kuma a yi amfani da su a matsayin toilet clinics.
Shaguna sun yi jinkirin yin rajistar, a cewar wani rahoto na ABC Australia a ranar 3 ga Maris wanda ya ce ba su da wani shiri na sanya takunkumin sayayya.
Russell Zimmerman ya kara da cewa akwai wasu kayayyakin da ake bukatar su, kamar su masks, masu tsabtace jiki, kayan shafawa, sabulu mai ruwa da kuma ruwa.
A waje da Australia, an lura da wani babban kanti na kan layi na Okadu a ranar Asabar da yamma cewa ya ƙuntata sayar da kayan wanka na Andres zuwa fakitin 12 na kwayoyin.
Hukumar lafiya ta duniya ta bayyana COVID-19 a matsayin annoba ta duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana ci gaba da yaduwar COVID-19 - cuta da ke haifar da cutar SARS-CoV-2 - a matsayin annoba ta duniya.
Ko da yake kalmar "marubuci" tana nufin yadda cutar ta yadu, ba yadda yanayi na musamman ke da haɗari ba, WHO ta lura cewa gwamnatoci suna bukatar su ɗauki mataki:
Tedros Adhanom Gabrisos, babban darektan WHO ya ce duk wata ƙasa za ta iya canja yanayin annobar.
Idan ƙasashe suka sanya hannu, su yi wa al'ummarsu horo, su warkar da su, su ware su, su bi su.
Muna da matukar damuwa game da yawan yaduwar cutar da kuma gaggawa da kuma rashin numfashi.
A cewar Dr. Tom Friedin, tsohon darektan Cibiyar Kula da Cututtuka ta Amurka, annobar "ba a yi tsammani ba".
Ya ce, a wani labarin da CNN ta wallafa a watan Fabrairu, "sai dai cutar mura, ba a biye da wani kwayar cutar ta hanyar numfashi ba tun daga bayyanar zuwa ci gaba da yaduwar duniya".
Gabruss ya yi magana game da irin wannan ra'ayi, yana cewa, "Ba mu taɓa ganin annobar da ta haifar da cutar coronavirus ba".
Ya kara da cewa, "Ba mu taba ganin annobar da za a iya sarrafawa a lokaci guda ba".
Wani sabon yanayi na annobar duniya ya biyo bayan shawarar WHO a watan Janairu na bayyana gaggawa na gaggawa na kiwon lafiyar jama'a da ke da damuwa a duniya.
Darakta Anthony Fauci, darektan hukumar kula da cututtuka masu saurin kamuwa da cuta da annoba ta Amurka, ya ce game da annobar "a takaice, tana da matukar damuwa".
A ranar Alhamis, Associated Press ta ruwaito cewa akwai akalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya haifar da mutuwar mutane fiye da 4,600.
Cutar coronavirus ta 2019-20 annobar cutar COVID-19 ce da ke ci gaba da kamuwa da cutar coronavirus (COVID-19) wanda ke haifar da kamuwa da cutar ta SARS-CoV-2 ta hanyar kamuwa da cutar ta numfashi.
An gano cutar a Wuhan, China a watan Disamba na 2019, an bayyana ta a matsayin gaggawa na lafiyar jama'a na duniya a ranar 30 ga Janairu, 2020, kuma an bayyana ta a matsayin annobar duniya a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an dakatar da mutum miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da yankuna, wanda ya yi sanadiyar mutuwar mutane 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta yawan mutuwar a kasar Sin da kashi 4 cikin 100, yayin da a duniya ta fara daga kashi 13.04 cikin 100 a Algeria zuwa kashi 0.08 cikin 100 a New Zealand.
Alamomin da aka saba gani sun hada da kumburi, kumburi, da kuma numfashi.
Abubuwan da suka fi rikitarwa na iya zama pneumonia da kuma alamun rashin lafiyar numfashi.
Lokaci na bayyanar cututtuka zuwa bayyanar cututtuka yana da kwanaki biyar, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Babu wani maganin rigakafi ko maganin rigakafi da aka sani.
Maganin farko na bayyanar cututtuka da kuma magani na gaba ne. Maganin da aka ba da shawarar na magunguna ya ƙunshi wanke hannu, rufe baki yayin shan barasa, nisantar da mutane, da kula da kai da kuma kula da waɗanda suke zaton suna da cutar.
A duk faɗin duniya, hukumomi sun amsa ta hanyar aiwatar da takunkumin tafiye-tafiye, killacewa, hana zirga-zirga, kula da haɗarin mai bin sawu, da rufe wuraren.
Cutar ta haifar da rushewar tattalin arzikin duniya, jinkirta ko ƙin ayyukan wasanni, addini, siyasa da al'adu, da yawan rage kayan aiki saboda sayayya.
Makarantun da jami'o'i a ko dai ƙasa ko ƙasa a ƙasashe 193 sun rufe, suna aiki a kan kusan kashi 99.4 cikin ɗari na ɗaliban duniya.
Bayanai marasa kyau game da cutar sun bazu a kan intanet, kuma akwai tsoron baƙi da nuna bambanci ga 'yan ƙasar Sin, sauran mutanen da ke cikin asalin ƙasar Sin da kuma kudu maso gabashin ƙasar Sin, da kuma wasu a yankunan da cutar ta kamu da cutar.
Saboda rage yawan tafiye-tafiye da kuma rufe manyan masana'antu, an rage yawan gurɓataccen iska da kuma fitar da carbon.
Hukumomin lafiya a Wuhan, babban birnin lardin Hubei, China, sun ba da rahoton wasu cututtukan cututtukan huhu a ranar 31 ga watan Janairu na 2019, kuma sun fara binciken a farkon watan Janairu na 2020.
Yawancin cututtuka sun kasance da alaƙa da kasuwar abincin teku na Havana, saboda haka an yi imanin cewa kwayar cutar ta fito ne daga dabbobi.
Kwayar cutar da ta haifar da yaduwar cutar ta zama SARS-CoV-2, sabon kwayar cutar da aka gano da ke da alaƙa da kwayar cutar coronavirus, cutar coronavirus ta penguin, SARS-CoV. Da farko an san mutumin da ke da alamun cutar kuma daga baya ya kamu da cutar a ranar 1 ga Disamba, 2019, mutumin da aka gani ba shi da alaƙa da ƙungiyar kasuwar naman sabo.
Daga cikin wadanda aka fara bayar da rahoton su a watan Janairun 2019, kashi biyu bisa uku na wadanda suka shafi kasuwar naman sabo.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar ba a cikin South China Monring Post ya ba da shawarar cewa wani labari ya fito daga ranar 17 ga Nuwamba, 2019, daga wani mutum mai shekaru 55 a yankin Hubei, yana iya zama farkon. A ranar 26 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya ta ce, tare da raguwar sabbin lokuta a China, amma ba zato ba tsammani ya tashi a Italiya, Iran, da Koriya ta Kudu, adadin sababbin lokuta a waje da China ya wuce adadin sabbin lokuta na cikin gida a karon farko.
Ba za a iya samun rahotanni masu yawa ba, musamman a cikin waɗanda ke da alamun rashin lafiya.
A ranar 26 ga Fabrairu, an samu kashi 2.4% na yawan cututtuka a tsakanin matasa, waɗanda shekarunsu 19 ne ko ƙasa da haka a duniya. Mai ba da shawara kan kimiyya na Burtaniya, Patrick Valance, ya yi hasashen cewa kashi 60% na yawan mutanen Burtaniya za su kamu da cutar kafin a samu rigakafin cutar.
Maganganun sun nuna yawan mutanen da aka yi wa allurar rigakafin COVID-19, kuma an tabbatar da gwajin su na tabbatacce bisa ga tsarin aiki.
Har zuwa 23 ga Maris, babu wata ƙasa da ta yi gwajin ga fiye da kashi 3% na yawanta, kuma yawancin ƙasashe suna da manufofin da suka kafa don hana waɗanda ke da alamun cutar kawai, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka wallafa a ranar 16 ga Maris ya nuna cewa a kasar Sin, har zuwa 23 ga watan Janairu, an samu kashi 86% na kamuwa da cutar COVID-19, kuma wannan kamuwa da cutar da ba a samu ba ya haifar da kashi 79% na kamuwa da cutar.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya yi hasashen cewa adadin kamuwa da cutar a Italiya ya fi yawan wadanda aka samu.
An yi hasashen cewa an yi amfani da R0 don yin kamuwa da COVID-19 a cikin kashi 1.4 zuwa 2.4.
Wani bincike da hukumar kula da cututtuka ta Amurka ta wallafa ya nuna cewa cutar tana da daraja 5.7.
Yawancin mutanen da ke da cutar COVID-19 za su warke.
Ga waɗanda ba su warke ba, lokacin bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, wanda ya fi dacewa kwanaki 14.
A ranar 10 ga Afrilu, 2020, an yi kusan mutuwar 97,000 sakamakon COVID-19.
A kasar Sin, a ranar 5 ga watan Fabrairu, kashi 80% na mutuwar mutane ne da suka wuce shekaru 60, kuma kashi 75% na cikinsu suna da wasu matsalolin lafiya kamar cututtukan zuciya da ciwon sukari. Yawan adadin mutuwar da aka yi a hukumance sakamakon cutar COVID-19 yawanci yana nufin mutuwar mutanen da suka tabbatar da cewa sun kamu da COVID-19 bisa ga tsarin gudanarwa.
Yawan mutuwar da ake samu daga COVID-19 na iya zama mafi girma, saboda yana iya ɗaukar mutane da suka mutu don yin gwaji - misali, a cikin tsofaffin kwayoyin halitta, da sauransu.
Bayanai na bangare a Italiya sun nuna cewa yawan mutuwar da aka samu a lokacin annobar ya ninka na mutuwar da aka samu daga COVID sau 4-5 a cikin shekara ta 2020.
Wani mai magana da yawun Cibiyar Kula da Cututtuka ta Amurka (CDC) ya ce "mun san cewa [da yawan mutuwar da aka bayar] ba a yi hasashen ba ne", a sanarwar da ke tattare da rahoton rashin yin lissafi a Amurka. Sau da yawa wannan ƙarancin lissafin yana faruwa a lokacin annobar, kamar annobar cutar N1H1 ta 2009.
Mutuwar farko a wajen kasar Sin ta faru ne a Philippines a ranar 1 ga watan Fabrairu, kuma mutuwar farko a wajen Asiya a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar sama da goma sha biyu, kowanne a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga watan Maris, fiye da kasashe da yankuna arba'in sun ba da rahoton mutuwar, a duk nahiyoyi sai Antarctica. Ana ɗaukar matakai masu yawa don rage yawan mutuwar.
Wadannan lambobi na iya bambanta da yankuna da lokatai, kuma suna shafar yawan bincike, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun lokacin da cutar ta fara, da kuma halaye na yawan jama'a kamar shekaru, jinsi, da kuma lafiyar jama'a. Yawan mutuwar yana nuna yawan mutuwar da aka rarraba bisa yawan alamun da aka gano a wani lokaci.
Bisa ga bayanan da aka samu daga Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu 2020.
Yawan zai bambanta daga yankin zuwa yankin.
A kasar Sin, an kiyasta cewa yawan mutuwar zai ragu daga 17.3 (ga wadanda suka fara da alamun cutar daga 1 zuwa 10 ga Janairu 2020* zuwa 0.7% (ga wadanda suka fara da alamun cutar bayan 1 ga Fabrairu 2020). Sauran ma'auni sun hada da CFR, wanda ke nuna kashi 100 na mutanen da aka gano cewa suna mutuwa saboda cutar, da kuma infirmary infirmary mortality rate (IFR), wanda ke nuna kashi 100 na mutanen da suka kamu da cutar (ba a gano su ba) da suka mutu saboda cutar.
Ƙididdigar ba ta da lokaci kuma suna biye da yawan mutanen da suka kamu da cutar ta hanyar magance yanayin.
Wasu masana kimiyya sun yi ƙoƙari su lissafa waɗannan lambobin ga al'umma.
Cibiyar Nazarin Kiwon Lafiya ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar cutar ta cutar ta kasance tsakanin 0.1% zuwa 0.39%.
Wannan ƙididdigar ta dace da sakamakon gwajin farko na COVID-19 a Jamus, da kuma nazarin kididdiga da ke nazarin tasirin gwajin akan ƙididdigar CFR.
Hukumar lafiya ta duniya ta tabbatar da cewa za a iya sarrafa cutar.
Ba a bayyana lokacin da cutar ta ƙare ba kuma za ta iya bambanta da wurin.
Masanin ilimin kimiyyar cutar Boney daga Penn State University ya ce, "Ba tare da bincike ba, cutar ta zama mai yawa kuma ta fara raguwa lokacin da cutar ta rasa damar yin amfani da kwayoyin halitta.
Amma ba za ka iya yin hasashen lokacin da hakan zai faru ba".
Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin, Zhong Nchan, ya yi jayayya cewa "za a iya kammala shi a watan Yuni" idan za a iya shirya dukkan kasashe su bi shawarar da WHO ta bayar game da matakan da za a dauka don hana yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kocharsky na Jami'ar London na maganin rigakafi da na Tropical Medicine ya ce SARS-CoV-2 "zai iya ɓace cikin shekara guda ko biyu".
A cewar wani bincike na Kwalejin Shugabancin Imperial wanda Neil Ferguson ya gudanar, ana bukatar yin zaman lafiya da sauran matakan da za su "canci samun allurar rigakafi (watakila watanni 18 ko fiye)".
William Shaffner na Jami'ar Vanderbilt ya ce, "Ina ganin cewa cutar korona ba za ta iya zama cikakkiyar cuta ba - saboda tana da yawa - kuma "yana iya zama wata cuta ta yanayi, wadda za ta dawo kowace shekara".
Rashin dawowa yana da mahimmanci dangane da juriya da yawan tsalle.
Alamomin COVID-19 na iya zama marasa kulawa kuma mutane da suka kamu da cutar na iya zama marasa alamun cutar.
Abubuwa biyu da suka fi kowa a cikin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Sauran alamun cututtuka na yau da kullum sun haɗa da bugun jini, numfashi mai ƙyama, rashin jin daɗin dandano, numfashi mai ƙyama, ciwon jijiyoyin jiki da haɗin gwiwa, ciwon huhu, ciwon hanci, haushi, haushi, zubar da jini tare da tari, ciwon ciki, ko kuma launin fata. Hukumar lafiya ta duniya ta ce kusan kashi ɗaya cikin shida na mutane suna fama da rashin lafiya mai tsanani kuma suna fama da matsalar numfashi.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta gano alamun gaggawa kamar rashin numfashi, ciwo ko matsa lamba na kullum a cikin hanci, tashin hankali na gaggawa, rashin tafiya, da fuska ko lebe mai launin shuɗi; ana buƙatar kulawa ta likita nan da nan idan waɗannan alamun sun kasance. Ƙarin ciwon zai iya haifar da ciwon huhu, ciwon huhu na lokaci-lokaci, cutar jini da mutuwa.
Wasu daga cikin waɗanda suka kamu da cutar na iya zama marasa bayyanar cututtuka, ba su da alamun asibiti amma sakamakon gwajin da ya tabbatar da kamuwa da cutar, saboda haka masu bincike sun ba da shawara cewa waɗanda suka yi hulɗa da mutane da suka kamu da cutar da aka tabbatar da su ya kamata a kula da su sosai kuma a yi musu allurar rigakafi don kawar da cutar.
Ana sa ran yawan rashin bayyanar cututtuka a kasar Sin daga kadan zuwa kashi 44 cikin dari.
Lokacin da aka yi amfani da shi (lokacin da aka yi amfani da shi tsakanin kamuwa da cutar da farawar bayyanar cututtuka) ya kai kwanaki 1 zuwa 14; mafi yawan kwanaki 5 ne. A matsayin misali mai kyau, ana ganin cewa adadin mutanen da ke da cutar COVID-19 da suka rasa ƙanshi ya fara da kashi 30 cikin 100 sannan ya ragu zuwa 15 cikin 100.
Har yanzu ba a gano wasu bayanai game da yadda cutar ta kasance ba.
Ana ganin cewa cutar ta fara ne a lokacin da aka yi wa mutum kusan magana, kuma ƙananan ƙwayoyin cuta suna yaduwa yayin shan barasa, yin magana ko magana; kusancin da aka yi wa mutum ya kai mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Bincike ya nuna cewa cocaine da aka saka a ciki zai iya kai kwari zuwa mita 4.5 (15 ft) zuwa 8.2 (27 ft).
Wasu sun bayar da shawarar cewa za a iya watsa cutar ta hanyar ƙananan saukad da da ke cikin iska na dogon lokaci, wanda zai iya faruwa yayin magana. Saukad da numfashi na iya faruwa yayin numfashi, ta hanyar magana, ko da yake ba a iya watsa cutar ta iska ba.
Ana iya yin saukad da su a bakin ko a cikin hanci ko kuma a cikin huhu.
Wasu hanyoyin magani kamar su cututtukan jijiyoyin jini da cututtukan zuciya (CPR) na iya sa numfashi ya shiga cikin iska, don haka ya haifar da yaduwar iska.
Ƙari ga haka, zai iya faruwa idan mutum ya taɓa tufafi marasa tsabta, ya taɓa fata, ya taɓa idanunsa, ya taɓa bakinsa ko kuma ya taɓa bakinsa.
Duk da yake akwai damuwa cewa za a iya yada shi ta hanyar gurbatawa, ana ganin wannan hadarin yana da ƙananan.
Gwamnatin kasar Sin ta yi watsi da yiwuwar kamuwa da cutar SARS-CoV2 ta hanyar zubar da jini. Kwayar ta yi yawa a cikin kwanaki uku na farko bayan bayyanar cututtuka, ko da yake yana iya faruwa kafin bayyanar cututtuka da kuma a cikin matakai na gaba na cutar.
Mutane da suka kamu da cutar sun tabbata har kwana uku kafin bayyanar cututtuka, wanda ya nuna cewa cutar za ta iya tashi kafin bayyanar bayyanar cututtuka.
Akwai rahotanni kaɗan na tabbataccen yanayin rashin bayyanar cututtuka, amma an sami karuwar marasa bayyanar cututtuka a ƙasashe da yawa a cikin binciken binciken bincike.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce yayin da ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar tana rayuwa a kan tufafi na tsawon sa'o'i.
A musamman, an gano cutar a kan filastik (polypropylene) da karfe 304 na kwana uku, a kan al'ada na kwana ɗaya, da kuma a kan tagulla na kwana hudu.
Koyaya, wannan yana iya haifar da zafi da zafi. Dabbobin gida da sauran dabbobi suna da cutar COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya watsa kwayar cutar ga mutane, ko da yake hukumomin Birtaniya sun ba da shawarar wanke hannayensu bayan sun rasa dabbobi, kamar bayan sun haɗu da tufafin da waɗanda suka kamu da cutar suka taɓa.
Cutar coronavirus ta biyu (SARS-CoV-2) sabon kwayar cuta ce, an fara rarraba ta daga mutum uku da ke fama da cutar huhu zuwa wani rukuni na masu fama da cutar huhu a Wuhan.
Dukkanin halaye na SARS-CoV-2 sun kasance a cikin yanayin coronavirus. A waje da jikin mutum, ana kashe kwayar tare da sabulu na gida, wanda ke lalata ƙwayar cutar mai karewa. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
An yi imani da cewa akwai zuriyar dabba.
Binciken da aka yi a gaba ya nuna cewa kwayar cutar ta kamu da kwayar cutar ta beta-coronavirus, a cikin wani nau'in SARS-CoV-2 (linear B) tare da kwayoyin halitta biyu da aka samo daga batsa.
Ya yi daidai da kashi 96% na kwayoyin halitta na sauran kwayoyin cutar kwayar cutar kwayar cutar BatCov TaTG13.
A watan Fabrairun 2020, masu binciken kasar Sin sun kammala cewa akwai bambanci guda daya na amino acid a cikin sassan da dama na jerin kwayoyin halitta tsakanin kwayar cutar penguin da na mutum.
A yau, an samu kusan kashi 92% na yawan al'amuran da aka danganta da kwayoyin halitta tsakanin cutar coronavirus ta Pangolin da SARS-CoV-2, wanda ba a samu isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isasshen isas .
Ana iya sanin ko cutar ta sa mutum rashin lafiya bisa ga alamun bayyanar cututtukan, ko da yake a ƙarshe ana tabbatar da hakan ta hanyar juyawa na polymerase chain reaction (rRT-PCR) ko kuma yin CT.
Wani bincike da aka yi a Wuhan ya nuna cewa CT tana da matukar damuwa fiye da PCR, ba a gano cututtukan ba, tare da halaye na haskakawa da suka yi daidai da sauran cututtukan cututtukan huhu da sauran cututtuka.
Har zuwa watan Maris na 2020, Kwalejin Nazarin Radiology ta Amirka ta ba da shawarar cewa "ba za a yi amfani da CT don ganewar asali ba ko kuma a matsayin gwajin farko don gano COVID-19".
Hukumar lafiya ta duniya ta fitar da wasu takardun shaida na gwajin RNA don SARS-CoV-2, wanda aka fara wallafawa a ranar 17 ga watan Janairu.
Binciken yana amfani da polymerase chain reverse-time (rRT-PCR) amsa.
Ana iya yin gwajin a kan numfashin numfashi ko jini.
A yawancin lokaci, sakamakon zai kasance bayan 'yan sa'o'i zuwa kwanaki.
Ana yin wannan gwajin ne a kan naman alade na hanci ko da yake ana iya yin amfani da naman alade mai tsabta. Yawancin dakunan gwaje-gwaje da kamfanoni suna ci gaba da gwajin sinadarai, wanda ke gano maganin.
Har zuwa 6 ga Afrilu 2020, babu wani daga cikin waɗannan da aka ba da izinin yin amfani da su don amfani da su.
A Amurka, Cellex ta ci gaba da kuma amince da gwajin sirrology don amfani da gaggawa ta hanyar gwaje-gwaje masu amincewa kawai.
Abubuwan da ke cikin musamman na radiography da CT na mutane da ke da alamun sun hada da rashin haske na gilashin gilashi da rashin fitarwa.
Ƙungiyar Radiology ta Italiya ta tattara wani bayanan kan layi na sakamakon hasken rana na yanayin da aka tabbatar.
Saboda rikice-rikice na wasu cututtuka kamar adenovirus, ba a tabbatar da PCR ba yana da iyakance ga gano COVID-19.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT da PCR kuma ya nuna cewa yayin da hasken ya fi ƙarancin cutar, ya fi sauri da kuma saurin kamuwa da cutar, ya ba da shawarar cewa ya zama kayan aikin bincike a wuraren da ake kamuwa da cutar.
An kirkiro cibiyar sadarwa ta neuronal ta hanyar fasaha ta wucin gadi don gano halaye na haskakawa tare da radiography da CT.
Dabarun hana kamuwa da cutar sun haɗa da kiyaye tsabta na mutum, wanke hannu, guje wa rasa idanu, hanci ko baki da hannu ba tare da an yi amfani da su ba, cocaine ko pyjamas da kuma jefa su cikin shara.
An gargaɗi waɗanda suke da wannan cuta su sa abin rufe fuska a fili.
Ana kuma ba da shawarar yin nesa da jiki don hana yaduwar cutar. Gwamnatoci da yawa sun ƙuntata ko kuma sun ba da shawara game da duk wani tafiya da ba ta da kyau da kuma kauce wa ƙasar ko yankunan da cutar ta kamu.
Koyaya, cutar ta kai ga yaduwar al'umma a wurare masu yawa a duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'umma, kuma wasu mutane ba su san inda ta fito ko kuma yadda ta kamu ba. Masu ba da kula da lafiya suna kula da wanda zai iya kamuwa da cutar kuma an umurce su da su yi amfani da daidaitaccen gargaɗi na farko da kuma ido. Kula da kamuwa da cutar yana da muhimmanci ga hukumomin lafiya don gano tushen cutar da kuma hana shi wucewa.
Amfani da bayanan wuri a wayoyin hannu ta gwamnatoci don wannan dalili ya haifar da damuwa ta musamman, tare da masu ba da shawara na ƙasa da fiye da 100 sauran ƙungiyoyi suna ba da bayani kuma suna neman ƙuntata irin waɗannan sa ido.
An tura ko kuma an ba da shawarar aikace-aikacen hannu da yawa don amfani da kai tsaye, kuma har zuwa 7 ga Disamba, 2020, fiye da dozin ƙungiyoyin ƙwararru suna aiki a kan hanyoyin da ke da alaƙa da sirri, kamar amfani da Bluetooth don yin rikodin kusanci na mai amfani a wasu wayoyin hannu.
Masu amfani za su karɓi wasiƙa idan sun kasance a cikin kusanci da wani wanda ya kamu da COVID-19. Akwai ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar; alal misali, wanke hanci da kuma yin amfani da tsabtace baki ba su da amfani.
Babu allurar rigakafin COVID-19, ko da yake ƙungiyoyi na iya aiki don samar da ɗaya.
Ana ba da shawarar yin wanka don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa aƙalla na tsawon dakika 20, musamman bayan sun shiga bayan gida ko kuma idan hannayensu sun kasance marasa tsabta; kafin cin abinci; da kuma bayan sun shafe hanci, cocaine ko sinadarin.
Wannan shi ne saboda a waje da jikin mutum, ana kashe kwayar da sabulu na gida, wanda ke kashe ƙwayar cutar ta atomatik.
CDC ta kara bada shawarar yin amfani da kayan tsabtace rufi wanda ya ƙunshi aƙalla kashi 60% na rufi lokacin da sabulu da ruwa ba su samuwa ba.
Hukumar lafiya ta duniya ta shawarci mutane su guji yin amfani da hannayen hannu wajen zubar da idanu, hanci, ko bakinsu.
Ana iya tsabtace sutura da yawa (a cikin minti daya bayan haɗuwa da mai tsabtace kayan aiki don yin laushi), yana dauke da kashi 62-71% na isanol, 50-100% na isopropanol, 0.1% na sodium hydrochloride, 0.5% na hydrogen peroxide, da 0.2-7.5% na iodine-povoiodine.
Sauran abubuwa, kamar benzalkonium chloride da gluconate chloroxide sun fi aiki.
CDC ta ba da shawarar cewa idan ana zargin ko tabbatar da wani COVID a wani wuri kamar ofishi ko wurin kula da mutane a kullum, duk wuraren da ake amfani da su kamar ofisoshin, dakunan wanka, wuraren da ake amfani da su, kayan lantarki da aka haɗa kamar allunan, allon allo, allon rubutu, na'urorin sarrafawa, da kuma na'urorin ATM da marasa lafiya ke amfani da su, ya kamata a tsabtace su da cutar.
Ƙungiyoyin kiwon lafiya sun ba da shawarar rufe bakinka da hanci da kuma clench a lokacin shan cocaine ko peach, kuma ka zubar da clench nan da nan.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda za su iya kamuwa da cutar, saboda yin amfani da abin rufe fuska zai rage girman da kuma nisan da za su iya wucewa yayin da suke numfashi yayin magana, fashi da kuma yin kuka.
Hukumar lafiya ta duniya ta fitar da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin halittu a Jami'ar Leeds, "sa mask zai iya rage yawan asarar fuska, wanda shine babban tushen kamuwa da cutar rashin tsabtace hannu". An kuma bada shawarar yin amfani da mask ga masu kula da wanda ya kamu da cutar.
Hukumar lafiya ta duniya ta ba da shawarar yin amfani da abin rufe fuska ga mutanen da ke da lafiya idan suna cikin haɗari, kamar waɗanda ke kula da wanda ke da cutar COVID-19, duk da cewa sun yarda cewa yin amfani da abin rufe fuska zai iya taimakawa mutane su guji rasa fuska.
Kasashe da dama sun fara inganta amfani da abin rufe fuska ga jama'a.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na masana'anta. China ta ba da shawarar musamman amfani da abin rufe fuska na likita ga jama'a masu lafiya, musamman a lokacin da suka kusanci (1 m (3 ft) ko ƙasa da haka) da wasu mutane.
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska na tiyata lokacin amfani da sufuri na jama'a ko kasancewa a wuraren da mutane ke da yawa.
Jami'an lafiya na Thailand sun bukaci mutane su yi amfani da fuska a gida kuma su wanke su kullum.
Jamhuriyar Czech da Slovakia sun haramta shiga ba tare da rufe fuska ko rufe hanci ba.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya sa abin rufe fuska a lokacin da ya shiga wuraren jama'a don kare kansa da kuma wasu.
Gwamnatin Austria ta ba da umarni cewa duk wanda ya je shagon dole ne ya sa abin rufe fuska.
Isra'ilawa sun umarci dukan mazaunan su sa abin rufe fuska a lokacin da suke cikin jama'a.
Taiwan, wadda ta samar da masks miliyan goma a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da bas su saka su a ranar 1 ga Afrilu.
Panama ta yi watsi da yin amfani da abin rufe fuska a lokacin fita, yayin da ta ba da shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya saya shi ba.
Ana amfani da masks a Japan, Koriya ta Kudu, Malaysia da Singapore.
Tsare-tsare na zamantakewa (wanda aka fi sani da tsare-tsare na farar fata) ya ƙunshi ayyukan sarrafawa na cutar da nufin rage yaduwar cutar ta hanyar rage haɗuwa tsakanin mutane.
Hanyoyi sun haɗa da killacewa, ƙuntata tafiye-tafiye; da rufe makarantu, wuraren tarihi, filayen wasa, gidajen wasan kwaikwayo ko wuraren cin kasuwa.
Mutane na iya yin amfani da hanyoyin da za su iya yin nesa da juna ta hanyar kasancewa a gida, ƙuntata tafiya, guje wa wuraren da mutane suke, yin amfani da gaisuwa ba tare da tuntuɓar juna ba, da kuma nisantar da kansu daga juna.
Yawancin gwamnatoci yanzu suna ba da umarni ko kuma suna ba da umarnin yin nesa da jama'a daga yankunan da cutar ta shafa.
An rage yawan taron da hukumomin gwamnatin Amurka da kungiyoyin kiwon lafiya suka yi daga 250 (idan babu sanannen yaduwar COVID-19 a yankin) zuwa 50, sannan kuma zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta haramta taron jama'a fiye da mutum biyu. Manya tsofaffi da waɗanda ke da yanayin likita kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, ƙwayoyin jini da kuma rashin lafiyar jiki suna fuskantar haɗarin kamuwa da cuta mai tsanani kuma CDC ta ba su shawara su zauna a gida a wuraren da jama'ar ke fama da cutar. A ƙarshen Maris, 2020, Hukumar Lafiya ta Duniya da sauran hukumomin kiwon lafiya sun fara canza amfani da kalmar "tsarewar zamantakewa" zuwa "tsarewar jiki", don bayyana cewa manufar rage haɗarin jiki yayin hulɗa da jama'a, ko dai ta hanyar kasuwanci ko ta nesa.
Yin amfani da manufar "tashar zamantakewa" ya nuna cewa mutane suna buƙatar shiga cikin cikakken zamantakewar zamantakewa, maimakon ƙarfafa su su bar hulɗa da wasu ta hanyar dalilai na daban. Wasu hukumomi sun ba da umarnin kiwon lafiya na jima'i don amfani a lokacin annobar.
Waɗannan sun haɗa da yin jima'i da mutumin da kake zama da shi kawai, wanda ba shi da cutar ko alamun cutar.
Ana ba da shawarar yin keɓewa a gida ga waɗanda ke da COVID-19 da waɗanda ake zaton suna da cutar.
Hukumomin lafiya sun ba da umarni masu kyau game da yin zaman kansu. Gwamnatoci da yawa sun ba da umarni ko kuma sun ba da shawarar yin zaman kansu ga dukan mutanen da ke zaune a yankunan da aka yi wa cutar.
An ba da ƙa'idodin ƙa'idodin keɓance kai ga waɗanda ke cikin haɗarin haɗari.
Waɗanda suka yi cuta da wani wanda ke da cutar COVID-19 kuma suka yi tafiya zuwa wata ƙasa ko yanki da aka yi amfani da shi a cikin jama'a, an shawarce su su keɓe kansu na kwanaki 14 bayan an yi musu sabon kamuwa.
Dabaru na sarrafa yaduwar cutar sun haɗa da hana ko hanawa, da ragewa.
Ana yin rigakafin cutar a farkon farkon annobar, kuma ana yin bincike da warewa don gano masu kamuwa da cutar tare da samar da ƙarin matakan sarrafa cutar da alluran rigakafi don hana cutar yaduwa zuwa sauran sassan duniya.
Idan ba a iya hana yaduwar cutar ba, sai a yi ƙoƙari a rage shi: ana yin matakan da za a rage yaduwar cutar da kuma rage tasirinsa a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya ɗaukar matakan ragewa da ragewa a lokaci guda.
Rigakafin yana bukatar ƙarin matakai, don juyawa yaduwar cutar daga mutum zuwa mutum zuwa ƙasa da kashi ɗaya na gudanarwa da kuma magance yaduwar cutar ta hanzari shine ƙoƙarin rage yawan yaduwar cutar ta hanyar daidaita yanayin yaduwar.
Wannan zai rage haɗarin samun ƙarin tallafi a kan ayyuka kuma ya ba da ƙarin lokaci don haɓaka alluran rigakafi da magani.
Ayyukan da ba na asibiti ba da za su iya hana yaduwar cutar sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da kuma warewa; ayyukan al'umma don yin nesa da jiki kamar rufe makarantu da hana manyan taron; haɗin gwiwar al'umma don ƙarfafa yarda da shiga cikin irin waɗannan ayyukan; da kuma matakan muhalli kamar tsabtace tufafi. Ayyukan da aka fi dacewa da nufin hana yaduwar cutar a China a lokacin da cutar ta fara, kamar hanawa birane gaba ɗaya da kuma sanya takunkumin tafiye-tafiye.
Ƙasashe da dama sun ɗauki wasu matakai don hana yaduwar cutar.
Koriya ta Kudu ta gudanar da bincike na jama'a da killace mutane a gida, kuma ta ba da sanarwar cewa mutane da suka kamu da cutar za su iya yin tafiya.
Singapore ta ba da tallafi na kudi ga waɗanda suka kamu da cutar da ke keɓe kansu kuma ta ba da tsauraran hukunci ga waɗanda ba su yi hakan ba.
Taiwan ta kara samar da masks kuma ta yi amfani da takunkumi don sayen kayan magani. Hakazalika ga Birtaniya da Amurka, rage (kashewa maimakon dakatar da yaduwar cutar) da kuma katatire (kashe ci gaban cutar) suna da manyan kalubale.
Kyakkyawan tsarin rage yawan cutar zai iya rage yawan bukatar karin kiwon lafiya da kashi biyu cikin uku da kuma mutuwar da ke faruwa, amma har yanzu yana haifar da mutuwar dubbai da kuma lalata tsarin kiwon lafiya.
Ana iya ganin ana iya yin maganin cututtuka amma dole ne a bar shi har sai an samu kamuwa da cutar a cikin ɗan adam (ko kuma har sai an samu allurar rigakafi, idan wannan ne farkon), saboda za a iya samun karuwar cutar idan an kawar da matakan.
Yin aiki na dogon lokaci don kawar da cutar zai haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman maganin cutar COVID-19, amma ana ƙoƙari a ci gaba da ci gaba, ta hanyar gwada hanyoyin da ake samu.
Shan maganin rigakafi, shan ruwa, da kuma hutawa na iya taimakawa wajen rage alamun.
Dangane da tsanani, ana iya buƙatar maganin oxygen, ruwa a cikin jijiyoyi, da kuma taimakon numfashi.
Yin amfani da abubuwan motsa jiki na iya sa sakamakon ya zama mafi muni.
Ana nazarin wasu abubuwa da aka amince da su a baya don magance wasu cututtukan cutar don amfani a maganin COVID-19.
Hukumar lafiya ta duniya ta ce wasu "magungunan da aka yi a gida" na iya taimakawa wajen rage alamun cutar SARX-CoV-19.
Ƙarfafawa da kuma amfani da kiwon lafiya don biyan bukatun marasa lafiya na COVID-19 an bayyana shi a matsayin wata hanya ta hana yaduwar cutar ta hanyar sadarwa ta hanyar WHO.
ECDC da Hukumar Kula da Lafiya ta Turai ta Hukumar Lafiya ta Duniya sun ba da umarni ga asibitoci da kuma cibiyoyin kiwon lafiya na farko don sauya albarkatu a matakai da yawa, ta hanyar haɗa da ƙarfafawa ga sabis na dakin gwaje-gwaje don gano COVID-19, hana zaɓin magani a duk lokacin da ya dace, ware masu cutar COVID-19, da haɓaka ikon kulawa mai tsanani ta hanyar horar da ma'aikata da kuma ƙara yawan na'urorin numfashi da kwanciya.
Akwai ra'ayoyi da yawa game da inda cutar ta farko (wanda ake kira cutar lamba) ta samo asali.
An fara samun sanannen kamuwa da cutar korona a ranar 1 ga watan Janairun 2019 a Wuhan, Hubei, China.
A cikin wata daya, adadin masu dauke da cutar korona a Hubei ya karu.
Wadannan sun kasance da yawa daga cikin kasuwar sayar da abincin teku na Huainan, inda aka sayar da dabbobi masu rai, kuma akwai ra'ayin cewa kwayar ta fito ne daga ɗayan waɗannan dabbobi; ko, a wata hanya, ta fito ne daga dabba. An lura da wani sanannen sanadin cutar huhu a ranar 26 ga watan Janairu kuma Dr. Zhang Jackson ya kula da shi a asibitin yanki na Hubei, wanda ya sanar da CDC na Jinghan a ranar 27 ga watan Janairu.
A ranar 30 ga watan Disamba, wata ƙungiyar likitoci a babban asibitin Wuhan ta sanar da abokan aikinta game da "kwararrun coronavirus kamar SARS".
Likitoci takwas, da suka hada da Li Wenliang, sun yi gargadi sosai daga 'yan sanda game da yin ƙarya, kuma wani, IFN, ya yi wa shugabansa barazana saboda ya kara yawan sanadin haɗari.
Bayan haka, Hukumar Lafiya ta Wuhan ta ba da sanarwar sanarwa a ranar 31 ga watan Disamba kuma ta sanar da Hukumar Lafiya ta Duniya.
An bayar da rahoton wani adadi mai yawa na cutar sankarar huhu da ba a san san dalilinsa ba ga hukumomin lafiya a Wuhan don fara bincike a farkon watan Janairu. A farkon farkon annobar, adadin al'amura ya ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairu na shekarar 2020, cutar ta yada a wasu yankunan kasar Sin, tare da taimakon bikin sabuwar shekara ta kasar Sin da kuma tashar jiragen kasa da tashar jirgin kasa ta Wuhan.
A ranar 20 ga watan Janairu, kasar Sin ta sake samun wasu sabbin mutane 140, ciki har da mutane biyu a Beijing da kuma daya a birnin Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa, a ranar 20 ga Janairu, 2020, kimanin mutane 6174 sun kamu da cututtukan cutar. A ranar 26 ga Maris, Amurka ta gabace China da Italiya da samun mafi yawan adadin masu kamuwa da cutar a duniya. A ranar 9 ga Afrilu, 2020, an samu fiye da miliyan 1.61 da aka ruwaito a duniya, fiye da mutane 97,000 sun mutu kuma fiye da mutane 364,000 sun warke.
Akwai aƙalla wasu cututtuka a cikin ƙasashe da yankuna 200 da suka faru.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun ƙuntata motsi na 'yanci kuma sun kafa iyakoki.
Amsar ƙasa ta ƙunshi matakan hanawa kamar keɓewa (wanda aka fi sani da dokar zama a gida, dokar fita a cikin shuttle, ko dokar hana fita daga gida) da kuma hana zirga-zirga. A ranar 2 ga Afrilu, kusan mutane miliyan 300, kusan kashi 90% na yawan jama'a, sun kasance a cikin wani nau'i na zama a gida a Amurka, fiye da mutane miliyan 50 a gida a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu, da kuma mutane biliyan 1.3 a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wani nau'i na rashin zama a gida, wanda ya karu zuwa biliyan 2.6 a cikin kwanaki biyu - kusan kashi ɗaya bisa uku na yawan duniya.
An samu mutum na farko da ya kamu da cutar COVID-19 a Wuhan a ranar 1 ga watan Janairu na 2019; wani rahoto da ba a tabbatar da shi ba ya nuna cewa an samu mutum na farko a ranar 17 ga watan Janairu.
Dr. Zhang Jackson ya lura da wani hali na cutar huhu da ba a san dalilinsa ba a ranar 26 ga Janairu, wanda ya sa asibitin ya sanar da CDC na Wuhan a ranar 27 ga Janairu.
Gwajin farko na kwayoyin halitta na marasa lafiya a ranar 27 ga watan Janairun 2019 ya nuna cewa akwai wani kwayar cutar coronavirus mai kama da SARS.
An bayar da sanarwar sanarwa ta hukumar kula da lafiyar birnin Wuhan a ranar 31 ga watan Disamba.
Hukumar lafiya ta duniya ta sanar da hakan a ranar.
A lokacin da aka yi wannan gargadin, 'yan sanda sun gargadi likitoci a Wuhan game da "fitar da jita-jita" game da yaduwar cutar.
Da farko dai Hukumar Lafiya ta kasar Sin ta ce babu "babban tabbaci" na cewa za a iya canja wurin mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na cin hanci da rashawa wanda sakataren jam'iyyar ta Communist Party ta kasar Sin ya bayyana a matsayin "yaƙin jama'a" don hana yaduwar cutar.
A ranar 23 ga watan Janairu, an sanar da wani hukunci na dakatar da zirga-zirga zuwa Wuhan da kuma wajenta, wanda aka mika wa biranen 15 a Hubei, inda ya shafi mutane miliyan 57.
An haramta amfani da motocin sirri a birnin.
Ana yin bikin Sabuwar Shekara ta Sin (25 ga Janairu) a wurare da yawa.
Hukumomi sun kuma sanar da cewa za a kammala ginin asibitin wucin gadi, Hussain Shan, cikin kwanaki 10.
Daga bisani aka gina wani asibiti, asibitin Lichetshan, don kula da ƙarin cututtuka.
Baya ga sababbin asibitoci da aka gina, kasar Sin ta kuma mayar da wasu wurare 14 a Wuhan, kamar cibiyoyin taro da wuraren wasanni, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta ɗauki wasu matakai don magance barkewar cutar COVID-19, ta haɗa da sanar da sakin lafiya ga masu yawon bude ido da kuma tsawaita hutun bikin bazara.
An rufe jami'o'i da makarantu a fadin kasar.
Yankunan Hong Kong da Macau suna da dokoki da yawa, musamman game da makarantu da jami'o'i.
Ana samun damar yin aiki a nesa a yankuna da yawa a kasar Sin.
An sanya takunkumin tafiye-tafiye a ciki da wajen Hubei.
An hana zirga-zirgar jama'a, kuma an rufe gidajen tarihi a duk faɗin China na ɗan lokaci.
An yi amfani da matakan hana zirga-zirgar jama'a a birane da dama, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) suna fama da wasu nau'ikan ƙuntatawa a waje. Bayan barkewar cutar ta shiga duniya a watan Maris, hukumomin China sun ɗauki matakan da suka dace don hana "tafiyar" cutar daga wasu ƙasashe.
Alal misali, Pakistan ta sanya dokar keɓewa ta kwanaki 14 ga dukan matafiya na duniya da ke shiga birnin. A ranar 23 ga Maris, a kasar Sin, an samu mutum daya da ya kamu da cutar a cikin kwanaki biyar, a wannan yanayin ta hanyar matafiya da ke dawowa daga Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keyang ya bayyana cewa an toshe yaduwar cutar ta gida kuma an hana yaduwar cutar a kasar Sin.
A wannan ranar ne aka rage takunkumin tafiye-tafiye a Hobi, banda Wuhan, watanni biyu bayan an kafa dokar hana fita daga gida. Ma'aikatar harkokin wajen kasar Sin ta sanar a ranar 26 ga Maris, 2020 cewa masu shiga visa ko masu riƙe da izinin zama za a dakatar da su har zuwa ranar 28 ga Maris, ba tare da wata sanarwa ba game da lokacin da wannan manufar za ta ƙare.
Masu son shiga kasar Sin suna bukatar su nemi takardar visa a ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta karfafa harkokin kasuwanci da masana'antu su bude a ranar 30 ga watan Maris, kuma ta ba da kudade masu yawa ga kamfanoni. Majalisar Dinkin Duniya ta yi ta yi makoki ranar da za a fara da minti uku na yin shiru a karfe 10:00 na dare a ranar 4 ga watan Afrilu, daidai da bikin Kingming, ko da yake gwamnatin tarayya ta bukaci iyalai su yi aiki tare don la'akari da kasancewa a waje don hana sabon yaduwar COVID-19.
A ranar 20 ga Janairu, 2020, an tabbatar da cewa COVID-19 a Koriya ta Kudu ya samo asali ne daga China.
A ranar 20 ga watan Fabrairu, Hukumar Lafiya ta Kasa ta ba da rahoton wani gagarumin tashin hankali, wanda ya kasance saboda taron da aka yi a cikin wani addini da ake kira Shinxiongji Church of Christ a Daegu.
Ma'aikatan yankin Sinji da suka ziyarci birnin Wuhan sun yi zargin cewa su ne tushen cutar.
A ranar 22 ga Fabrairu, daga cikin masu bin Ikilisiya 9,336, 1,261 ko kusan 13% na masu bin sun sami alamun cutar. Koriya ta Kudu ta ba da sanarwar mafi girman matakin gargadi a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an samu karin karin karin mutum 2,000 da aka tabbatar da cutar a Koriya, daga ranar 29 ga watan Fabrairu zuwa 3150.
An killace dukkan sansanonin soja na Koriya bayan an tabbatar da cewa sojoji uku sun kamu da cutar.
An yi amfani da shi a kan jadawalin jiragen sama kuma an canza su. Koriya ta Kudu ta kirkiro abin da ake kira mafi girma da mafi kyawun shirin gudanarwa a duniya don bincika yawan jama'a don cutar, kuma ware duk wanda ya kamu da cutar da kuma bin diddigin waɗanda suka kasance masu cutar.
Hanyar gwajin kanta ta ƙunshi yin rahoton da aka tilasta wa sababbin 'yan ƙasa da suka shigo ta hanyar aikace-aikacen hannu, yin gwajin mota don gano cutar tare da samun sakamako a rana mai zuwa, da kuma ƙara ƙarfin gwajin don samun mutane 20,000 da za a iya gwadawa kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin nasara wajen hana yaduwar cutar duk da cewa ba a killace biranen ba. An fara raba al'ummar Koriya ta Kudu a kan yadda Shugaba Moon Jae-in ya amsa wannan rikicin.
Sun yi ikirarin cewa gwamnati ba ta yi aiki mai kyau ba, ko kuma sun yaba da amsar da suka bayar.
A ranar 23 ga watan Maris, an sanar da cewa Koriya ta Kudu ta samu karamin adadin wadanda suka kamu da cutar a rana daya a cikin makonni hudu.
A ranar 29 ga watan Maris, an sanar da cewa daga 1 ga watan Afrilu, za a yi wa dukkan jiragen da ke shigowa daga kasashen waje killace na tsawon makonni biyu.
A ranar 1 ga watan Afrilu, kafofin yada labarai sun ruwaito cewa Koriya ta Kudu ta karbi buƙatun taimako na gwajin cutar daga kasashe 121.
A ranar 19 ga watan Fabrairu, Iran ta ba da rahoton farkon tabbatar da cutar SARS-CoV-2 a cikin Sand, inda, a cewar Ma'aikatar Kiwon Lafiya da Ilimin Likita, mutane biyu suka mutu a baya a ranar.
Dokokin farko da gwamnati ta sanar sun haɗa da hana kide-kide da sauran al'adu, wasanni, sallar Jumma'a, da rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da tiriliyan 5 na kasar Sin don magance cutar.
A ranar 26 ga watan Fabrairun 2020, Shugaba Hassan Rouhani ya ce babu wani shiri na killace wuraren da cutar ta shafa, mutane ne kawai za a killace.
A watan Maris, an sanar da shirin rage zirga-zirgar jiragen ruwa tsakanin birane, ko da yake zirga-zirga tsakanin birane ya ci gaba kafin sabuwar shekarar Farisa ta Nuwara.
Har zuwa 16 ga watan Maris, 2020, wuraren ibada na Shi'a a Sand na ci gaba da bude wa masu ziyara. Iran ta zama cibiyar yada cutar a watan Fabrairu bayan kasar Sin.
A kan zargin ɓoye adadin annobar a Iran, a ranar 28 ga Fabrairu, fiye da kasashe goma sun mayar da al'amura ga Iran, suna nuna cewa yawan annobar na iya zama mafi muni fiye da 388 da gwamnatin Iran ta bayyana a lokacin.
An rufe majalisar dokokin Iran, tare da 23 daga cikin 290 da aka yi wa kamuwa da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Hukumar Kula da Hakkokin Dan Adam ta bukaci hukumomin kurkuku na Iran da su saki masu kare hakkin dan Adam da aka kama da rashin lafiya saboda rashin amincewa da zaman lafiya, da kuma sake sakin sauran fursunoni masu cancanta.
Ya ce akwai babban haɗari na yaduwar cutar a wuraren da aka rufe kamar cibiyoyin kula da mutane, inda ba a buƙatar kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, wanda ya fi yawan mutane da aka samu a rana guda a kasar tun lokacin da cutar ta fara.
Akalla 'yan siyasa 12 na yanzu ko na baya da kuma jami'an gwamnati na Iran sun mutu daga cutar a ranar 17 ga watan Maris.
A ranar 23 ga watan Maris, Iran ta samu karin mutum 50 da suka kamu da cutar a kowace awa, kuma a kowace minti goma, mutum daya ya mutu sakamakon cutar ta coronavirus.
Wani jami'in Hukumar Lafiya ta Duniya ya ce, ana iya samun karin mutum biyar a Iran fiye da yadda aka ruwaito.
An kuma yi shawarar cewa takunkumin da Amurka ta dauka kan Iran zai shafi karfin tattalin arzikin kasar wajen magance yaduwar cutar.
Babban kwamishinan Majalisar Dinkin Duniya na kare hakkin dan Adam ya bukaci a rage yawan matsalolin tattalin arziki da ake fama da su a kasashen da cutar ta shafa, ciki har da Iran.
An tabbatar da kamuwa da cutar a Italiya a ranar 31 ga Janairu, lokacin da matafiya biyu na kasar Sin da ke Roma suka kamu da cutar SARS-CoV-2.
Al'amuran sun karu da sauri, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen sama zuwa da zuwa China kuma ta ayyana dokar ta baci.
Daga bisani an gano wani rukuni na marasa alaƙa na COVID-19, tare da 16 da aka tabbatar a Lamborghini a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, majalisar Ministoci ta ba da sabon umarni don hana yaduwar, kamar yin killace fiye da 50,000 a cikin garuruwa 11 daban-daban a arewacin Italiya.
Firayim Minista Gusipi Conte ya ce, "Ba a ba da izinin shiga ko fita daga wuraren da cutar ta yadu ba.
An kuma ba da umarnin a dakatar da ayyukan aiki da kuma wasanni a yankunan. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin a rufe dukan makarantu da jami'o'i na kasar saboda mutuwar Italiya ta kai 100.
Duk manyan wasanni, ciki har da wasannin Serie A, za a yi su ba tare da wani dalili ba har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasanni na akalla wata guda.
A ranar 11 ga watan Maris, Firayim Minista Gusipi Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci banda manyan kantuna da kantunan magani. A ranar 6 ga watan Maris, Cibiyar Kula da Ragewa, Ragewa, Ragewa da Kulawa da Cutar (SIAARTI) ta fitar da shawarwarin likita game da tsarin kimantawa da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta bi China a matsayin ƙasa da ke da mafi yawan mutuwar da ke tattare da cutar coronavirus a duniya bayan da ta ba da rahoton mutuwar 3,405 daga cutar.
A ranar 22 ga watan Maris, an sanar da cewa Rasha ta tura jiragen sama na soja tara zuwa Italiya tare da kayan aikin likita.
A ranar 5 ga Afrilu, an tabbatar da shari'o'i 128,948, mutuwar 15,887, da kuma warkewar 21,815 a Italiya, mafi yawan lokuta a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa yawan tsofaffi a Italiya da rashin iyawar gano duk wadanda suka kamu da cutar a yau na iya haifar da yawan mutuwar.
Amsar da Birtaniya ta bayar game da cutar ta coronavirus ta fara bayyana a matsayin daya daga cikin kasashe da suka fi fama da cutar, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya wani matakin warewar jama'a ko keɓewa ga jama'a ba.
A sakamakon haka, an soki gwamnati saboda rashin yawan aiki da kuma rashin jin dadi a cikin amsa ga damuwar da ke tattare da rashin samun mutane. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar game da duk wani tafiya da kuma rashin amfani da zamantakewa, yana ba da shawarar mutane su yi aiki daga gida kuma su guji wuraren kamar clubs, gidajen cin abinci da kuma wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnatin ta sanar da cewa za a rufe dukkan wuraren da ake ciyar da lokaci kamar clubs da gyms a wuri-wuri, kuma ta yi alkawarin bayar da kashi 80% na albashi ga ma'aikata har zuwa £2,500 a kowane wata don hana rashin aikin yi a lokacin rikicin. A ranar 23 ga watan Maris, Firayim Minista ya sanar da tsaurara matakan nisantar zamantakewa, ya hana taron mutane fiye da biyu da kuma hana tafiya da ayyukan waje har sai da ya zama dole.
Ba tare da an yi amfani da dokoki na baya ba, 'yan sanda sun yi amfani da waɗannan ƙuntatawa ta hanyar zaɓan da kuma sanar da taron.
An ba da umarnin rufe yawancin kasuwancin, tare da cirewa ga kasuwancin da aka ɗauka "da ake buƙata", kamar su manyan kantuna, kantunan magani, bankunan, shagunan kayan aiki, shagunan mai da garages.
A ranar 20 ga watan Janairu, an tabbatar da cewa mutum na farko da ya kamu da cutar COVID-19 a Pacific Northwest, Washington, ya dawo daga Wuhan a ranar 15 ga watan Janairu.
An kafa tawagar cutar korona a fadar White House a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta bayyana dokar ta baci ta kiwon lafiya ta jama'a, kuma ta sanya takunkumi kan shigowar masu yawon bude ido daga China.
A ranar 28 ga watan Janairun 2020, Cibiyar Kula da Cututtuka - babbar cibiyar kiwon lafiya ta jama'a a gwamnatin Amurka - ta sanar da cewa Ketty ta ci gaba da gudanar da gwajin ta.
Duk da haka, Amurka ta samu jinkirin fara bincike, wanda ya bayyana ainihin yawan yaduwar cutar a lokacin.
A watan Fabrairu, gwajin ya kasance da matsala saboda takardun gwajin cutar ta jini da gwamnatin tarayya ta samar, rashin amincewar gwamnatin tarayya ga takardun gwaji na gwamnati (ta hanyar jami'o'i, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma ƙuntatawa ga jama'a su cancanci yin gwaji har zuwa farkon Maris (wanda daga bisani aka nemi umarnin likita).
A ranar 27 ga watan Fabrairu, Washington Post ta ruwaito cewa an yi fiye da bincike 4,000 a Amurka.
A ranar 13 ga watan Maris, Atlantic ta ba da rahoton cewa an yi fiye da 14,000 na binciken.
A ranar 22 ga watan Maris, Associated Press ta ruwaito: "Mutane da yawa da ke da alamun likita da umarni sun jira sa'o'i ko kwanaki don yin gwaji". Bayan an sanar da mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Alkalin J. Inselli ya sanar da dokar ta baci, wani aiki da sauran jihohi suka yi a baya.
Makarantun yankin Seattle sun yi watsi da koyarwar su a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu sun rufe a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, Amurka ta nemi wani kwamitin kwararru na cutar ta coronavirus a Imperial College London su yi hasashen tasirin sabon coronavirus a kasar.
A wannan rana, Shugaba Trump ya sanya hannu kan Dokar Kudin Shiga na Shirye-shiryen Kariya da Amsar Coronavirus, wanda ya ba da dala biliyan 8.3 daga asusun kudi na gaggawa ga hukumomin tarayya don magance cutar.
Kamfanoni sun ƙuntata tafiye-tafiyen ma'aikata, sun ƙi taron, kuma sun ƙarfafa ma'aikatansu su yi aiki daga gida.
An hana wasanni da wasanni. A ranar 11 ga Maris, Trump ya sanar da ƙuntata tafiye-tafiye zuwa yawancin Turai, ban da United Kingdom, na kwanaki 30, daga 13 ga Maris.
Kashegari, ya faɗaɗa takunkumin zuwa United Kingdom da Ireland.
A ranar 13 ga Maris, ta sanar da dokar ta baci ta kasa, inda ta ba da kudaden tarayya don amsa matsalar.
Tun daga ranar 15 ga Maris, yawancin kasuwancin sun rufe ko kuma sun iyakance lokutan aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da kamuwa da cutar a duk jihohi 50 da kuma yankin Columbia. A ranar 23 ga Maris, an sanar da cewa New York City na da shari'o'in cutar coronavirus 10,700, wanda ya fi yawan mutanen Koriya ta Kudu.
A ranar 25 ga Maris, Hakim ya ce zaman zaman lafiya ya zama tasiri, kamar yadda aka yi hasashen ya ninka daga 2.0 zuwa 4.7 days.
A ranar 28 ga Maris, an samu mutum 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu saboda cutar. A ranar 26 ga Maris, an sanar da cewa Amurka tana da mafi yawan mutane da suka kamu da cutar coronavirus a duniya, ciki har da China da Italiya. A ranar 8 ga Afrilu, an samu mutum 400,335 da suka kamu da cutar a Amurka, kuma mutane 12,841 sun mutu.
A cewar rahotanni a kafofin yada labarai a ranar 30 ga Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita dokokin keɓewa ta zamantakewa har zuwa 30 ga Afrilu.
A wannan rana, UNSS Comfort ta mamaye wani asibiti mai asibiti mai asibiti 1,000 a New York.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 sakamakon cutar coronavirus a cikin sa'o'i 24.
A ranar 3 ga watan Afrilu, a jihar New York, adadin mutane sun wuce 100,000. An soki fadar White House saboda rashin karbar barazanar da kuma kula da rahotanni ta hanyar tura jami'an lafiya da masana kimiyya don hada kai da bayyanawa da kuma wallafa bayanan da suka shafi cutar tare da ofishin mataimakin shugaban kasar Mike Pence.
A general yarda da gwamnatin Trump ga rikicin ya rabu da bangarorin jam'iyyun.
Wasu jami'an Amurka da masu ruwa da tsaki sun soki amincewar Amurka da shigo da abubuwa masu mahimmanci, kamar kayayyakin kiwon lafiya na asali daga China.
An yi amfani da nazarin hanyoyin sufuri na iska don ganowa da kuma hango ko hasashen hanyoyin yaduwar cutar kuma an buga shi a cikin Travel Medicine a tsakiyar watan Janairu 2020.
Bisa ga bayanan 2018 na Hukumar Kula da Sufuri ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei sun sami mafi yawan fasinjoji daga Wuhan.
Dubai, Sydney da Melbourne sun zama wuraren da aka fi so su yi tafiya daga Wuhan.
An bayyana Bali a matsayin mafi ƙarancin ƙarfin cikin birane 20 da suka fi dacewa da kasancewa a shirye, yayin da birane a Ostiraliya suka kasance mafi ƙarancin ƙarfi. Ostiraliya ta sanar da shirin gaggawa na gaggawa don sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Wannan ya sa an samu karin bayanai game da COVID-19, kuma Australia ta mai da hankali kan kula da iyaka da sadarwa a cikin amsawa ga annobar.
A ranar 21 ga Maris, an sanar da wani abu na rashin tsaro na mutum a Australia.
Saboda takunkumin da ke shafar zirga-zirgar jiragen sama a Wuhan da Hobi, kasashe da dama suna shirin mayar da 'yan ƙasarsu da ma'aikatan diflomasiyyarsu daga yankin, musamman a cikin jiragen sama na gida, tare da bayyanawa ga hukumomin kasar Sin.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand sun kasance daga cikin na farko da suka shirya don dawo da 'yan ƙasarsu.
Pakistan ta ce ba za ta koma da wani dan kasarsa daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta dawo da 'yan Brazil 34 ko kuma danginsu, tare da 'yan Poland hudu, wani dan kasar Sin, da kuma dan kasar Indiya.
'Yan ƙasar Poland, China, da Indiya sun sauka a Poland, yayin da jirgin Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan kasar da suka je Wuhan a wani sansanin soja da ke kusa da Brazil.
A wannan rana, an mayar da 'yan Kanada 215 (176 a jirgin farko, da 39 a jirgin na biyu da gwamnatin Amurka ta ba da izini) daga Wuhan zuwa Trenton CFB don keɓewa na makonni biyu.
A ranar 11/2, wani jirgin sama na 185 na jirgin Kanada ya sauka a Wans a sansanin soja na Kanada a Trenton.
Gwamnatin Ostiraliya ta tura 'yan kasar 277 zuwa cibiyar kula da tsibirin Kirsimeti, wadda aka tanadar da ita a matsayin wuri na keɓewa, inda za su zauna har kwana 14.
Rundunar jiragen sama ta New Zealand ta isa Auckland a ranar 5/2; fasinjoji (wasu daga cikinsu sun kasance a Ostiraliya da Pacific) da aka keɓe a tashar jiragen ruwa ta HangoutParo a arewacin Auckland.
A ranar 15 ga Fabrairu, Majalisar Dinkin Duniya ta sanar da cewa za ta dauki fasinjojin Amurka a kan jirgin Diamond Prince.
A ranar 21/2, jirgin sama mai dauke da fasinjoji 129 na Kanada da ke tashi daga Diamond Princes ya isa Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara jigilar 'yan kasar daga kasar Ira. A 14/3 jirgin saman sufuri na Afirka ta Kudu da gwamnatin Afirka ta Kudu ta haya ya kawo 'yan Afirka ta Kudu 112 zuwa kasar.
An gudanar da bincike na asibiti don gano zafin jiki, kuma an yi wa 'yan Afirka ta Kudu hudu da ke da alamun cutar coronavirus kulawa mai tsanani don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da aka gano ba su da cutar a gwajin su ne kawai aka mayar da su ƙasarsu.
Sakamakon binciken ya tabbatar da cewa duk 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji sun shiga aikin soja na kare 'yan adam. A matsayin mafita ga matsalolin, an sanya su a karkashin kula kuma an killace su na kwanaki 14 a Ranch Resort.
A ranar 20/3, Majalisar Dinkin Duniya ta fara tura rundunarta daga Iraqi saboda barkewar cutar.
A ranar 5 ga watan Fabrairun, Ministan Harkokin Wajen Sin ya sanar da cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga Sin.
Wasu manyan dalibai daga jami'o'i a Amurka sun haɗu don aika taimako zuwa yankunan da ke fama da cutar kan nono, tare da wani babban rukuni na United Chicago Area Reporting Division wanda ya jagoranci aikawa da nauyin N95 50,000 zuwa asibitocin Hubei a ranar 30/1.[1] Ƙungiyar agaji ta aika da taimakon taimako na taimako, tare da haɗin gwiwar Fedex, sun aika da nauyin 200,000 da sauran kayan kariya na mutum, wanda ya hada da na'urar hannu da na'urar daukar hoto, ta hanyar jigilar iska ta gaggawa zuwa asibitin Van Onien a ranar 30/1.[2]
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun ba da sanarwar cewa za su ba da kyautar dala miliyan 100 ga waɗanda suka sami magani da kuma magani "a cikin yankin da ke da haɗari ga 'yan Afirka da kuma Kudancin Asiya".
Interaction ta ruwaito cewa gwamnatin Sin ta ba da masks 200,000 ga 'yan Philippines a watan Yuni, bayan da Cibiyar ta Richards Gordon ta kawo masks miliyan 3.16 zuwa birnin Vaan.
A ranar 19 ga watan Fabrairu, Red Cross ta Singapore ta sanar da cewa za ta aika da dala miliyan 2.26 zuwa Sin.
Kasar Japan ta ba da takunkumi miliyan daya, kuma Turkiyya ta tura kayan aikin likita. Rasha ta tura kayan aikin likita fiye da tan 13 zuwa birnin Wan. Malaysia ta ba da kyautar kayan aikin likita miliyan 18 zuwa Sin. Jamus ta tura kayan aikin likita na cuta mai dauke da rigakafin cutar cuta 10,000. Majalisar Dinkin Duniya ta tura kayan aikin likita tan 17.8 zuwa Sin.
A watan Maris, Cuba da Rasha sun tura taimakon likita da kwararrun mutane zuwa Italiya don magance yaduwar cutar a kasar.
Mai Kasuwanci ya aika da kayayyakin bincike na asibiti miliyan 1.1 da abin rufe fuska miliyan 6 da kuma tufafin tsaro 60,000 zuwa Addis Ababa, Ethiopia don rarrabawa a kan layi na kungiyar Afirka.
Daga nan sai ya tura kayan aikin bincike na likitanci 5,000, na'urori masu amfani da maganin rigakafi 100,000 da kuma na'urori masu amfani da iska 5 zuwa Panama.
Ma ta kuma tura kayayyakin kiwon lafiya zuwa Kanada. Netherlands, Spain, Turkiyya, Georgia da Jamhuriyar Czech sun bayyana ra'ayoyinsu game da masks da kayan aikin bincike na hanci.
Alal misali, Spain ta dawo da takardun magani na 58,000 na cutar sankara ta hanta da aka yi a cikin Sin, tare da kashi 30 cikin dari na yawan cutar. Netherlands ta dawo da takardun rufe hanta 600,000 da suka yi matsala.
Belgium ta dawo da masks 100,000 da ba a yi amfani da su ba, ana tsammanin an yi su ne daga Sin, amma a zahiri an yi su ne a Colombia.
A gefe guda, an yi maraba da taimakon Sin a sassa na Latin Amurka da Asiya a ranar 4 ga watan Afrilu.
Hukumar lafiya ta duniya ta yaba wa Sin da kokarin da ta yi wajen sarrafawa da kuma hana yaduwar cutar.
Hukumar lafiya ta duniya ta lura da bambancin yaduwar cutar SARS tsakanin 2002-2004. Gwamnatin Sin ta yi zargin cewa ta ɓoye kwayar cutar da ta kawo matsala ga ƙoƙarin hanawa da kawar da cutar da kuma rikicin da ke faruwa a yanzu da gwamnatin tarayya ta "ba da izinin doka don kauce wa cutar a lokacin hutun New York City".
A ranar 23 ga watan Janairu, a cikin martani ga shawarar da gwamnatin tarayya ta yanke na hana zirga-zirga a birnin Wan, wakilin hukumar lafiya ta duniya Gaudin Gallaya ya ce yayin da hakan "ba ya saba wa dokar hana zirga-zirga ta WHO ba" ya kasance babban siginar hana yaduwar cutar a yankin da cutar ta yi tsanani. Ya ce "ba a san tarihin lafiyar jama'a ba". A ranar 30 ga watan Janairu, an yi rahoton cewa cutar ta yadu daga mutum zuwa mutum a wajen Sin da kuma yawan adadin mutane a wasu ƙasashe. Hukumar lafiya ta duniya ta ce barkewar cutar ta zama gaggawa ta kiwon lafiyar jama'a ta kasa (PHEIC), karo na shida da ake sanar da gaggawa ta kiwon lafiyar jama'a ta kasa a karon farko tun bayan an fara annobar ta a shekara ta 2009.
Babban daraktan hukumar ta kasa ta duniya, Tedros Adhanom, ya ce sanar da dokar ta baci ta kiwon lafiya ta kasa ta haifar da "fargabar yaduwar cutar a duniya, musamman a kasashe masu talauci da kuma tsakiya da ba su da ingantaccen tsarin kiwon lafiya.
A cikin martani ga aiwatar da dokar hana zirga-zirga, Tedros ya ce "babu wani dalili da zai sa a yi kokarin hana tafiye-tafiye da kasuwanci a duniya" kuma "Ba a ba da umarnin duniya na hana kasuwanci da zirga-zirga".
A ranar 5 ga watan Fabrairu, Hukumar Lafiya ta Duniya ta yi wa al'umma ta duniya kira da ta ba da dala miliyan 675 don ba da gudummawar kuɗin don shirya don ƙasashe marasa galihu, tana kira ga kotun tarayya ta goyi bayan ƙasashe da "ba su da tsarin kula da mutanen da ke da cutar, ko da a cikin mawuyacin hali".
Tedros ya kara da cewa "mu samu nasara da kokarinmu na kowa" kuma ya bukaci al'ummar duniya su "ba da karin kudi a yau ko a baya" a ranar 11/2, Hukumar Lafiya ta Duniya ta bayyana COVID-19 a wani taron manema labarai.
A wannan ranar, Tedros ya sanar da cewa babban jami'in asirin Majalisar Dinkin Duniya Antonio Guterres ya amince da samar da "dukan sojojin tsarin Majalisar Dinkin Duniya a aiki".
An kunna darektan ƙungiyar rikicin Majalisar Dinkin Duniya a sakamakon haka, yana ba da damar haɗin gwiwar Majalisar Dinkin Duniya ta ba da izinin WHO don "daidaita kan ƙasashen lafiya yayin da sauran masu ba da shawara za su iya kawo kwarewarsu don haɗa al'umma, tattalin arziki da ci gaban yaduwar cutar.
A ranar 14/2, an ba da gudummawar wani darektan ƙungiyar gudanar da aikin WHO tare da Sin don samar da ƙwararrun masanan duniya da kuma jagororin kiwon lafiya na duniya zuwa ƙasar Sin don taimakawa wajen tantancewa da gudanar da gida "ƙarfin cutar da yaduwar cutar", shirya taron bita da haɗuwa da manyan hukumomin ƙasa da kuma gudanar da balaguron yanki don yanke shawara kan "samar da martani ga ayyukan da ke faruwa ga mutanen da ke zaune a cikin ƙasashe masu nisa da kuma sauran ƙasashe, wanda ya haɗa da tsara birane da ƙauyuka". A ranar 25/2, Hukumar Lafiya ta Duniya ta ba da sanarwar cewa "duniya dole ne ta kara shirya don yiwuwar yaduwar cutar coronavirus" ta bayyana cewa yayin da har yanzu ba a kira cutar ba, dole ne kasar ta kasance "a shirye".
A cikin martani ga ci gaban yaduwar cutar a Iran, Hukumar Lafiya ta Duniya ta tura tawagar da ta hada kai zuwa Iran don duba halin da ake ciki. A ranar 28 ga watan Fabrairu, Hukumar Lafiya ta Duniya ta sanar da cewa tsoron yaduwar cutar coronavirus a duniya zai tashi daga "mai tsanani" zuwa "mai tsanani", wanda aka kiyasta a matsayin mafi girman matakin barazana da damuwa".
Mike Ryan, mai gudanar da shirin gaggawa na Hukumar Lafiya ta Duniya, ya yi gargadin duniya a wata sanarwa cewa "akwai takamaiman gwaji ga dukan gwamnatocin duniya: tashi daga barci.
Wataƙila cutar tana cikin hanya kuma dole ne ku kasance a shirye, "neman hanyoyin da za a amsa daidai zai iya taimaka wa duniya ta guje wa mafi munin ɓangaren cutar".
Sun ce bayanan da aka samu yanzu ba su da wata hujja ta kiwon lafiyar jama'a ga sanarwar annobar duniya, suna cewa wannan sanarwar tana nufin "mun yarda cewa kowane mutum a duniya yana da hadarin kamuwa da cutar".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta bayyana cewa annobar korona ta zama annoba.
Darakta janar ya ce WHO "ta yi tunanin cewa cutar ta yi ta yaduwa da ƙarfi da tsanani, kuma matakin da ta yi muni na yaduwar ta yi jinkiri", WHO ta yi magana game da muhimmin kalubalen da ke tattare da wannan ɓangaren annobar, wanda ya haɗa da sanar da dokar ta baci ta gaggawa ta kiwon lafiya ta jama'a da kuma rarraba cutar a matsayin annoba.
Tunanin jama'a ya hada da korafin zuwa ga babban darektan hukumar lafiya ta duniya, Tedros Adamon, na neman a yi masa murabus, wanda mutane 733,000 suka rattaba hannu a ranar 6 ga watan Afrilu.
A ranar 26 ga watan Maris, ƙungiyar kwararrun 'yancin bil adama ta Majalisar Dinkin Duniya ta sake tabbatar da cewa ana girmama hakkokin kowa a lokacin annobar COVID-19.
Kungiyar ta ce an ba kowa rai mai lafiya kuma gwamnati ta dauki alhakin hakan.
Kungiyar ta tabbatar da cewa ba za a taba bayar da rashin albarkatu ko inshorar lafiya a matsayin abin karewa ga rabuwa da wani rukuni ba.
Masana sun tabbatar da cewa kowa yana da hakkin kiwon lafiya, ciki har da mutane da ke da nakasa, kungiyoyin 'yan tsiraru, tsofaffi, 'yan gudun hijira na gida, marasa gida, masu zaman kansu, masu kurkuku, da dubban 'yan gudun hijira da kuma kungiyoyin da ba a san su ba da bukatar tallafin gwamnati.
Gwamnatin ƙasa ta yi magana game da tasirin tattalin arziki da zamantakewar al'umma a cikin rikicin COVID-19.
Hukumar Tattalin Arziki da Ci gaban Kasashen Duniya ta kaddamar da dandamali don samar da cikakken bayani game da ayyukan siyasa a ƙasashen duniya, da ra'ayoyi da shawarwari.
Daga 'yan sanda zuwa tsarin kiwon lafiya da tattalin arziki na duniya masu ƙarfi don nuna tasirin ƙuntatawa da dakatar da tafiya, jigon dijital na 'yan sanda na ƙasa ya ƙunshi bin diddigin, da kuma manufofinsa na taimaka wa ƙasashe su koya wa juna da kuma sauƙaƙe haɗin gwiwar duniya don magance cutar coronavirus.
Gwamnatin Sin ta fuskanci sukar Majalisar Dinkin Duniya da kuma ministan Birtaniya ga majalisar wakilai na kasar Michael Gove da dan shugaban Brazil Eduardo Bolsonaro saboda rashin kula da annobar, wadda ta fara a Sin, a yankin Hubei.
Wasu shugabannin jam'iyyun Shuwa a yankin Sin sun yi watsi da kokarin da ake yi na yin amfani da yankin Sin, wani abu mai ban mamaki da ya nuna yadda manyan hukumomin siyasa suka yi amfani da shi wajen yaduwar yankin.
Wasu masu faɗar ra'ayi sun yi imanin cewa an yi wannan aikin ne don kare Sakataren Janar na jam'iyyar Sin-Hai Jinping daga yunwa a lokacin barkewar cutar coronavirus.
Wasu daga cikin hukumomin Sin, kamar su Shugaba Lijian sun ƙi amincewa da cutar coronavirus ta hanyar yaduwar birnin Wany, suna goyon bayan tsarin ka'idar COVID-19 a cikin Majalisar Dinkin Duniya ko Italiya.
Gwamnatin Donald Trump ta yi magana game da cutar a matsayin "Cin virus" ko "One virus", inda ta ce masu kula da Sin sun inganta wani cutar da ta zama annoba ta duniya.
Shafin labarai na Daily Beast ya fara cewa wani bangare na shirin Majalisar Dinkin Duniya na yin yarjejeniyar canja wurin da ke da tushe na Consular National Defense, kuma an ba da labarin dabarun da ake kira "All About Cinema".
An gaya mana mu yi kokarin yada wannan sakon a kowane hali, a taron manema labarai na Rasha da kuma a talabijin, kafofin kamar 'yan siyasa, 'yan sanda na kasashen waje da Bloomberg sun bayyana cewa kokarin da Sin ke yi na taimaka wa kasashen da suka kamu da cutar ya zama wani nau'i na sanar da annobar duniya.
Shugaban 'yan sandan kasashen waje na Tarayyar Turai Joseph Borel ya yi gargadin cewa tushen yanayin siyasar rikici na cutar ya ƙunshi warware matsalar da kuma nuna karimci na siyasa.
Burrell ya kuma ce "Sin tana yada sakon da ya fi karfi cewa, ba kamar Majalisar Dinkin Duniya ba, ita ce mai daukar nauyin da kuma amintacciyar hadin gwiwa.
Sin kuma ya tuntubi Majalisar Dinkin Duniya don ta yi wa Syria, Venezuela da Iran horo, inda suka ce sun aika da taimako ga kasashen biyu.
An kama kyautar Jack Ma na 100,000 masks zuwa Cuba ta Majalisar Dinkin Duniya a 3/4.
Majalisar Dinkin Duniya ta kuma zargi ta da canja manufar taimakon da ta yi daga wata ƙasa zuwa ta kanta.
An kuma yi yarjejeniyar aikawa da abin rufe fuska tsakanin kasashe, kamar Jamus, Austria da Switzerland da Jamhuriyar Czech da Italiya.
Bugu da ƙari, Turkiyya ta kama injunan iska guda uku da aka ba wa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin goyon bayan da Tarayyar Turai ke bayarwa ga mutanen da ke dauke da cutar a Italiya.
Jakadan Italiya a Tarayyar Turai, Maurizio Masari, ya ce "abin da ya faru shi ne cewa an yi amfani da Sin ne kawai don yin aiki tare da 'yan tawaye".
Hakika, wannan ba kyakkyawan alama ce ta goyon bayan Turai ba.
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya shirya rundunar sojin Rasha don aika da sojojin likita, motocin da aka kashe, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta ba da hujja daga wata majiya mai zurfi da ba a san ta ba cewa kimanin taimakon Rasha 80 ba su da amfani ko kuma ba su da amfani ga Italiya.
Majiyar ta zargi Rasha da yin amfani da matsalar (dangin siyasa da na diflomasiyya) da kuma kai hare-hare ga bangarorin.
Shugaban Lombard, Attolio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahotannin kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma tura wani jirgin sama na kayan aikin likita zuwa Amurka.
Kakakin gwamnatin Kremlin Dmitry Peskov ya ce: "A lokacin da yake aika da taimako ga Majalisar Dinkin Duniya, Putin ya ce idan kayan aikin likita na Majalisar Dinkin Duniya da kayan aikin su suka zo, za su kasance a shirye su musanya idan ya cancanta.
A shekarar 2020 ne NATO ta gudanar da wani horo a Jamus, Poland da kasashen Baltic, wanda ya kasance mafi girma a duniya tun bayan yakin sanyi.
Kamfen din rundunar sojin kasar Janar Kate Hudson ya soki aikin soja na 2020 na wakili, "A cikin wannan rikicin na kiwon lafiyar jama'a na yanzu, wannan yana barazanar rayukan mutane ba kawai sojojin Majalisar Dinkin Duniya da kuma yawancin kasashen Turai ba amma kuma mazaunan kasashen da suke yin hakan suna cikin hatsari". Gwamnatin Iran ta kamu da cutar sosai, an kamu da 'yan majalisa dubu biyu da kuma mutane 15 da suka kamu da cutar.
Shugaban kasar Iran Hassan Rouhani ya rubuta wata wasika ta gaggawa ga shugabannin duniya inda ya nemi taimako a ranar 14/3/2020, yana mai cewa kasar ta sha wahala daga yaduwar cutar saboda rashin hulda da kasuwannin duniya kamar yadda ya shafi hukuncin Majalisar Dinkin Duniya akan Iran, yaduwar cutar ta sa sun tuntubi Majalisar Dinkin Duniya kai tsaye don kula da zamantakewar al'umma a cikin kasashe masu tasowa, wanda ya hada da kula da lafiyar duniya, kula da yara na duniya, hukumar kula da iyalansu, da kuma babban matakin ba da kudi ga lafiyar jama'a.
Masu sharhi kan harkokin siyasa sun yi hasashen cewa hakan na iya shafar farin cikin Trump na sake zabarsa a zaben shugaban kasa na 2020. Dangantakar diplomasiyya tsakanin Japan da Koriya ta Kudu ta haifar da mummunan yaduwar cutar.
Koriya ta Kudu ta soki "ƙoƙarin da ba a yi ba" na Japan. Bayan Japan ta bayyana cewa duk wanda ke cikin Koriya ta Kudu, dole ne a keɓe shi na tsawon makonni biyu a wasu wuraren da gwamnati ta ke.
Koriya ta Kudu ta rabu a kan hanyoyi biyu game da yadda tsohon shugaban kasar Moon Jae-in ya amsa wannan rikici.
Yawancin 'yan kasar Korea sun yi korafin cewa dole ne a yi wa Mutun Mu'un shari'a saboda rashin kula da yaduwar cutar. Ko kuma a bayyana ƙoƙarinsa.
Wasu masu fafutukar ra'ayi sun ce hakan zai ba gwamnatoci damar kara karfin su.
A Hungary, majalisa ta amince da izinin Firayim Minista Viktor Orbán ya ba da umarnin doka, kuma ta soke zaben da kuma hukunta waɗanda suka yi amfani da bayanan da ba daidai ba game da cutar da kuma yadda gwamnati ke magance matsalar.
An yi amfani da cutar coronavirus don yin amfani da misalai kamar rage yawan taimako. Dakatar da yawan amfani da kayan aikin soja tare da yaduwar cutar a duniya, da wahala, da kuma mawuyacin yanayi ga ma'aikata da ayyukan sufuri na soja.
Hukumar Abinci da Magunguna ta Majalisar Dinkin Duniya ta bayyana matsalar rashin magani da kayan aikin likita saboda karuwar bukatar masu sayarwa da kuma tarin kayan aiki a cikin mawuyacin yanayi.
Yawancin yankuna sun shaida yawan kuɗin shiga da aka samu a kan ɗakunan ajiya na shaguna, kamar abinci, ci gaban gidajen wanka, da kuma ruwan sha, wanda ke nuna rashin kayan aiki.
Masana'antun fasaha suna faɗakar da mu musamman game da jinkirin yanayin yanayin kayan lantarki.
A cewar babban darektan hukumar lafiya ta duniya Tedros Adhanom, bukatar kayan kariya ta mutum ta karu da kusan 100 da suka kai.
Wannan bukatar ta sa farashinsa ya karu zuwa 20 bisa dari na farashin yau da kullum.
Wannan kuma ya haifar da raguwar kayan kariya a duniya, tare da faɗakarwar Hukumar Lafiya ta Duniya cewa wannan yana haifar da haɗarin lafiyar ma'aikata.
A Ostiraliya, annobar ta ba wa masu sayarwa sabuwar dama don sayar da kayayyakin Ostiraliya a Sin.
Wannan aikin ya haifar da matsalar karancin madara ga jarirai a manyan kantunan sayar da abinci, kuma an dakatar da shi daga baya ta gwamnatin Ostiraliya. Duk da haka, yawan adadin COVID-19 a arewacin Italiya da yankin, da kuma yawan sha'awar abinci mai kyau, sun haifar da matsalar rashin abinci a yankunan biyu.
Kotu da Italiya sun yi nasara wajen yaki da karbar kudi da kuma cinikin kayayyakin da aka yi wa korafi, suna kauce wa matsalar rashin abinci da ake tsammani za ta auku a Turai da Arewacin Amirka.
Aikin gona na arewacin Italiya bai yi raguwa sosai ba, amma farashinsa na iya ƙaruwa, a cewar masana'antun masana'antu.
Rashin abinci a kan shiryayye na ɗan lokaci, har ma a birni, yayin da jami'an gwamnatin Sin suka wallafa tarin naman alade don tabbatar da yawan jama'a ba su raba abinci ba.
Akwai irin wannan doka a Italiya don buƙatar masana'antun abinci su tattara abinci don abubuwan gaggawa.
Ana iya jin lalacewar tattalin arzikin duniya a Sin; a cewar wani rahoto na 16/3, tattalin arzikin Sin ya yi mummunan rauni a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka don rage yaduwar cutar, kuma ya rage yawan tallace-tallace na mutum zuwa 20.5%.
A matsayin babban yanki na nahiyar, babban tattalin arziki da kuma batun sana'a shine yanayin tattalin arziki. An ga yaduwar cutar a matsayin babbar barazana ga tattalin arzikin duniya.
Agaci Desmaria's na Economic Intelligence ya yi hasashen cewa kasuwanni za su zama masu haɗari har sai an ba da cikakken hoto game da sakamakon da aka samu.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa mummunan yanayin tattalin arzikin da ke tattare da annobar ta yi tasiri a kan ci gaban duniya fiye da yadda cutar SARS ta yi a shekarun 2002-2004.
Wani masanin jami'ar Washington a St. Louis ya ba da dala biliyan 300 ga jerin kudaden ajiya na duniya wanda zai iya wucewa tsawon shekaru biyu.
Hukumar kasashen da ke fitar da man fetur ta OPEC ta ce ta yi watsi da wannan yarjejeniyar bayan da farashin man fetur ya ragu saboda raguwar bukatarsa a sinadarin.
Kasuwancin duniya sun rufe a ranar 24 ga watan Janairu saboda alamun karuwar shari'o'in COVID-19 a waje da Sin.
A ranar 27 ga watan Fabrairu, saboda tashin hankali game da yaduwar cutar coronavirus, kasancewar cutar a Majalisar Dinkin Duniya wanda ya ƙunshi NASDAQ-100, ya ƙunshi shari'o'in S&P 50, inda Dow Jones ya ba da matsakaicin mummunan yanayin faɗuwar masana'antu a shekara ta 2008 wanda ya kai maki 1,191, mafi girma a cikin rana ɗaya a cikin rikicin kuɗi na 2007-2008.
Dukkanin waɗannan sun kawo ƙarshen mako a sama da kashi 10.
A ranar 28/2, kamfanin Scoob Ratings GmbH ya tabbatar da matsakaicin kudin shiga na Sin, amma ya ba da mummunan ra'ayi.
Rikicin ya sake barkewa saboda tsoron cutar coronavirus, wanda ya kai kashi 16 cikin 3 na asarar.
Mutane da yawa suna ganin cewa ana sa ran samun koma baya.
Masanin tattalin arziki Muhammad E-Erian ya gode wa bankuna da jihohin tsakiya da suka yi gaggawa wajen magance wannan matsalar.
Babban bankin ya yi sauri fiye da yadda ya yi a lokacin rikicin kudi na 2008.
Tafiya tana cikin mafi munin abubuwan da ke faruwa saboda dakatar da tafiya, rufe wuraren jama'a da ke haɗa da sha'awar tafiya, da kuma ba da shawara ga gwamnati game da duk wani irin tafiya a duniya.
A sakamakon haka, an hana jiragen sama da yawa saboda raguwar buƙata, ciki har da British Airways, East Sin Airways, da Kantas Airways, yayin da aka rufe yankin Flyby.
Tasirin da aka samu a kan masana'antu da kuma cin nasara ya kasance a matakin da ba a taɓa gani ba.
An rufe tashoshin jiragen ruwa da tashoshin jiragen ruwa da dama.
Cutar ta shafi bikin zabe, da kuma tafiye-tafiye da yawa na shekara-shekara da suka shafi hutun shekara ta Sin.
Gwamnatocin ƙasa da na yanki sun ƙi yin taron jama'a da yawa, ciki har da bikin Sabuwar Shekara na shekara-shekara, kuma kamfanoni masu zaman kansu sun dakatar da tafiye-tafiye kamar Hong Kong Disneyland da Shanghai Disneyland.
Yawancin bikin Kirsimeti da tafiye-tafiye sun dakatar da yin tarurruka, misali birnin Forbidden a Beijing da kuma manyan wuraren taro na gargajiya.
A yankuna 24 da 31 na Sin, municipalities da yankuna, gwamnati ta kara hutun gani na shekara har zuwa 10/2, inda ta yi gargadin cewa ba za a bude wuraren kasuwanci ba har sai an bude filayen.
Wannan yanki ya ƙunshi kashi 80 cikin 100 na ma'aikatan samar da kayayyaki na kasar da kuma kashi 90 cikin 100 na kwararrun.
Hong Kong ta kara yawan yadda ta amsa cutar zuwa wani babban matakin, ta bayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta ƙi bikin Sabuwar Shekara. Kasuwancin ta ya shafi duniya, tare da rage lokutan kasuwa ko rufewa na wucin gadi.
Ana iya rage yawan ziyarar kasuwanci zuwa Turai da Latin Amurka da kashi 40 cikin dari.
Kasuwancin Kudancin Amirka da Gabas ta Tsakiya sun yi asarar kashi 50 zuwa 60 cikin 100.
Wannan ya kuma haifar da asarar kashi 33 zuwa 43% na kaya a cikin wuraren cin kasuwa a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da kasuwanci a duk faɗin duniya sun ba da wasu shawarwari, kamar ƙara kayan tsabtace jiki, samar da na'urorin bincike na zafin jiki ga abokan ciniki, da kuma mutanen da suka taru a wuraren taron. A cewar Hukumar Tattalin Arziki ta Amurka ta Latin Amurka, annoba mai rikitarwa na iya haifar da talauci tsakanin mutane miliyan 14 zuwa 22 a Latin Amurka waɗanda ke cikin wannan yanayin ba tare da cutar ba.
A cikin watan Janairu da Fabrairu na shekarar 2020, yayin da annobar ta tashi a birnin Wan, kusan mutane miliyan 5 suka rasa ayyukansu a Sin.
Yawancin ma'aikatan karkara a Sin da ke da kusan miliyan 300 an tura su gidajen ruwa ko kuma an ajiye su a yankin Hubei. A watan Maris na 2020, fiye da Amurkawa miliyan 10 sun daina aiki kuma sun nemi taimakon gwamnati.
A cewar kimantawa na Federal Reserve Bank of St. Louis, dokar hana zirga-zirga a Indiya ta sa 10 miliyan na ma'aikatan da ke neman aikin yi (wanda ake biyan su albashi a kullum). Wani kimantawa na The O'Gahn-Redd Institute ya gano cewa kashi 44% na iyalai na Kanada sun rasa aikin yi. Kimanin ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da dokar ta yi aiki a tsakiyar watan Maris na 2020,
A cikin rabin watan Maris, ma'aikata 4 miliyan na Faransa sun nemi biyan bashin rashin aikin yi na lokaci, kuma ma'aikata 1 miliyan na Burtaniya sun nemi shirin biyan kuɗi na duniya. Kimanin rabin miliyan na kamfanoni a Jamus sun aika da kudaden gwamnati ga ma'aikatansu ta hanyar shirin gajeren aiki da aka sani da Kurzarbeit.
An aiwatar da shirin rarraba kudaden aiki na ɗan lokaci na Jamus a Faransa da Burtaniya.
Al'amurran fasaha da al'adun al'umma sun sha wahala sosai daga annobar, kuma ta shafi ayyukan da aka sarrafa, wanda ya shafi ma'aikata da kuma masu amfani da duniya.
Ƙungiyoyin fasaha da al'umma sun yi ƙoƙari su tada kudaden da suka tara don samar da damar yin amfani da kayayyakin birni ga al'umma, ci gaba da kare wuraren su da kuma taimaka wa masu fasaha idan ya dace.
A watan Maris na shekarar 2020, a duk faɗin duniya, jami'o'i, gidajen tarihi, dakunan karatu, wuraren gabatarwa da sauran cibiyoyin gwamnati sun rufe ba tare da sanarwa ba kuma an ƙi ko jinkirta baje kolin, abubuwan da aka yi da kuma gabatarwa.
A cikin kasar akwai gagarumin ƙoƙari na yin hidima ta hanyar dandamali na dijital, sabon cuta mai cutarwa ya yada addinai masu haɗari kuma ya dakatar da wasanni da al'amuran zamantakewa, kamar bukukuwa na kiɗa da kide kide, taro na fasaha da kuma nuna kayan kwalliya.
An yi watsi da samar da fim din, kuma an yi watsi da mako mai tsarki a birnin Roma, wanda ke cikin makon karshe na tuba na Kirista a lokacin Lent.
Yawancin firistoci sun gaya wa tsofaffin Krista su zauna a gida kuma kada su halarci bukukuwan ibada na ranar Lahadi; wasu majami'u suna yin hidimarsu ta rediyo ko kai tsaye ta kan layi ko ta talabijin, yayin da wasu ke yin hidima a kan titi.
Tare da rufe cocin Roman Katolika a Roma, an rufe majami'u da rassan da kuma wuraren da masu bin addini na Kristi suke, sauran masu bin addini sun daina yin hidima kuma sun daina taruwa a majami'u da majami'u da wuraren ibada na Yahudawa da majami'u da kuma majami'un Sikh.
Ministan lafiya na Iran ya ce an rufe sallar Juma'a da masallatai a yankunan da cutar ta shafa, kuma Saudiyya ta dakatar da masu zuwa haikalin Makka da Madina.
Cutar ta haifar da babbar tasiri ga ayyukan wasanni a duk faɗin duniya tun bayan yakin duniya na biyu.
Yawancin wasanni na wasanni sun kasance ko dai na dakatarwa ko na jinkiri, ciki har da gasar zakarun Turai 2019-2020, gasar Premier 2019-2020, NBA 2019-2020, NHL 2019-2020.
Cutar ta haifar da matsala ga shirye-shiryen wasannin Olympics na bazara na 2020, wanda aka shirya a watan Yuli. Hukumar Olympic ta kasa ta sanar a ranar 24/3 cewa an dage gasar Olympics zuwa bayan 2020 amma ba za a jinkirta ba bayan bazara ta 2021, Gasar wasanni a duk duniya sun rufe kuma an dakatar da ko kuma an jinkirta ko an dakatar da wasannin.
Wannan ya sa masu caca su nemi mafaka ta yanar gizo, shafukan yanar gizo da yawa sun ƙara yawan sababbin masu caca, wuraren da 'yan ƙasa ke ciyarwa suna da lahani, kuma tare da bayyanar cutar, ƙungiyoyin kiɗa sun jinkirta ko kuma sun dakatar da bukukuwa.
Yawancin wasan kwaikwayo na musamman kamar Broadwood sun jinkirta duk ayyukan su.
Wasu masu fasaha sun gwada sababbin hanyoyi don ci gaba da samar da kayayyaki da kuma buga ayyukan su a kan layi a matsayin zaɓi don nuna al'adun rayuwa, kamar ƙirƙirar kide kide ta kan layi ko ƙirƙirar gidan yanar gizon bikin don masu zane-zane su fito.
A kan layi, an wallafa wasu batutuwan ban dariya game da cutar coronavirus wanda ya ƙunshi wasu jita-jita, shakku da matsaloli.
Tun bayan barkewar COVID-19, an lura da tsani mai yawa, tsoro a ƙasashe masu kewaye, da kuma nuna bambanci tsakanin mutanen Sin da kuma yankin Asiya ta Gabas ta Kudu, da kuma a kan mutanen da ke cikin yankunan siyasa na Turai, Majalisar Dinkin Duniya da sauran ƙasashe.
An lura da tsoro, shakka da kuma nuna rashin amincewa a ƙasashe da yawa, musamman a Turai, Asiya ta Gabas, Arewacin Amirka, da kuma yankin Asiya ta Pacific.
Rahotanni na watan Fabrairu (lokacin da yawancin shari'o'in har yanzu ke Sin) sun nuna nuna rashin jin daɗi daga kungiyoyin ƙwayoyin cuta a duk faɗin duniya waɗanda ke cewa mutanen Sin sun cancanci kamuwa da cutar ko kuma sun ƙi abin da aka nema su yi a matsayin masu kula da azabtarwa.
Wasu ƙasashen Afirka suna da irin wannan ra'ayin game da ƙirãza.
Mutane da yawa a cikin biranen Wuhan da Hubei sun bayyana rabuwa saboda asalin yankin.
Akwai tallafi ga masu nono, ta hanyar kai tsaye da kuma offline, don taimaka musu zuwa yankunan da suka kamu da cutar.
A Italiya, wadda ta kasance ƙasa ta farko a Turai da ta sami adadin mutane da suka kamu da cutar COVID-19, an yi ta daɗaitarwa da kuma tsoratarwa. Mutane a Malaysia, New Zealand, Singapore da Koriya ta Kudu sun yi korafi game da haramta wa Sin shiga ƙasarsu, a matsayin ƙoƙarin hana cutar.
A Japan, Twitter ta mallaki 'yan uwan Sin.
Sunnis, kamar sauran 'yan Asiya na Birtaniya da Majalisar Dinkin Duniya, sun yi ikirarin karuwar Farisa, da kuma kai hare-hare na ruhaniya.
Shugaban Amurka Donald Trump ya fuskanci zargi saboda kiran coronavirus "ciwon nono", wanda masu sukar suka yi la'akari da shi a matsayin mai nuna bambanci da kuma anti-ciwon nono.
Masu zanga-zangar Ukrainian sun kai hari kan bas din da ke dauke da 'yan Ukraine da kuma 'yan kasashen waje da aka kawo daga birnin Vann zuwa birnin Novi Sanjary.
Masu aikin jinin da suka zo daga arewacin Indiya da ke kusa da Sin, sun gudanar da gwaje-gwaje masu yawa na kimiyya game da yaduwar cutar korona a jami'o'i da dama a Indiya.
Shugaban jam'iyyar Bharatiya Janata Party a West Bengal, Dillip Bhas, ya ce Sene ya lalata yanayi kuma "saboda haka wannan fansa ce daga Allah a kansu".
Bayan haka, Consul Sin na Kolkata ya ba da jawabi, ya kira shi "masu-faɗakarwa". A Sin, ana nuna ƙiyayya da kuma nuna bambanci tsakanin jinsi da kuma al'umma a kan baƙi da ke zaune a Sin, saboda annobar, ana kwatanta baƙi a matsayin "ɓataccen baƙi" kuma ana nufin kawar da su.
Yawancin 'yan jarida masu zaman kansu sun share labarai daga intanet saboda labarin cutar coronavirus.
Yawancin masu wallafa kimiyya na shafin yanar gizon sun shirya game da yaduwar cutar tare da shiga cikin labarin.
Wasu masana sun zaɓi su buga sakamakon su cikin sauri a cikin wani ɓangare na kan layi kamar bioRxiv.
bayyanar cututtuka - bayyanar cututtuka na hanyar watsawa, bambancin yadda suka yada da kuma yadda suka yada.
Duniya da cututtuka - An gabatar da kimantawa ta duniya da cututtuka.
Jerin cututtuka da annoba - Jerin mutuwar da aka yi saboda wata cuta.
Gudun daji da warewa - Akwai haɗarin kiwon lafiya da ke tattare da cinikin dabbobi.
Gwaje-gwajen gwaji na cutar coronavirus 2019 (COVID-19) da kuma SARS-CoV-2 da ke tattare da cutar sun ƙunshi wasu batutuwa da ke bincika kasancewar cutar da waɗanda ke gudanar da bincike za su iya samar da maganin rigakafi.
An gano cewa cutar tana cikin samfurori ta hanyar RT-PCR wanda ke nazarin RNA na coronavirus.
Wannan gwaji na musamman ne kuma an tsara shi ne don nazarin RNA na SARS-CoV-2 kawai.
Ana amfani da wannan don yin amfani da sababbin cututtuka masu aiki.
Ana iya amfani da binciken maganin rigakafi don gano cututtuka da kuma kula da al'umma.
Gwaje-gwajen maganin sun nuna yawan mutanen da suka kamu da cutar, waɗanda ba su da alamun bayyanar da za a iya bayyanawa, da waɗanda ba su da alamun cutar.
Ana iya sanin ainihin yawan mutuwar da aka samu daga cutar da kuma yawan mutuwar da aka samu daga gwajin.
A cikin gwajin da aka yi a cikin iyaka, a watan Maris na 2020, babu wata ƙasa da ta sami tabbataccen bayani game da yaduwar cutar a cikin al'ummarta.
A kashi 23 cikin 3, babu wata ƙasa da ta yi gwaji ga fiye da kashi 3 cikin dari na yawan jama'a, kuma akwai ra'ayoyi daban-daban game da yadda ake gudanar da gwaji a cikin ƙasashe.
Wannan bambanci yana nufin yawan tasirin cututtukan cututtuka masu tsanani, wanda ake sa ran yin kimantawa a wasu ƙasashe.
Ana iya amfani da gwajin rRT-PCR don gano matsalolin numfashi da ke tattare da nau'in kwayar cutar. Wannan gwajin ya ƙunshi gwajin ƙashi da ƙuƙwalwa da kuma gwajin leak.
Sakamakon zai kasance a cikin sa'a ɗaya zuwa kwana biyu.
Gwajin RT-PCR da aka yi tare da gwajin ƙwayoyin cuta shi ne kawai gwajin da aka amince da shi a farkon makon cutar.
Daga nan, kwayar cutar za ta iya ɓacewa a cikin hanji yayin da take ci gaba da ƙaruwa a cikin huhu.
Ga mutanen da ke da gwajin da aka yi a mako na biyu, ana iya ɗaukar samfurin daga cikin numfashi ta hanyar na'urar inji ko kuma a yi amfani da shi ta hanyar yin amfani da ƙwayar cuta.
An kirkiro wani gwaji na farko na PCR a Jami'ar Charity a Berlin a watan Janairun 2020 wanda ya yi amfani da rRT-PCR (rRT-PCR) wanda ya hana polymerase chain reaction. Kuma ya samar da kayayyakin kiwon lafiya 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta ci gaba da yin gwaji a ranar 23/1/2020. Kamfanin Cogenibioch na Koriya ta Kudu ya gano sabon hanyar magani, PCR ya danganta da bayyanar SARS-CoV-2 (Covid-19 mai ƙarfi) a ranar 28/1/2020.
Wannan gwajin ya nemi samfurin "E" wanda ya bazu a cikin dukkan masu karɓar kwayar cutar coronavirus, kuma samfurin RdRp na SARS-CoV-2 na musamman. A Sin, BGI Group na ɗaya daga cikin kamfanonin farko da suka karɓi kayan gaggawa daga Ma'aikatar Samfurin Lafiya ta Sin, PCR mai dogaro da kayan aikin bincike na SARS-CoV-2, a Amurka, da Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta wallafa sabon gwajin cutar coronavirus na 2019 (RT-PCR) a cikin manyan dakunan gwaje-gwaje na duniya.
Wani gwajin da aka yi na kwayoyin halitta na samfurin gwajin ya haifar da sakamakon rashin inganci saboda amfani da kwayoyin da ba daidai ba da tabarau na gwaji a CDC a Atlanta; wannan ya haifar da auna a kan matsakaici kasa da 100 samfurori a kowace rana a cikin watan Fabrairu na 2020.
Ba a tabbatar da gwajin amfani da abubuwa biyu daban-daban ba a ranar 28/2/2020. Har zuwa wannan lokacin, ya bayyana cewa an ba da izinin gwaje-gwaje ga gida da na jihar.
Hukumar kula da abinci da magunguna ta amince da gwajin. A lokacin da ake bukatar gaggawa, cibiyar ta fara gwajin a farkon watan Maris na 2020.
A ranar 5/3/2020, LabCorp ta sanar da samun gwajin COVID-19 a matakin ƙasa dangane da RT-PCR
Hukumar Kula da Binciken Cutar ta fitar da wani nau'i na rarraba gano COVID-19 a kasa a ranar 9/3/2020.
Babu wani adadin da aka bayyana, tarin samfurori da kuma bin sawun dole ne a bi bisa ga buƙatun CDC.
A Rasha, cibiyar bincike ta VECTOR ta ci gaba da samar da gwajin COVID-19.
A ranar 11/2/2020 ne aka yi rajistar gwajin ta Hukumar Kula da Lafiya ta Tarayya. A ranar 12/3/2020, Mayo Medical ta sanar da cewa an ci gaba da yin gwajin don nazarin kamuwa da cutar COVID-19. A ranar 13/3/2020, Hukumar Kula da Cututtukan Roche ta sami amincewar FDA don gwajin da za a iya yi a cikin sa'o'i 3.5 a cikin kamuwa da cuta mai tsanani, don haka muna ba da damar na'urar guda ɗaya ta gudanar da gwaje-gwaje 4,128 a cikin sa'o'i 24.
A ranar 19/3/2020, FDA ta ba da izinin EUA ga Labs na Abbott don gwaji a kan tsarin Abbott na 2000m. FDA ta ba da izinin farko don ba da izinin maganin maganin halogenic da LabCorp da kuma Scientific SermoFisher.
A ranar 21/3/2020, Safeyd ta samu izinin EUA daga FDA don gudanar da gwajin da ya ɗauki minti 45.
FDA ta amince da gwajin da ya yi amfani da fasahar hada-hadar acid mai ciki maimakon PCR.
Saboda wannan ba ya buƙatar jerin canje-canje na zafin jiki, wannan hanyar na iya samar da sakamako mai kyau a cikin minti 5 kawai kuma sakamako mara kyau a cikin minti 13.
Yanzu akwai kusan 18,000 na'urori a cikin Majalisar Dinkin Duniya. Kuma Abbott ya yi hasashen cewa za a ƙara yawan su zuwa 50,000 a kowace rana. Wani gwaji da ke amfani da bayanan antibody da kuma haɗa da ƙwayoyin cuta da ƙwayoyin cuta na N protein na sabon coronavirus za a ci gaba a Taiwan, tare da fatan cewa zai iya samar da sakamako a cikin minti 15 zuwa 20 daidai da gwajin sauri na mura.
Wani bita na wallafe-wallafen Maris 2020 ya nuna cewa "ra'ayoyin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinadarin Sinad
Abubuwan da ake amfani da su a kan CT sun haɗa da na'ura mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwakwalwa mai kwak
Ana bi da ciwon hanci, rashin hankali, da kuma rashin ƙarfi a matsayin ciwon ci gaba.
Wani bincike na kimiyya na PCR da CT a birnin Wan a farkon annobar ta yanzu ya nuna cewa CT ya fi tsananin gaske fiye da PCR, ko da yake ba shi da cikakken bayani, tare da nuna bambanci mai kyau ga cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
A watan Maris na 2020, Kwalejin Nazarin Magunguna ta Amurka ta bayyana cewa " CP ba za a iya amfani da shi don bincika ganowa da gano COVID-19 ba. " A watan Maris na 2020, CDC ta ba da izinin PCR don fara shan magani.
Wani ɓangare na maganin rigakafi ga kamuwa da cuta shine samar da maganin rigakafi wanda ya hada da IgM da IgG.
Ana iya amfani da su wajen gudanar da bincike a kan mutane a cikin kwanaki 7 na farkon kamuwa da cutar ko kuma bayan bayyanar cututtuka na farko don gano rigakafi da kuma gano cutar a cikin jiki. Ana iya yin gwaje-gwaje a cikin cibiyar bincike ta asibiti (CLT) ko ta hanyar gwajin wuri na gargadi (PoCT).
Yawan tsarin sarrafa kansa na yau da kullum a cikin dakunan gwaje-gwaje na likita zai kasance a shirye don yin waɗannan gwaje-gwajen amma kasancewa a shirye zai dogara ne akan matsakaicin samarwa ga kowane tsarin.
Ana amfani da gwajin jini na waje don CLT, amma ana iya amfani da jerin samfurori don jinkirta amsawar ƙwayar cuta.
Ana amfani da samfurin jini don PoCT a matsayin samfurin jini na fata.
Ba kamar matakan PCR ba, ba a buƙatar wani mataki na fitarwa kafin gwajin. A ranar 26/3/2020, FDA ta ba da sunayen masu izini 29 waɗanda suka ba da sanarwar zuwa ga mai amfani kamar yadda aka nema kuma yanzu suna samuwa don rarraba maganin rigakafin gwajin su.
A ranar 7/4/2020, FDA ta amince da gwajin kawai a ƙarƙashin kulawar Hukumar Kula da Amfani da Magunguna na gaggawa. A ƙarshen Maris 2020, Laboratories na Kula da Magungunan dabbobi da Epithet sun sami amincewar Turai don kayan aikin su, wanda zai iya yin bincike don maganin IgG da IgA na cutar daga samfurin jini.
Wannan gwajin yana da ikon yin samfurori shida a awa daya kuma saboda haka ya fi sauri fiye da gwajin PCR na yau da kullum na RNA na kwayar cutar.
Ana iya gano maganin rigakafi sau 14 bayan kamuwa da cutar, a farkon watan Afrilu, Birtaniya ta gano cewa babu maganin rigakafi a dakin gwaje-gwaje, don haka ta sayi maganin rigakafi da ke da amfani.
Hong Kong ta gabatar da shirin da ke ba da izinin marasa lafiya masu laifi su zauna a gida, sashen jigilar kayayyaki na gaggawa ya ba da sirinji don karɓar samfurin marasa lafiya, ya ba su leaks kuma ya dawo da su, sannan ya sami sakamakon binciken. NHS ta Burtaniya ta sanar da cewa za ta gwada shirin don bincika masu laifi a gida, wanda zai iya sa wasu mutane su kamu da cutar idan sun shiga asibiti ko kuma su yi amfani da motar asibiti. Yayin da ake ba da gudummawa ga masu zargin COVID-19, ƙwararren likita na kiwon lafiya zai karɓi misalai ta amfani da matakan tsaro masu dacewa.
Cibiyoyin isarwa sun taimaka wa Koriya ta Kudu, suna gudanar da wasu gwaje-gwaje masu sauri da kuma mafi girma a cikin ƙasashen. A Jamus, Kungiyar Tarayyar Kasuwancin Kasuwancin Kasuwancin Kasuwanci ta ce a 2/4 cewa ta sami damar gudanar da gwaje-gwaje 12,000 a kowace rana a aikin da ke yin hijira, kuma an gudanar da gwaje-gwaje 10,700 a makon da ya gabata.
Asusun inshorar lafiya zai biya kuɗin lokacin da likita ya nemi a yi maka jarrabawa.
A cewar shugaban cibiyar Robert Koch, Jamus na da damar gudanar da bincike sama da 160,000 a kowane mako.
A ranar 19 ga watan Maris, an gabatar da gwajin baƙi a manyan birane da yawa.
A ranar 26/3/2020, yawan adadin gwajin da aka yi a Jamus ba a sani ba, saboda an ba da sakamako mai kyau kawai.
Labarin farko na auna siginar ya nuna cewa kamar yadda a cikin kalandar mako 12/2020, sun yi aƙalla samfura 483,295 a gaba ɗaya kuma tsakanin mako 12/2020 da 33,491 wanda ya kai (6.9%) a matsayin masu kyau ga SARS-CoV-2, a Isra'ila masu bincike a asibitin Tekneon da Rambam sun haɓaka sabuwar hanyar gwaji don bincika samfura ga marasa lafiya 64 a lokaci guda, ta hanyar tattara samfura da cikakken gwaji don yiwuwar samun tabbataccen samfurin hade.
Ta hanyar dubawa ta hanyar Wanda ya kafa BGI Wang Jian da kuma kwanaki 5, ayyukan sun nuna cewa akwai lokuta a Hubei da ya kamata su kasance 47% mafi girma kuma farashin da aka yi watsi da ƙoƙarin killacewa zai ninka idan ba a sami damar yin gwajin ba.
Labarin su ya kasance kai tsaye daga dakin gwaje-gwaje na Hue-yan a Shenzhen da Tianjin da kuma Beijing da Shanghai gaba ɗaya daga biranen Sin 21.
A ranar 4/3/2020, yawan gwajin yau da kullum ya kai 50,000 a kowace rana, an wallafa wani shafin bude ido na Chemical Map, wanda aka bayyana ta hanyar Orygam Tests cewa za su iya gwada 1122 marasa lafiya don COVID-19 ta amfani da gwajin 93 kawai, ana iya amfani da waɗannan taswirar a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar na'urar gwajin ruwa ba.
A watan Maris, rashin da kuma rashin gilashin sunadarai, gilashin Melbourne ya kasance mai amfani da gwaje-gwaje masu ƙarfi a Turai da Birtaniya.
Wannan ya sa marubuta su yi bincike don aiwatar da tsarin shirya gwajin samfurori da ke nuna yanayin zafin jiki na 98 ° C (208 ° F) na minti 5 don nuna kwayoyin RNA don cikakken bincike. A ranar 31/3 an sanar da cewa UAE ta yi gwajin cutar coronavirus ga kowane mutum fiye da sauran ƙasashe, kuma suna ƙoƙari su ƙara yawan gwajin zuwa mafi yawan yawan yawan jama'a.
Wannan ya danganta da haɗuwa da ikon gwajin balaguro da sayen kayan aikin dakin gwaje-gwaje a cikin ƙungiyoyi 42 da BGI (wanda ya haɗa su da dakin gwaje-gwaje na gaggawa na Hu-wan a Sin).
Ta hanyar kiyaye su har kwana 14, dakin gwaje-gwaje na iya yin gwajin ST-PCR 10,000 a kowace rana kuma zai zama kashi na farko da aka yi a waje da wuri.
An yi gwaje-gwaje daban-daban na masu karɓa don gano nau'ikan kwayoyin cutar coronavirus a Sin, Faransa, Jamus, Hong Kong da Majalisar Dinkin Duniya.
Hukumar lafiya ta duniya ta dauki ra'ayin Jamus na samar da kayan aikin bincike kuma ta tura shi ga kasashe masu talauci da ba su da wadata don bunkasa kayan aikin kansu.
An fitar da ra'ayin Jamus a ranar 17/2/2020, yarjejeniyar da Cibiyoyin Kula da Cututtuka na Majalisar Dinkin Duniya suka ci gaba ba ta kasance ba har zuwa 28/2, jinkirta samun gwajin a Sin da Majalisar Dinkin Duniya sun yi matsala game da amincewa da kayan aikin gwaji a farkon barkewar cutar, waɗannan ƙasashe da Ostiraliya sun kasa samar da kayan aikin gwaji don gamsar da buƙatun da umarnin don gwaji ta hanyar masana kiwon lafiya.
A akasin haka, masana sun ce samun wadataccen gwajin cutar ta Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
An yi amfani da gwaje-gwaje masu yawa, da kuma manyan dakunan gwaje-gwaje na musamman a cikin shekaru da yawa a kan layi na gwamnatin Koriya ta Kudu.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta yi kira ga karin shirye-shirye don nuna yadda cutar ta COVID-19 ta ci gaba. Babban bukatar gwaji saboda yaduwar cutar ta haifar da gwajin gwaji 300,000 a cikin dakunan gwaje-gwaje na Majalisar Dinkin Duniya, da kuma samar da kayan gwaji da gilashin sinadarai.
A watan Maris na shekarar 2020, Sin ta bayyana cewa tana da matsala da daidaito da kuma daidaito na kayan aikin ta.
A Majalisar Dinkin Duniya, an ci gaba da kayan aikin gwaji a kan layi na CDC wanda ya yi kuskure sannan gwamnati ta kawar da matsalolin doka, wanda ya hana su yin gwaji na musamman. Spain ta sayi kayan gwaji daga Seneca, Shenzhen Biotechnology Co Ltd, amma ta gano cewa sakamakon bai kasance mai kyau ba.
Kamfanin ya bayyana cewa sakamakon da bai dace ba zai iya kasancewa sakamakon tattara samfurori ba ko kuma yin amfani da kayan aiki ba daidai ba.
Ma'aikatar kasar Spain ta ce ta dawo da kayan aikin da suka yi kuskure, kuma ta maye gurbin su da kayan aikin dakin gwaje-gwaje daban-daban. An samar da kayan aikin shenzhen na kwayoyin halitta. Kashi 80% na kayan aikin dakin gwaje-gwaje da Jamhuriyar Czech ta saya daga Sin sun yi kuskure. Slovakia ta sayi kayan aikin dakin gwaje-gwaje miliyan 1.2 daga Sin wanda ya bayyana ba daidai ba ne.
Firayim Ministan Slovakia Matović ya ba da shawarar a yi musu nesa zuwa Danube. Atis Kara a Ma'aikatar Lafiya ta Turkiyya ya ce kayan aikin dakin gwaje-gwaje na Turkiyya da ya saya daga Sinai sun "zama da lahani", kuma "ba su da amfani". Birtaniya ta sayi kayan aikin dakin gwaje-gwaje miliyan 3.5 a watan Satumba na 2020 amma a farkon watan Satumba ta ce ba su da amfani.
Gwaji, killace wadanda suka samu sakamako mai kyau da kuma gano wadanda suka yi alaƙa da masu kamuwa da SARS-CoV-2 da kuma wadanda suka kamu da cutar tun lokacin da suka kamu.
Masu bincike suna aiki a garin Voye, Italiya, inda aka fara samun mutuwar da aka yi a sakamakon COVID-19. Sun gudanar da bincike biyu a duk mazaunin da ke da mutane 3,400 a cikin kwanaki goma.
Kusan rabin mutanen da suka samu sakamako mai kyau ba su da wata alama, kuma an killace duk waɗanda aka gano.
Ta hanyar tafiya zuwa yankuna na musamman, ba ta bar sabon yanayin gaba ɗaya ba.
Ta hanyar yin bincike mai tsauri, taƙaita dokokin tafiye-tafiye, da kuma yin bincike da killacewa, annobar korona ta 2020 ta bazu a Singapore a hankali fiye da sauran ƙasashe masu tasowa. Ba tare da ƙa'idodi masu ƙarfi kamar tilasta rufe gidajen abinci da wuraren sayarwa da sayarwa ba.
An ƙi yin taron da yawa, kuma Singapore ta fara ba da shawara ga mazauna su zauna a gida a ranar 28/3 amma an buɗe makarantu a kan lokaci bayan hutu a ranar 23/33.
Yawancin ƙasashe sun yi aiki da rarraba masu haƙuri da dakatar da tafiya da bincike da killacewa a lokacin annobar, amma ba tare da tsauraran takunkumin zirga-zirga ba kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya nuna cewa kasashen da suka yi bincike mai yawa da suka shafi yawan mutuwar, suna da ƙananan adadin mutuwar, wanda zai iya sa waɗannan ƙasashe su fi shirye su gudanar da bincike ga mutanen da ba su da alamun cutar ko kuma marasa lafiya.
Hukumar lafiya ta duniya ta ce kasashen da ba su da damar yin gwajin COVID-19 da kuma dakunan gwaje-gwaje na kasa da suka saba da su, za su tura manyan biyar da suka yi nasara da kuma 10 da suka yi nasara da cutar zuwa ɗaya daga cikin wuraren gwaje-gwaje 16 na WHO don yin gwaji.
Daga cikin hanyoyin bincike guda 16, bakwai daga cikin su na Asiya ne, biyar daga Turai, biyu daga Afirka, daya daga Arewacin Amirka, daya daga Australia.
A cikin jerin sunayen, an kirkiro "ƙididdigar gwajin gwaji na tabbatacce" ta hanyar 'yan sanda na kasar.
Kasashen da ke duba wadanda aka kai asibiti ne kawai za su samu kashi shida na masu cutar a cikin wadanda ke duba dukkan al'ummar kasar, ko suna da alamun cutar ko a'a, duk abin da ya kasance daidai ne.
Wanke hannu (wanda aka fi sani da wanke hannu) yana nufin wanke hannu don cire ƙura, kitse, ƙwayoyin cuta, da sauran abubuwa marasa amfani.
Yin wanke hannu da sabulu don tabbatar da "lokaci mai haɗari"; yana hana yaduwar cututtuka da yawa a rana, kamar kumburi, da kuma cutar kwalara da ke kamuwa da cutar ta gurbatawa.
Mutane kuma suna fama da cututtukan numfashi kamar mura ko kumburi na yau da kullum, misali, idan ba su wanke hannu kafin su taɓa idanunsu ko bakinsu ba.
Abubuwa guda biyar masu muhimmanci a rana da ake amfani da su wajen wanke hannayenka da sabulu sun hada da kafin ka yi wanka, bayan ka wanke suturarka ko kuma ka yi maye gurbin nono, ka ba da jariri kafin ka ci abinci, kafin ka ci abinci, da kuma bayan ka dafa ko ka dafa nama, kifi, tsuntsu.
Idan babu ruwa da sabulu, za ka iya ɗaure hannayenka da toka. Hukumar Lafiya ta Duniya ta ba da shawarar yin wanka hannu a:
Kafin da kuma bayan dafa abinci.
Kafin da kuma bayan kula da mai haƙuri.
Bayan an canja wurin mahaifa ko kuma an wanke jariri a bayan gida.
Bayan na sha kashi, da cocaine, da kuma fumina.
Bayan cin naman dabbobi da abincin dabbobin dabbobin dabbobin da aka kashe.
Tsabtace hannu na nufin aikin tsabtace hannu wanda ya shafi kayayyakin kiwon lafiya.
Yin wanka kafin aikin likita ko kulawar likita na iya rage ko rage yaduwar cututtukan.
Babban manufar maganin wanke hannu shine wanke hannayen hannu daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu kwayoyin cuta waɗanda zasu iya haifar da cututtuka), da kuma sunadarai waɗanda zasu iya haifar da cutar ko cutar.
Wannan yana da mahimmanci ga mutanen da ke dafa abinci ko aiki a cikin wani yanki na likita, amma kuma yana da mahimmanci ga ayyukan jama'a.
Yin wanka hannu yana da fa'idodi masu yawa na kiwon lafiya, wanda ya haɗa da rage yaduwar cutar mura da coronavirus da sauran cututtukan cututtuka; hana abubuwan da ke haifar da kamuwa da cutar, rage yawan guba a numfashi.
Ƙarƙashin mutuwar yara da aka haifa a gida ya haɗa da hakan.
Wani bincike na kimiyya a 2013 ya nuna cewa ci gaba a cikin aikin wanke hannu na iya taimakawa wajen rage tsawon lokacin ci gaba a cikin yara a karkashin shekaru 5.
A ƙasashe masu tasowa, yawan mutuwar yara yana da alaƙa da cututtukan numfashi da na hanji wanda za a iya rage shi ta hanyar gabatar da halaye daban-daban kamar wanke sabulu.
Wannan aiki mai sauki zai iya rage yawan mutuwar a cikin wadannan kasashe da kusan kashi 50 cikin 100.
Shawarwarin likitoci sun ce wanke hannu zai iya rage kusan kashi uku na jerin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttuk
Kashi 48 cikin dari na rage yawan cututtukan numfashi na iya danganta da wanke hannu da sabulu. Wanke hannu da sabulu yana daya daga cikin hanyoyin da suka fi dacewa da kuma rahusa na hana numfashi mai tsanani (ARI), kamar yadda ake yin ta atomatik a gidaje, makarantu da al'ummomi a duniya.
Rashin haihuwa, babban ɓangare na ARI, shine babban dalilin mutuwar yara a ƙarƙashin shekaru biyar, wanda aka kiyasta mutuwar miliyan 1.8 a kowace shekara.
Cutar ciki da kuma ciwon hanci suna kashe kusan yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, yin wanka da sabulu kafin cin abinci da bayan yin amfani da wanka tare da kwanon rufi na iya ceton rayuka fiye da duk wani magani da magani, yana hana mutuwar shan wahala ta hanyar kashi 50% kuma yana hana mutuwar rashin numfashi ta kashi 1 cikin 4.
Yin wanka a hannu sau da yawa yana da alaƙa da wasu hanyoyin tsabtace jiki kamar su ruwa da ruwa da kuma tsabtace jiki.
Yin wanka zai kuma hana ka samun kyan fata wanda za ka iya samu ta hanyar yin jima'i.
Wani sakamako mai kyau na wanke hannu shi ne cewa wanke hannu da yawa zai iya haifar da lalacewar fata ta hanyar bushewar fata.
Wani bincike na kimiyya na Danish a shekara ta 2012 ya gano cewa wanke hannu a waje na iya haifar da tari da kuma yanayin fatar fata da aka sani da hannayen riga ko hannayen riga, wanda ya fi kowa a cikin ma'aikatan kiwon lafiya.
Ana ganin yawan wanke hannu a kai a kai a matsayin wata alama ce ta rashin lafiyar jiki (OCD).
Akwai lokatai biyar na kwanaki da wanke hannu da sabulu ke da muhimmanci wajen rage haɗarin kamuwa da cutar ta hanyar ƙazantawa; bayan wanka (tabbata da cin abinci), bayan wanke suturar jariri (canja sutura), kafin abinci da kuma kafin da kuma bayan dafa abinci ko dafa nama da kifi da tsuntsu.
Sauran lokuta da ake amfani da fasaha na wanke hannu don hana kamuwa da cutar, sun haɗa da kafin da bayan warkar da rauni, bayan an shafe ƙuƙwalwa ko ƙashi, bayan an zubar da dabba ko kuma an yi amfani da dabba, da kuma bayan an zubar da shara.
A ƙasashe da yawa, akwai ƙarancin yawan wanke hannu da sabulu.
Wani bincike na wanke hannu a kasashe 54 a shekarar 2015 ya nuna cewa a matsakaita kashi 38.7 cikin dari na mutane suna wanke hannu da sabulu a gida. Wani bincike a shekarar 2014 ya nuna cewa Saudiyya tana da mafi yawan yawan wanke hannu a kashi 97 cikin dari, kuma Amurka tana da matsakaici kashi 77 cikin dari, kuma Sin tana da mafi ƙarancin yawan wanke hannu da sabulu a kashi 23 cikin dari. Akwai canje-canje daban-daban na halayyar yanzu don ƙara yawan ayyukan wanke hannu da sabulu a lokacin da ake buƙata.
Tsarin kula da lafiya na asali da aka aiwatar a sassan Turai a cikin Philippines misali ne mai kyau na inganta lafiyar yara da ilimi.
Yin wanke hannu sau biyu a shekara. Ƙara wanke hannu da sabulu a kullum, wanke hakora a kullum da ruwan albasa, shi ne muhimmin ɓangare na wannan shirin na duniya.
An yi nasarar yin hakan a Indonesia.
An yi amfani da sabulu ko tawada don cire kwayoyin a fata.
Mafi muhimmanci ga sabulu da ta'aziya shi ne rage matsalolin da ake samu da kuma kara karfin da ake samu.
Ruwa kawai yana da tsabtace fata na wajibi saboda kitse da furotin, wanda ba ya fitowa daga asalin da ya ƙazantu.
Tsabtace ruwa yana taimakawa wajen tsabtace shi ta hanyar ruwa.
Sabulu mai wuya, saboda yanayin sake amfani da shi, yana riƙe da ƙwayoyin cuta da ake buƙata daga masu amfani da shi a baya.
Ƙananan bincike da suka yi kan ƙwayoyin cuta na ƙwayoyin cuta a cikin sabulu na cire ruwa na cats sun gano cewa ƙwayoyin cuta na ƙwayoyin cuta suna ƙara ƙwayoyin cuta zuwa ƙwayar cuta.
Hukumar ta CDC ta ce "sabo mai ruwa tare da sarrafa hannu ya dace da tsabtace jiki".
Sabulu na antibacterial suna da tsada sosai don samun kulawa ta kiwon lafiya.
A halin yanzu, babu wata hujja da ta nuna cewa ana amfani da maganin rigakafi ko kwayoyin cuta masu kisa don kare kwayoyin cuta na gabobin a yanayi.
Koyaya, sabulu na antibacterial yana dauke da maganin rigakafi na yau da kullun kamar yadda ake amfani da shi don samar da maganin rigakafi, wanda ke da jerin jerin abubuwan da ke hana rigakafin ga gabobin.
Saboda haka, ko da ba a ba da takardar rigakafin rigakafi ga sabulu na rigakafi ba, ba zai iya zama da tasiri kamar yadda ake tallatawa ba.
Tare da sabulu da kuma maganin fata, tsarin da ya fi dacewa zai iya haɗawa da acid (acetic acid, ascorbic acid, lactic acid) kamar su pH, benzoic acid da antibacterial acid da kuma cututtukan fata (Alon Vera, bitamin, mensole, kayan shuka). Wani bincike na gaba ɗaya a Jami'ar Lafiya ta Oregon School of Public Health ya nuna cewa sabulu na yau da kullum kamar sabulu yana da tasiri a kan kwayoyin cuta wanda ke ƙuntata hana da kuma hana kwayoyin cuta a hannu.
Ruwan da ke da zafi don wanke hannu ba shi da yawa don kashe ƙwayoyin cuta.
Kwayar cuta tana girma da sauri fiye da (37) zafin jiki.
Koyaya, ruwan sabulu mai zafi ya fi ruwan sanyi sanyi kyau kuma yana kawar da kitse na halitta wanda ke ɗauke da ƙazanta da ƙwayoyin cuta.
Koyaya, wannan ya saɓa wa ka'idar ƙasa. Gwajin kimiyya ya nuna cewa amfani da ruwan zafi ba ya tasiri a kan karɓar ƙwayoyin cuta a hannu.
Ruwan wanka ko kayan wanke hannu na wanke hannu ne mai tsabtace hannu ba tare da amfani da ruwa ba.
A ƙarshen shekarun 1990 da kuma farkon karni na 21, kayan wanke hannu na giya ba tare da amfani da ruwa ba (wanda aka fi sani da wanke hannu na giya, kayan wanke hannu, wanke hannu) ya zama na kowa.
Yawancin su sun dogara ne akan isopropyl ko ethanol da aka haɗa tare da microbut purifiers kamar carbamide (acrylic acid polymer) don yin amfani da kayan shafawa, ko halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen halayen ha
Ƙara yawan oxygen a cikin ruwan 'ya'yan itace na antioxidant yana ƙara aikin antimicrobial. Mai tsabtace hannu yana dauke da mafi ƙarancin kashi 60% zuwa 95% na barasa wanda ke kashe kwayoyin cuta.
Mai tsabtace barasa yana kashe kwayoyin cuta, kwayoyin cuta masu saurin kamuwa da kwayoyin cuta (MRSA da VRE), cututtukan daji, da wasu ƙwayoyin cuta (ciki har da HIV da cututtukan kwayoyin halitta da RSV da kwayar cutar Reno, ƙwayoyin cuta da mura da kuma cutar shan magani na hanta) da kuma fungi.
Abincin shan giya ya ƙunshi kashi 70 cikin dari na shan giya, kashi 99.97 cikin dari (ƙarancin sigogi 3.5 ne, daidai da na'urar rage sauti 35) na kwayoyin cuta a hannayen mutum a cikin dakika 30 bayan amfani da shi da kashi 99.99 cikin dari zuwa 99.999 cikin dari (4-5 rage sigogi) na kwayoyin hannu a cikin minti daya bayan amfani da shi, kuma yana da tasiri sosai a kan ƙwayoyin cuta kuma yana da ƙarancin tasiri a kan ƙwayoyin cuta.
Abin shan giya ba ya hana hannu ya wanke daga kwayar cutar da ake watsawa (ko kuma kwayar cutar Norwalk), wadda ta haifar da kamuwa da cutar sankara, dole ne a yi amfani da kayan wankewa ko kuma tsabtace hannu don a rufe hannu sosai.
Ana tsabtace gaba da baya na hannayen hannu, da tsakanin da kuma ƙarshen dukkan yatsunsu na tsawon dakika 30 har sai an wanke ruwa, kumfa, ko kuma ruwa.
Dole ne a wanke yatsunsu sosai kuma a yi suturarsu ta hannun. Cibiyar Kula da Cututtuka ta Majalisar Dinkin Duniya ta ba da shawarar wanke hannu kafin wanke hannu, musamman idan hannuwan sun zama masu tsabta.
Yawan waɗannan abubuwa ya dogara da sauƙin amfani da kuma saurin kashe kwayoyin cuta, duk da haka, kada su yi aiki a matsayin maye gurbin wanke hannu sai dai idan sabulu da ruwa suna samuwa.
Yin amfani da kayan shafawa da yawa na barasa zai iya haifar da bushewar fata sai dai idan an ƙara cream ko kayan shafawa don yin aikin.
Ana iya rage ko hana tasirin shan giya ta hanyar ƙara cream na glycerin ko wasu cream na fata don aikin.
A cikin magani, kayan wanke hannu na barasa sun ƙunshi cream na fata wanda ba ya haifar da ciwon fata ko bushewa fiye da sabulu da maganin rigakafi.
Sanin shan magani na hanci, shan ruwan gishiri mai narkewa ko kuma shan barasa ko kayan shafawa na kayan shafawa na iya faruwa a cikin rare.
Ƙananan shirye-shiryen ƙara yawan ruwan zãfi ya zama mai yawa fiye da wanke hannu da sabulu da ruwa.
Duk da tasirin su, masu tsabtace ruwa ba su tsabtace dukkan sassan hannu gaba ɗaya ba amma suna tsabtace su sosai.
Wannan shi ne saboda wannan lokacin da kayan wanke hannu kamar ruwa da sabulu ba su da tasiri wajen hana yaduwar cututtuka da yawa, wanda shine dalilin da ya sa cututtuka har yanzu ke kasancewa a hannun.
Aikin tsabtace hannayen giya yana dogara ne da tsarin da zane, kuma ya gaza a tarihi.
A kwanan nan, an nuna cewa magungunan da ke amfani da benzodiazepine chloride suna da ci gaba da aiki mai ƙyama da kuma ƙwayar cuta bayan amfani, sabanin abin sha, wanda aka nuna yana da tasiri kaɗan bayan sake amfani, wannan na iya zama saboda yawan halayen cututtukan fata.
Mutane da yawa a ƙasashe masu tasowa ba za su iya samun sabulu ba kuma za su yi amfani da toka ko toka a maimakon haka.
Gasa ko toka na iya zama mafi tasiri fiye da ruwa kadai, amma zai iya zama ƙasa da tasiri fiye da sabulu.
Wani abin da ake damuwa shi ne, idan ƙura ko toka ya ƙazantu da kwayoyin cuta, zai iya ƙara yaduwar cutar fiye da yadda zai rage.
Kamar sabulu, ƙura da toka suna kashe kwayoyin cuta saboda sun haɗu da ruwa, suna haifar da wani abu mai ƙanshi.
Hukumar lafiya ta duniya ta ba da shawarar turmi da turmi a matsayin madadin sabulu lokacin da sabulu ba su da samuwa.
Hanyar da aka ba da shawarar da Cibiyoyin Kula da Cututtuka na Majalisar Dinkin Duniya za su yi don hana yaduwar cutar ta ƙunshi:
Ka wanke hannayenka da ruwan da ke gudana, mai zafi da sanyi.
Ana ba da shawarar ruwa mai gudana saboda yana iya zama mai ƙazanta idan ya kasance a ƙasa, yayin da zafin jiki na ruwa ba zai iya haifar da bambanci ba.
Yin wanke hannu ya ƙunshi wanke hannu da sabulu, bayan hannu, da tsakanin yatsunsu da kuma ƙarƙashin yatsunsu.
Sabulu yana kawar da kwayoyin cuta a fata, kuma bincike na kimiyya ya nuna cewa mutane sun fi son wanke hannu yayin da suke da sabulu fiye da wanke hannu da ruwa.
Ka yi amfani da sabulu don yin amfani da shi aƙalla na minti 20.
Yin amfani da sabulu a hannu yana haifar da yin amfani da sabulu, wanda ke taimakawa wajen kawar da ƙwayoyin cuta daga fata, kuma idan ka yi amfani da sabulu a hannu, za ka kawar da ƙwayoyin cuta da yawa.
Yi wanka da hannuwanka da ruwa mai gudana.
Yin wanka a kan gado na iya gurɓata hannayen.
Ka wanke shi da tsabta ko kuma ka bushe shi a cikin iska.
Hannun da ke da ruwa suna da sauƙi su zama masu ƙazanta, mafi yawan wuraren da ke da haɗari su zama masu ƙazantawa sune ƙwanƙolin doki, ƙwanƙolin ƙuƙwalwa, yankin da ke tsakanin yatsunsu da kuma ƙarƙashin yatsunsu.
Ƙarƙashin ƙwayoyin cuta da na halitta na iya zama wuraren haɗuwa da ƙwayoyin cuta.
Ana ba da shawarar yin amfani da suturar fata mai laushi don kare hannayen daga bushewa, fata mai bushewa na iya zama sanadin cutar fata wanda zai iya ƙara watsa cututtukan.
Za a iya yin zaɓuɓɓukan maganin rigakafi don sauƙaƙe wanke hannu lokacin da ruwa mai tsabta da sabulu ba su samuwa ba, misali, adana ruwa a cikin kwalba ko kwalban ruwa a cikin lambar da aka yi ko amfani da toka idan ya cancanta a cikin ƙasashen da ke da jinkiri. A wasu lokuta ƙuntataccen samar da ruwa (kamar makarantu ko yankunan karkara na ƙasashen da ke da jinkiri), akwai hanyoyin adana ruwa kamar "a cikin kwalban ruwa" da sauran zaɓuɓɓukan ruwa masu arha.
Yin amfani da ruwa yana da fasaha mai sauƙi ta amfani da na'ura mai ɗauke da igiya, kuma ya haɗa da kayan shafa don yayyafa ruwa a hannayen hannu da kuma sabulu.
Tasirin bushewa na hannu yana da mahimmanci a cikin aikin wanke hannu, amma akwai wasu ra'ayoyi game da tasirin wanke hannu a cikin wankewa na jama'a.
Wani littafi mai zurfi na bincike ya nuna cewa toilet cleanse ya fi tsabta fiye da na'urar wanke wutar lantarki da ke cikin wasu na'urori.
A shekara ta 2008, wani bincike da Jami'ar Westminster ta London ta gudanar, kuma masana'antun masana'antun masana'antun masana'antun Turai na samar da ruwan tabarau na gida, sun ba da tallafi, don kwatanta matakan tsabtace ruwan tabarau na gida, da kuma yanayin zafi na masu wanke hannu da na'urorin wanke hannu na zamani.
Bayan wanke hannu da kuma wanke hannu da iska mai sanyaya iska, adadin kwayoyin a yatsunsu ya karu da kashi 194 cikin 100 kuma a jikin hannayensu ya karu da kashi 254.
Yin amfani da na'urar kwantar da hankula ta hannu ya nuna cewa adadin kwayoyin a yatsunsu ya karu da kashi 42 cikin 100 da kuma a cikin hanci ya karu da kashi 15 cikin 100.
Bayan wanke hannu da kuma wanke hannu da ruwan wanka, an rage yawan kwayoyin a yatsunsu da kashi 76 cikin 100 da kuma 77 cikin 100 na wanke hannu. Masana kimiyya sun kuma gudanar da gwaje-gwaje don gano yiwuwar gurɓataccen gurɓataccen kayan wanka daga sauran masu amfani da wanka zuwa yanayin dakin a sakamakon hanyoyin wanke hannu.
Wani na'urar bushewa ta hannu mai zurfi da ke fitar da iska a cikin saurin 180m/s (650km/h ;400) na iya lalata kwayoyin halitta a cikin hannu da sashi kuma yana ɓoyewa sauran masu amfani da wanka da kuma gurɓata yanayin wanka na tsawon mita 2.
Yin amfani da na'urar bushewa ta hannu na iya haifar da yaduwar kwayoyin cuta zuwa mita 0.25 daga na'urar.
Clint Toilet ya nuna cewa ba shi da wani kwayoyin cuta. A shekara ta 2005, TUV Proct and Umwellt sun gudanar da bincike, inda suka kimanta hanyoyin wanke hannu.
An lura da canje-canje a cikin adadin kwayoyin bayan an wanke hannayensu:
Akwai wasu magunguna masu yawa na sana'a, kuma ana kwatanta magunguna da magunguna na toilet.
Yin wanka yana nufin yin amfani da ruwan tabarau na waya a matsayin madadin rashin ruwa da sabulu a lokacin tafiya.
Dole ne a yi amfani da kayan tsabtace hannu don a sha giya aƙalla kashi 60 cikin ɗari.
Yin amfani da maganin wanke hannu ya zama dole bayan masanin ilimin likitancin Hungary Ignaz Semmelweis ya gano cewa yana da tasiri (a cikin 1846) a hana cutar a cikin asibiti.
Akwai na'urori masu amfani da wutar lantarki da ke sa ma'aikatan asibiti su yi wanka a lokacin da suka manta.
Wani bincike ya nuna cewa yin wanka yana rage yawan kamuwa da cuta.
Yin wanka na hannu na tsawon lokaci zai ɗauki akalla 15 seconds, ta amfani da sabulu da ruwa ko ruwa don wanke hannu da kuma wanke hannu.
Dole ne a wanke hannayen hannu ta hanyar haɗa da haɗa sassan hannu tare.
Idan akwai ƙura a ƙarƙashin yatsunsu, ana iya amfani da wani wuka mai kaifi don cire shi.
Tun da yake ƙwayoyin cuta suna iya zama a cikin ruwa a kan hannayenka, yana da muhimmanci ka wanke shi da kyau kuma ka rufe shi da tsabta.
Bayan an wanke, dole ne a yi amfani da ruwan wanka don cire ruwa (ko kuma a buɗe kofa a rufe idan ya cancanta).
Wannan zai kare hannayensu daga sake gurɓatawar da ke tattare da wannan.
Manufar wanke hannu a cikin tsarin kula da lafiya shine kawar da abubuwan da ke haifar da rashin lafiya.
Mujallar likitancin New England ta ruwaito cewa rashin wanke hannu ba shi da inganci a cikin yanayin likita, kuma yawancin likitoci da ma'aikatan jinya da suka manta su wanke hannu kafin su taɓa marasa lafiya, suna ba da damar kamuwa da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka na iya rage kamuwa da kwayoyin cuta a cikin jini da kashi 66%. Hukumar lafiya ta duniya ta fitar da wani rahoto na sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanann
Ana iya samun hanyar yin amfani da maganin wanke hannu ta hanyar gudanarwa a shafin yanar gizon ga jama'a.
An gudanar da bincike mai kyau daga Hittby da sauransu.
Kayan aiki na kasuwanci na iya farawa da tabbatar da tsabta, idan an nemi nuna daidaitaccen daidaitaccen mai amfani.
Hukumar lafiya ta duniya ta ba da "lokaci biyar" don wanke hannu:
Bayan ya sha jini.
kafin aikin tsabtace kwayoyin halitta, da
Bayan kula da marasa lafiya. Sabo na sabulu (abin sha ko sabulu mai hana kwayoyin cuta) yana ba da aikin kashewa tare da wanke hannu.
A matsayin aikin kisa, ana iya amfani da shi don yin aiki ko a cikin tsarin da ke cikin tsarin rigakafi na antibody wanda ke da yawan.
Dole ne a kawar da dukan kwayoyin.
Wannan aikin yana bukatar wanke hannu da hannu har sai an gama, yawanci a cikin minti 2-6.
Ba a buƙatar wanke hannu na dogon lokaci (minti 10) ba.
A lokacin wanka, dole ne a hana ruwa daga zurfin ruwa daga zubewa zuwa hannayensu.
Bayan an gama wanke hannu, ana wanke hannu da sutura mai tsabta kuma ana saka sutura na likita.
Don rage yaduwar cutar, ya fi kyau a wanke hannu ko kuma a yi amfani da wanke hannu kafin da bayan kula da wani mai haƙuri.
Don hana kamuwa da cuta a asibitoci, an gano cewa mafi yawan amfanin wanke hannu ya kasance a cikin kashi 20 cikin dari na wanke hannu na farko. Wannan amfanin zai kasance ba shi da yawa idan yawan wanke hannu ya karu zuwa kashi 35 cikin dari.
Yin wanka da sabulu na yau da kullum yana da sakamako sau uku a kan matsakaicin yawan mutanen da ke fama da cutar kwayar cuta fiye da yin wanka da sabulu na barasa. Idan aka kwatanta wanke hannu da sabulu na barasa da wanke hannu da sabulu na dakika 30, za a iya ganin cewa wanke hannu da giya ya rage ƙazantar da kwayoyin cuta da kashi 26 cikin 100 fiye da sabulu na barasa.
Amma sabulu da ruwa sun fi tasiri wajen wanke hannu da giya wajen rage kamuwa da cutar H1N1. Kwayar cuta da kwayar cuta ta Clostridium a hannu. Ayyuka don inganta tsabtace hannu a cikin tsarin kula da lafiya na iya haɓaka ilmantarwa ga ƙungiyoyin wanke hannu, ƙara samun damar yin amfani da maganin hana shan giya, da kuma rubuta da kuma yin tunatarwa ga ƙungiyoyi.
Ana buƙatar ƙarin bincike don gano ayyukan da suka fi tasiri wajen daidaita tsarin kula da lafiya.
A ƙasashe masu tasowa, wanke hannu da sabulu an san shi da kayan aiki na asali don samun lafiya mai kyau, har ma da abinci mai kyau.
Koyaya, rashin ingantaccen ruwan tabarau, sabulu ko kayan wanke hannu a gidajen 'yan ƙasa, a makarantu da wuraren aiki sun haifar da wani tasiri na kawo halin wanke hannu a duniya.
Alal misali, a yawancin ƙauyuka na Afirka, ba a samun kwantena masu tsabta a cikin gidajen wanka na jama'a da na masu zaman kansu, ko da yake akwai zaɓuɓɓuka masu rahusa don samar da wanka na yau da kullum.
Koyaya, rashin yawan wanke hannu na iya zama sakamakon rashin amfani da sabulu da ruwa.
Ƙara yawan yin amfani da sabulu da kuma yin taƙama game da shi zai iya shafar yanke shawara na siyasa da kuma ƙara yawan masu hankali game da amfanin wanke hannu da kuma kasancewa da ɗabi'a mai dorewa a cikin al'umma.
Domin wannan ya yi aiki yadda ya kamata, ana bukatar kulawa da kimantawa.
Tsarin bita na bincike na kimiyya 70 ya nuna cewa hanyoyin zamantakewa sun fi tasiri wajen inganta wanke hannu a cikin LMICs, yayin da kamfen ɗin tallan zamantakewa ba su da tasiri. Misali na yawan wanke hannu a makarantu (ta hanyar taurari uku) ta UNICEF wanda ke ƙarfafa makarantu su ɗauki samfurin, matakin da ba shi da tsada don tabbatar da cewa ɗalibai sun fara wanke hannu tare da sabulu a cikin sauran buƙatun tsabta.
Idan aka ƙayyade mafi ƙarancin ƙimar, za a iya canza makarantu daga ɗaya zuwa taurari uku.
Gina wuraren wanke hannu na yanzu na iya zama wani ɓangare na ƙaddamar da ƙarin wanke hannu da aka yi don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na yakin neman wayar da kan jama'a game da wanke hannu wanda ke kokarin sauya halaye, a sakamakon annobar coronavirus ta 2019-2020, UNICEF ta fitar da wani hoto na wanke hannu.
Wasu bincike sun ƙayyade tasirin wanke hannu a ƙasashe masu tasowa a cikin hulɗa da DALY.
Duk da haka, wani bita ya nuna cewa yin amfani da sabulu a hannu ya fi tasiri fiye da ruwa da sauran kayan tsabta.
Tasirin wanke hannu ga lafiyar mutum - musamman ga mutanen da ke cikin yanayi mai rauni kamar uwaye da ke da yara ko kuma sojoji da aka ji rauni a asibiti an fara bayyana shi a cikin karni na 19 ta hanyar masu binciken tsabtace hannu biyu: Masanin ilimin likitancin Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, mai binciken tsarin kula da Turanci.
A lokacin, mutane da yawa sun yi imani cewa kamuwa da cuta ta sa mutum ya yi turare, wato, ƙanshi mai ƙanshi.
A cikin shekarun 1980, cututtuka na abinci da kuma sanarwa game da cututtuka masu alaƙa da kamuwa da cuta sun sa Cibiyoyin Kula da Cututtuka na Amurka su ƙara amfani da wanke hannu a matsayin hanyar da za ta hana kamuwa da cuta.
Cutar da aka samu na cutar sankarar kwayar cutar a shekarar 2009 da kuma annobar COVID-19 a shekarar 2020 sun haifar da karuwar wayar da kan jama'a game da muhimmancin wanke sabulu a kasashe da dama don kare mutane daga cututtukan da ke faruwa.
Alal misali, an ajiye "Hanyar wanke hannu daidai" a kusa da wanke hannu a cikin gidajen wanka na jama'a da kuma a cikin gidajen wanka na ofisoshin gine-gine da na filayen jirgin sama a Jamus.
Kalmar nan "wanke hannu" tana nufin sanar da wani mutum mai lafiya cewa ya ɗauki alhakin abin da ya faru ko kuma ya yi abin da ya faru.
Wannan ya fito ne daga wani nassi na Matiyu inda Pontius Pilate ya wanke hannayensa a kan hukuncin gicciye Annabi Yesu, amma wannan ya zama kalmar da aka fi amfani da ita a wasu al'ummomin Turanci.
A cikin littafin Macbeth Shakespeare, Macbeth ta fara wanke hannayenta a ƙoƙarin kawar da wani mummunan tunani, ta ji laifi da ta yi kuma ta rinjayi matarta ta yi.
An gano cewa mutane bayan sun yi tunanin yin wani abu marar kyau, sun fi amfani da wanke hannu fiye da sauran abubuwa, sun fi amfani da kayan wanke hannu.
Duk da haka, waɗanda aka tsara don wanke hannu bayan tunani mai zurfi ba sa shiga wasu ayyukan tsabtace jiki, kamar aikin sa kai.
Addinai suna bayyana wanke hannu don dalilai na tsabtace jiki da kuma zama alama, alamar wanke hannu, amfani da ruwa ba amfani da sabulu don wanke hannu ba wani ɓangare ne na al'ada a yawancin addinai, kamar imani na Baha, Hindu da Tiwilah da Netilath Yadayim a cikin Yahudanci, da Lawab a cikin Kiristanci, da kuma addinin addinin Islama, addinai suna bayyana wanke hannu musamman bayan yin ayyuka.
Hindu, Yahudawa da Musulunci suna yin wanka bayan bayan bayan bayan gida.
Haka kuma, addinai kamar Hindu, Buddha, Sikh, Yahudawa, da Musulunci sun haramta wanke hannayensu kafin da bayan cin abinci.
Kula da lalacewar wuraren aiki don COVID-19
Dokar hana lalacewar wurin aiki don COVID-19 shirin ne na samar da matakan tsaro da kiwon lafiya don sarrafa lalacewar cutar coronavirus 2019 (COVID-19)
Yin amfani da ikon sarrafa cutar a wurin aiki ya dogara da wurin aiki da kuma aikin da ake yi, dangane da haɗarin da ke tattare da albarkatun aiki, yadda cutar take a cikin al'umma, da kuma haɗarin da ke tattare da dalilai na musamman na ma'aikata waɗanda za su iya zama masu rauni don magance COVID-19.
A cewar Hukumar Kula da Lafiya da Tsaro (OSHA), ƙananan haɗarin aiki sun fi ƙarancin haɗari ga jama'a da ma'aikatan kamfanoni, saboda haka an sanar da matakan kariya na asali, wanda ya haɗa da wanke hannu da kuma ƙarfafa ma'aikata su koma gida idan suna da rashin lafiya ko matsalolin numfashi, da kuma tsabtace al'ada da kuma maganin kamuwa da cuta a cikin yanayin aiki.
Babban hadarin aiki ya ƙunshi waɗanda suke neman a hana su tuntuɓar mutanen da ba a san su ba ko kuma waɗanda ake zargin suna da COVID-19, amma suna iya kamuwa da cutar ta hanyar sufuri ko tafiya ta duniya.
Wannan ya haɗa da ma'aikata da ke da alaƙa da jama'a kamar makarantu da yanayin aiki na masana'antu da kuma wasu ƙa'idodin jirgin sama.
Gudanar da haɗarin ga wannan rukuni, da kuma hanyoyin hana kamuwa da cuta na asali, wanda ya haɗa da daidaitaccen iska tare da matattarar iska mai inganci da kuma kariya ta ƙura da kuma samun kayan kariya na musamman idan mutum yana da COVID-19.
OSHA ta yi la'akari da ma'aikatan kula da lafiya da kuma dakunan da aka kashe da ke fuskantar haɗarin kamuwa da COVID-19 a cikin yanayin haɗari mai tsanani, kuma haɗarin zai iya ƙaruwa idan ma'aikaci ya yi amfani da iska mai iska ko ya tattara samfurori na waɗanda ake zargi ko waɗanda ke da cutar COVID-19.
Gudanar da ingantattun kayan aiki ga ma'aikatan da ke aiki a sashen sarrafa injiniya kamar su dakunan musayar iska mai ƙarancin iska da kayan kariya na mutum masu dacewa da aikin.
Yaduwar COVID-19 na iya shafar yanayin aiki a hanyoyi da dama.
Ma'aikata na iya kasancewa a wurin aiki saboda haɗarin rashin lafiya da bukatar kula da wasu ko tsoron kamuwa da cutar.
Abokan ciniki na iya canza sha'awar kayan da ake buƙata da kuma dalilin da ya sa ake buƙatar waɗannan kayan (kamar sayarwa a lokacin da mutane suka zo kasuwa ko kuma isar da kayayyaki ko sayarwa).
A cikin 'yan shekarun nan, jiragen ruwa masu sufuri a yankunan da suka sami lalacewar COVID-19 na iya dakatar da su. Ana iya amfani da shirye-shiryen kamuwa da cuta da kuma shirin fuskantarwa don yin ayyukan tsaro.
Shirye-shiryen suna bayyana matakan haɗari da suka shafi wuraren aiki da ayyukan aiki, wanda ya haɗa da tushen kamuwa da cuta da kuma daidaita abubuwan da ke haifar da haɗarin haɗari a gida da kuma a cikin al'umma da kuma abubuwan haɗari na mutum kamar tsufa ko yanayin rashin lafiya na dogon lokaci.
A wasu lokuta, suna taƙaita matakan da suka dace don magance haɗari da kuma gaggawa don yanayin da zai iya ƙara yaduwar.
Shirye-shiryen cututtukan cututtuka da tsare-tsaren cututtuka na iya zama batun dokokin ƙasa da ƙasa.
Manufofin da ake da su na magance yaduwar cutar sun hada da rage yaduwar cutar a cikin tawagar da kuma kare mutanen da ke da haɗarin kamuwa da cuta da kuma rage ma'aikatan da ke aiki a kan sauran takardun da aka sanya su.
Ana samun karuwar cutar ne a cikin al'ummomin da aka yi wa cutar.
Ƙarfin lalacewar lalacewa shine ra'ayin da aka yi amfani da shi a cikin aikin tsaro da tsaro ga ƙungiyar da ke kula da lalacewa ta hanyar aiki.
Lokacin da cutar COVID-19 ba za a iya sarrafa ta ba, mafi yawan ayyukan sarrafawa sune sarrafa injiniya wanda ke bin sarrafawa da kayan kariya na sirri.
Gudanar da aikin injiniya ya ƙunshi hana ma'aikata yin asara ba tare da la'akari da halin ma'aikaci ba kuma zai iya zama mafi ingancin maganin aiwatarwa.
Gudanar da sarrafawa shine sauya aikin aiki ko matakan da ke buƙatar aiki daga ma'aikata.
Kayan kare mutum (PPE) ana ganin ba su da tasiri kamar na injiniya da na gudanarwa, amma suna iya taimakawa wajen hana kamuwa da cuta.
Dole ne a ƙayyade duk nau'ikan PPE bisa ga lalacewar ma'aikata, yadda ake amfani da su (misali matsalar numfashi), yadda ake kulawa da su, yadda ake ba da doka, yadda ake tsawaitawa, yadda ake bi, yadda ake cire su, yadda ake tsabtace su, yadda ake ajiye su ko kuma yadda ake shirya su don kauce wa gurɓata.
A cewar Hukumar Tsaro da Tsaro ta Majalisar Dinkin Duniya (OSHA), ƙananan haɗarin aiki yana da ƙananan dangantaka da jama'a da ma'aikatan kamfanoni.
Ƙididdigar rigakafin kamuwa da cuta ta ba da shawarar cewa a duk wuraren aiki a yi wanka sosai da kuma ƙarfafa ma'aikata su zauna a gida idan suna da rashin lafiya da kuma matsalolin numfashi wanda ya shafi ƙwayoyin cuta da ƙura, samar da tufafi da ƙura, shirya don sadarwa ta nesa ko musayar mako idan ya cancanta, sanar da ma'aikata game da amfani da kayan aiki da kuma tsawaita ayyukan tsabtace da kuma hana kamuwa da cuta a cikin yanayin aiki.
Ƙarfafawa da kuma nisantar da mutane masu cutarwa yana da muhimmanci wajen kare ma'aikata, abokan ciniki, masu ziyara, da kuma wasu a wurin aiki.
Cibiyoyin Kula da Cututtuka na Majalisar Dinkin Duniya (CDC) sun ba da shawarar cewa ma'aikata da ke da alamun rashin lafiya su zauna a gida har sai sun warke daga ƙafafun, alamun ƙafafun da duk wani alamun cutar aƙalla awanni 24 ba tare da amfani da maganin rage nauyi ko wasu magunguna ba, kuma idan yanayin rashin lafiya ya kwanta, su ba ma'aikata damar zama a gida don kula da marasa lafiya na iyalansu, da kuma ma'aikata da ke da damuwa game da matakan.
A cewar OSHA, haɗarin aiki na musamman ya ƙunshi waɗanda ke da dangantaka mai yawa ko kusa da mutane masu tsayi na ƙafa shida (1.8m) waɗanda ba masu dauke da COVID-19 ba ne ko kuma waɗanda ake zargi da su, amma suna iya kamuwa da SARS-CoV-2 ta hanyar watsawa ta jama'a ko kuma ta hanyar tafiya ta duniya zuwa wurin da COVID-19 ke kamuwa da shi.
Waɗannan sun haɗa da ma'aikata da ke da alaƙa da wuraren jama'a kamar makarantu, wuraren aiki na masana'antu ko kuma hanyoyin sayarwa da sayarwa. Gudanar da aikin injiniya don wannan da kuma rukunin haɗari masu haɗari waɗanda suka haɗa da shigar da matattarar iska mai ci gaba da haɓaka yawan kayan aikin iska da kuma shigar da shinge na likita kamar su rigar filastik da kuma shigar da sabis na isar da taga ga abokan ciniki. Gudanar da sarrafawa da kuma manyan haɗari na haɗari don motsa ma'aikata marasa lafiya su zauna a gida, maye gurbin haɗari da ke tattare da haɗin lantarki, shigar da siginar lantarki da kuma dakatar da ɓoyewar ɓoyewar ɓoyewa don lura da COVID-19 da kuma samar da wasu hanyoyin da za a iya amfani da su don kula da yanayin da ke tattare da cutar, don kula da yanayin da ke tattare da yanayin da ke tattare da yanayin da ke tattare da yanayin da ke tattare da yanayin da ke tattare da yanayin da ke tattare da yanayin da ke tattare da yanayin da ke tattare da yanayin da ke tattare da yanayin da yanayin da ke tattare da yanayin da yanayin da ke tattare da yanayin da yanayin da yanayin da ke tattare da yanayin da yanayin da yanayin da ke tattare da yanayin da yanayin da yanayin da ke tattare da yanayin da yanayin da yanayin da yanayin da ke tattare da yanayin da yanayin da yanayin da yanayin da ke ke tattare da yanayin yanayin yanayin da yanayin da yanayin da ke ke ke ke ke ke ke ke ke ke tattare da yanayin.
Ma'aikata a cikin wannan rukunin masu haɗari ba sa yawan samun buƙatun yin amfani da na'urar numfashi.
Idan mutum bai kamu da rashin lafiya a filin jirgin sama, ana yin amfani da matakan tsaro na ma'aikata da matafiya da ke nuna cewa ware mai haƙuri daga wasu mutane tsawon ƙafa 6 da kuma sanya wani daga cikin rukunin don kula da mai haƙuri ya ƙunshi samar da abin rufe fuska ga mai haƙuri ko kuma buƙatar mai kula da bakin mai haƙuri ya yi amfani da Clenex lokacin da yake taɓawa ko ya bushe.
A cikin rukuni, ma'aikaci ya kamata ya saka rigakafin likita lokacin da yake hulɗa da wani mai baƙo mai rashin lafiya ko kuma ya yi amfani da ruwa ko kuma gurɓataccen jiki, kuma ya ƙara kayan kariya idan mai baƙo yana da ciwon kumburi ko kuma numfashi mai tsanani.
Dole ne a shirya kayan tsaro a cikin jakar filastik kuma a tsabtace da kuma bincika shara. Don kasuwanni masu kaya, wanda ya haɗa da zirga-zirgar kasuwanci da jiragen ruwa masu tafiya, kula da lalacewa kamar jinkirta tafiya lokacin da mutum yake rashin lafiya ko keɓewa, da kuma sanar da cibiyar likitancin jirgin kai tsaye idan wani ya kamu da cutar ko wasu alamun cutar a jirgin.
A cikin wani nau'i na musamman, dole ne a sami magani a cikin ɗakin da aka keɓe. Makarantun da sassan kula da yara da CDC za su sanar da rufewar gajere don tsaftacewa ko bincike idan mai cutar ya kasance a cikin ɗakin makaranta, saboda yaduwar zamantakewa.
Lokacin da babu ƙoƙari don rage yawan jama'a, ana iya amfani da hanyoyin nesa da zamantakewa kamar hana tafiye-tafiye da tarurruka da sauran manyan taro kamar ilimin likita ko taron addini ko cin abinci a cikin kantin, ƙara lokaci tsakanin tebur da shirya tafiye-tafiye da hutun ɗalibai da iyakance balaguron da ba dole ba da amfani da ofishin likita don yara da ke fama da alamun mura.
Lokacin da akwai yaduwar jama'a a cikin gida, duk da kasancewa da hanyoyin nesa da zamantakewa, ana iya la'akari da hutu na makaranta. Domin dokokin hukumar gudanarwa na aiwatar da ayyukan yau da kullum, CDC ta rage haɗarin lafiyar kai tsaye.
Jami'an dokar hana fita da ke bukatar tuntuɓar wanda ke da cutar ko kuma wanda ake zargin yana da COVID-19 an shawarce su da su bi irin wannan fasahar gaggawa ta likita, wanda ya haɗa da kayan kariya na sirri.
Idan akwai kusanci a lokacin da ake yin kaya mai haɗari, ma'aikata za su tsabtace belunansu da kuma karkatar da su don sake amfani da su, ta amfani da kayan aikin tsabtace gida, da kuma amfani da ayyuka na tsabtace.
OSHA ta tabbatar da cewa ma'aikatan kiwon lafiya da dakunan mutuwa suna fuskantar haɗari mai yawa.
Akwai haɗarin aiki mai girma, wanda ya haɗa da isar da kulawar lafiya da tallafi, da kuma asibiti da kuma canja wurin ma'aikata da aka sani ko kuma ake zargin suna da cutar COVID-19.
Waɗannan ma'aikata suna cikin haɗari idan ma'aikata suka yi amfani da na'urar canja iska ko kuma sun tattara samfurin marasa lafiya ko waɗanda ake zargi da COVID-19.
Na'urar canja iska ta iska don kula da rashin lafiya da na'urar motsa jiki na ɗakin ajiya da na'urar duba iska da wasu na'urori na haƙori da gwaji ko kuma ƙonewa.
Babban hadarin aiki a cikin dakunan matattu shi ne ma'aikata da ke shirya gawarwakin da suka kamu da COVID-19 a lokacin mutuwarsu; ma'aikata masu haɗari idan sun yi aiki, ƙara kula da aikin injiniya ga waɗannan rukunin haɗari su sanya dakunan keɓewa ga marasa lafiya waɗanda ke da cutar ko kuma suna da shakkar COVID-19, lokacin da ake amfani da na'urar musayar numfashi.
Na'urorin matsa lamba masu cutar numfashi na iya zama masu dacewa a wasu tsarin kula da lafiya da na matattu.
Dole ne a yi amfani da samfurori ta hanyar na'urar gwajin Level 3.
Hukumar Lafiya ta Duniya (WHO) ta gargadi marasa lafiya da su yi nesa da wuraren jiran gwajin cutar COVID-19.
A Majalisar Dinkin Duniya, NIOSH na bukatar amfani da N95 mask mai matse matse matse ko mafi kyau a cikin wuraren da aka haɗa, shirin rubutaccen shirin rigakafin numfashi wanda ya ƙunshi gwajin numfashi da horo da gwaji na likita.
Sauran kayan numfashi suna ba da ƙarin kwanciyar hankali ga ma'aikata. Hukumar Lafiya ta Duniya ba ta ba da shawarar cewa ana iya ɗaukar maganin jelly a matsayin cutar numfashi ta COVID-19 amma ana iya ɗaukar ta ta hanyar ruwa.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar yin amfani da abin rufe fuska na tiyata kawai ga hukumar kula da marasa lafiya.
Ga waɗanda ke tattara alamun matsalar numfashi daga kula da marasa lafiya na COVID-19 ba tare da na'urar canja wurin iska ba, WHO ta ba da shawarar yin amfani da masks na tiyata, tabarau, da kuma kariya ga fuska da rigar likita.
Idan an yi amfani da na'urar musayar numfashi, za a canja abin rufe fuska zuwa N95 ko FFP2.
Ganin cewa an amince da taimakon PPE daban, WHO ta ba da shawarar rage bukatun PPE don isar da bayanai, hana shinge na likita kamar windows na likita, ba da izinin shiga ɗakin kulawar marasa lafiya na COVID-19 kawai, kawai amfani da kayan PPE don aiki na musamman, ci gaba da amfani da na'urorin numfashi iri ɗaya ba tare da cire su ba yayin kula da marasa lafiya ta hanyar gano cutar, lura da daidaita jerin taimakon PPE, da kuma ba da shawarar amfani da masks ga waɗanda ba su da alamun cutar.
A: Katherine Maher, Shugaba na Wikimedia Foundation.
Ga: Duk ma'aikatan Wikimedia Foundation.
Batun: [Covid-19] Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Alhakin Kula da Al'amura.
Lokaci da kuma lokacin aikawa: 14/3/2020 a 00:24.
CCO: Babu haƙƙoƙin da aka kāre.
Za mu ga kanmu a wani yanayi na musamman a wannan watan.
Cutar COVID-19 ta hana mu daidaita dangantakarmu ta zamantakewa da kuma hakki da muke da shi a tsakaninmu.
Ba mu da wani labari game da kalubalen da muke fuskanta, amma mun san cewa mafi kyawun amsawa ta dogara ne akan haɗin kai, hadin kai da kuma haɗin gwiwarmu wanda shine mafi mahimmanci a cikin wannan tsari.
Muna ganin tausayi da kuma fahimtar juna tsakanin dukkan abokanmu ta hanyar imel, waya da tattaunawa, wanda shine babban taimako ga 'yan adam da muke farin cikin amfani da su.
Ba zan iya ƙara gode muku ba, da yake kuna da haɗin kai.
A makon da ya gabata, wasu mutane sun yi mini ba'a don aikinmu.
Sun yi tunani a kan yadda ake amfani da Wikipedia a duniya a yanzu, yadda ake amfani da alamomi masu ƙarfi a matsayin tushen kan layi da kuma samun dama ga kowa.
Ayyukanka suna sa ka yi hakan, idan ka sa shafin ya zama abin da ake yi, ko ka biya ma'aikatanmu ko kuma ka ɗauki nauyin ƙungiyarmu.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Yanzu ba lokaci ba ne kawai don sanin abin da muke yi, amma yadda muke yi yana da tasiri sosai a duniya.
Saboda muhimmancin wannan aiki da kuma rawar da kake takawa, za mu yi wasu muhimman canje-canje a yadda za mu yi aiki tare, farawa a wannan makon.
Ayyukanmu da jadawalinmu
Kamar yadda Robin ya ambata a baya, a daren jiya ne Team C suka taru don tattauna hanyoyinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi alkawarin cewa ra'ayoyinmu za su zama muhimmin abin da za mu fuskanta kuma za su zama hanya mafi kyau don ci gaba da yin hakan a wannan lokacin.
A yawancin lokaci, muna so mu rage damuwa kuma mu yi aiki tare don dogon lokaci.
Idan kana bukatar ragewa, babu matsala.
Ga dukan ƙungiyar, masu ba da alkawari, alkawarin ma'aikata:
Muna aiki kusan sa'o'i 4 a kowace rana, ko kuma sa'o'i 20 a mako.
Ba mu ba da hutu ba. Idan ka iya yin aiki fiye da sa'o'i na yau da kullum, aikin zai iya amfani da kai.
Duk da haka, a yanzu duniya tana cikin yanayi da ba a zata ba, kuma idan kana bukatar ka kula da ƙaunatattunka, ka je kantin sayar da kayan lambu ko ka je wurin likita, lafiyarka ita ce mafi muhimmanci a gare mu.
Ba za mu ɓata lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ya kamata a yi haka ba tare da an faɗi ba, amma muna faɗi haka.
Babu ranar rashin lafiya ko biyan kuɗin rashin lafiya na lokaci, kawai ka tambayi manajanka kuma ka taimaka wa tawagarka ta canja matakan da jadawalin don tabbatar da cewa an gudanar da ayyukan yankin aiki.
(Idan kana da cutar COVID-19, ka tuntubi Bryan's T&C Ops Team, T&C na iya taimaka maka wajen tallafawa da kuma tabbatar da cewa yanayin ka yana da kulawa ta musamman.)
Don kowane sa'a, mutane suna karɓar kuɗin su.
Mun faɗi haka kuma muna maimaita shi da alfahari da umarninmu da abokanmu da abokan aikinmu.
Ana biyan kowa bisa ga yawan lokutan aiki a cikin yanayi na yau da kullum.
Wannan ya haɗa da waɗanda ba su da lafiya ko kuma ba su da ikon yin aiki.
Idan kana son yin aiki, za mu goyi bayanka.
Yawancin mutane suna amfani da aiki a matsayin hanyar da za su iya kawar da matsin lamba a duniya.
Abin da za mu iya bayarwa ba zai yiwu ba, musamman a lokacin da muke ciki.
Bugu da ƙari, yana da game da kula da kanka.
Muna bukatar ka yi magana da manajanka, don haka mun san abin da za mu yi tsammani kuma za mu iya shirya abin da ya dace.
Wasu ayyuka suna da mahimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
Ƙungiyoyin SRE, HR Ops, Trust&Safety, Fundraising (da sauransu) suna yin aiki mai mahimmanci wanda zai iya buƙatar tallafi.
Muna fara aiki tare da dukkan sassan don daidaita manufofinmu na yanzu kuma muna mai da hankali kan tallafawa abin da ke tushen aikinmu.
Dukanmu muna da aiki da yawa da za mu yi, muna mai da hankali ne kawai ga ayyukan asali.
A hankali yanzu ba zai cutar da kai ba.
Ba mu da shirin yin "ƙoƙarin yin abu sau biyu" da zarar annobar ta wuce.
Ba za mu ƙara yin aiki ba don samun lasisi wanda yanzu ya zama mummunan aiki.
Mun yarda cewa yanayin ya canza, kuma muna aiki don saita sababbin manufofi da lokacin da za mu iya.
Menene zai faru da APP?
Don daidaita sabon aikinmu da kuma lokutan aiki na yau da kullum, muna so mu daidaita jadawalin don kawo shirin shekara-shekara na 2020-2021.
Muna da niyyar bayar da shawarar tsawaita shirin 2019-2020 wanda zai ba mu karin lokaci don tara kudade don bawa ma'aikata damar yin aiki mai mahimmanci da kula da kansu da kula da ƙaunatattunmu yayin da muke taimaka wa waɗanda suke bukatar su rage jadawalin su na makonni masu zuwa.
Wannan jadawalin na ƙarawa yana da kyau sosai don rage nauyin shirin aiki na yanzu kuma yana sanya matsin lamba a kan dukkan hanyoyin.
Za mu gabatar da shawararmu ga majalisar a mako mai zuwa kuma za mu sabunta jami'anmu da kuma tawagarmu a mataki na gaba.
Na gode wa ƙungiyar APP don gudanar da wannan.
Ofishin Yanayi, Hadari da Tsabtace
A makon da ya gabata, mun gano cewa wani abokina na FS na iya kamuwa da COVID-19.
Duk da haka, ba tare da yin hankali ba, mun kafa ƙungiyar tsabtace kwayar cutar don tsabtace dukkan wuraren da ke ofishinmu na San Francisco.
Sun yi amfani da maganin rigakafi na asibiti don tsabtace dukkan wurare, da kuma dakunan jiran aiki da kuma ɗakunan ɗakunanmu.
Gidan yana sanya masu kula da lafiyar su da ke tallafawa lafiyar masu haya.
Muna jin dadi cewa ofishin zai kasance a shirye sosai don lokacin da muka yanke shawarar komawa.
Ofishinmu na DC yana cikin WeWork, wanda ya ba mu dokoki na COVID-19 da kuma duk ma'aikatan DC.
A makon da ya gabata, ofishinmu na DC ya koma wani wuri mai kyau a San Francisco, inda aka yi amfani da shi a matsayin layin tsaro.
Kamar yadda wasu daga cikin abokanmu na NYS suka sani, muna tattaunawa game da yin hayar wani wuri a Baukleyn.
Wadannan tattaunawar suna ci gaba amma za a iya bi da su.
Wasu abokanmu suna aiki daga gidajensu, a karon farko.
Ma'aikatan da ke aiki daga gida na dogon lokaci sun san cewa hakan zai iya zama matsala, kuma muna so mu ba ku wasu shawarwari:
Ka iyakance lokutan aiki na hanci zuwa sa'o'i daya ko biyu.
Idan an nemi taro na dindindin, za ku yi la'akari da yadda za ku kammala karatun a cikin kwanaki.
Ka bayyana taron a fili, ka yi shirin aiki, kuma ka aika da gabatarwa.
Matsalolin suna da bidiyo, tare da Google Docs da Xoom don sauƙaƙe haɗin kai da sadarwa ta kai tsaye.
Ka sanya jagora don sauƙaƙe duk tarurruka, ka sanya wani ya lura da hira don tambayoyi da kuma yin rajistar jerin masu magana, kuma wani ya karɓi tsokaci (ko ya taimaka wajen karɓar tsokaci).
Aika imel na goyon bayan fasaha idan kana bukatar mai sauraron kunne.
Yi amfani da zaɓin lafiyarka don cin abinci mai gina jiki.
Ka shiga tashoshin e-taƙwalwar ajiya na Stack don yin magana da ma'aikatanka game da aikin da aka rarraba.
Ƙungiyar HR tana aiki don gudanar da wani aikin kimiyya na e-aiki don taimakawa wajen bunkasa haɗin gwiwar a cikin cibiyar.
A cikin makon da ya gabata, mun ba masu karɓar allurar rigakafi don su ƙi duk wani abu na taimakon Wikimedia kamar gyara bayanai, har sai WHO ta kawo ƙarshen annobar.
Muna gaya musu cewa mun fahimci cewa bukatarmu ta ƙi da kuma wasu takardun shaida na iya hana su kammala aikin ba da gudummawa, kuma ba wanda zai yi jinkiri ko ya sauya manufofin su.
A cikin mako mai zuwa za mu ci gaba da yin amfani da ƙarin tsarin don Wikimedia da taron yanki da kuma sauran labarai.
Ƙarfin da ake yi a duniya yana sa mutane su yi baƙin ciki game da yadda yanayin ya ɓace amma suna jin daɗin isar da sako da kuma kasancewa da ikon yin tunani a kan hanyoyin da suke bi da kuma Wikimedia da kuma akasin haka.
A ci gaba, CRT tana aiki don sanya shafi a kan Meta-Wiki don samar da hanyar da za a bi don lura da tasiri da kuma wallafa hulɗarmu da su.
Rashin aiki a kan matsalolin da suka shafi COVID-19.
Za mu aika muku da gayyatar ranar lissafin kuɗi a ranar Alhamis da ƙarfe 14:00 UTC ko 07:00 PT don taron ma'aikata na musamman.
Muna amfani da wannan lokaci don buga sabuntawa, amsa tambayoyinku, da kuma ciyar da lokaci don sadarwa tare.
Mun kasance tare a nan kuma muna nan don taimakawa duk abin da zai yiwu.
A lokaci mai dacewa, za mu iya ci gaba da samun bayanai a cikin wannan imel ɗin, da kuma duk bayanan da suka shafi COVID-19, a ofishin Wiki.
CRT tana sabunta waɗannan shafuka da bayanai a kowane wuri.
Muna kuma aiki don ci gaba da yin hulɗa da ma'aikatan da ke aiki a ƙasashen da ake cutar yanzu.
Idan kana da tambayoyi game da tafiya, abubuwan da suka faru, irin aikin da ke cikin lantarki ko matsakaicin matsakaici ko kuma wani abu da za ka iya bukatar taimako, kada ka yi jinkirin yin aiki tare da CRT.
Muna nan don taimaka muku wajen samar da tallafi da taimako idan ya cancanta.
Idan kana da wata matsala ta sirri ko kuma ta musamman, ka tuntuɓi Dukan Ƙasar Duniya ta Dukan Ƙungiyoyin HR ta hanyar imel.
Babu wani daga cikin waɗannan canje-canjen da za a iya ɗauka a matsayin barin aikinmu da kuma wajibi.
Maimakon haka, suna manta cewa a wannan lokacin, ayyukanmu da kuma ayyukanmu suna bukatar su dace da yanayin da ba mu taɓa yi ba.
Waɗannan su ne matakan da muka yi imani suna da muhimmanci don tallafa wa juna, don haka za mu iya ci gaba da aiki, ba da taimakonmu da suke bukata, da kuma sabis ɗin da duniya ke tallafawa.
Za a yi aikin da aka tsara a kan lokaci.
A yanzu. Lokaci ne na tallafa wa juna da kuma samar da wuri don muhimman ayyuka da za a yi a cikin kwanaki da watanni masu zuwa.
Muna bukatar ku duka ku yi wannan aiki, don haka muna bukatar ku kula da kanku da kuma iyalanku don haka ku kasance cikin yanayi mafi kyau a lokacin da muke bukatar ku.
Yanzu fa, ku wanke hannuwanku, kada ku taɓa fuskarku.
katherine, CRT (Amanda K, Amy V, Bryan J, Doreen-D, Gergory V, Jamine V, Lynette L, Ryan M, da Tony S), da sauran manajojin kungiyar (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Ryan M, da Toby N).
Angiotensin carrier enzyme 2 (ACE2) wani enzyme ne wanda yake da ƙyalli a waje na ƙwayoyin halitta a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE2 yana hana ayyukan (ACE) na ƙwayoyin cuta na angiotensin-shaped enzymes ta hanyar rage adadin ƙananan ƙwayoyin cuta na angiotensin da kuma ƙara (Ang1-7) zuwa magani mai kyau don magance cututtukan zuciya. ACE2 kuma yana da amfani a matsayin hanyar shiga cikin kwayoyin halitta don wasu ƙwayoyin cuta na coronavirus.
Fassarar mutum ga enzyme ta bayyana a matsayin hACE2.
Ƙarfin zinc na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙarfe na ƙar
Protein ACE2 ya ƙunshi N-zone na ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
ACE shine nau'in I na furotin, tare da enzyme mai aiki a kan ƙwayoyin mai karɓa a saman ƙwayoyin huhu da sauran ƙwayoyin.
A cikin ACE2, an cire kwayar halitta daga babban furotin wanda ake kira shedis, kuma ya zama furotin mai ƙwayoyin cuta a cikin jini kuma ya rabu da shi sosai kuma ya shiga cikin fitsari.
ACE2 yana samuwa a cikin yawancin gabobin: ACE2 yana da gashin jikin kwayoyin halitta musamman ƙwayoyin cuta na cyclin-type cell, ƙwayoyin cuta na ciki, ƙwayoyin cuta na jini da kuma ƙwayoyin cuta na jini a cikin yawancin gabobin.
Ana kuma samun kalmar ACE2 a cikin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar.
Ayyukan farko na ACE2 shine daidaita daidaitattun ACE.
ACE yana ba da hormone anotensin guda ɗaya don ya zama na biyu a cikin jini.
ACE2 yana amfani da carboxyl-thermial amino acid phenylalanine daga anigotensin II (Asp-Arg-Bal-Tyr-IIe-His-Pro-Phe) da kuma hydrolyses (vasodilator angiotensin (1 - 7, H-Asp-Arg-Val-Tyr-Lle-His-Pro-OH) a lokacin da aka yi amfani da su.
ACE2 kuma zai iya hana wasu sauran kwayoyin halitta kamar -[des-Arg9] bradykinin, apelin neurotensin, dynorp hin A, ghrelin.
ACE2 kuma yana daidaita yawan maye gurbin amino acid SLC6A19 na halitta kuma an samo shi a cikin cutar Hartnap.
A matsayin furotin mai watsawa, ACE2 yana aiki a matsayin babban hanyar shiga cikin kwayoyin halitta na wasu ƙwayoyin cuta, kamar HcoV-NL63; SARS-CoV (wannan cutar tana haifar da SARS); da kuma SARS-CoV-2 (wannan cutar tana haifar da COVID-19).
A zahiri, ta hanyar haɗa S1 fasalin SARS-CoV-2 da SARS-CoV-2 zuwa kwayar halitta ta ACE2, sakamakon haka shine canza babban mai hanawa da kuma mai bin duka kwayar cutar da enzyme zuwa endosomes a cikin sel.
Akwai ra'ayi cewa rage yawan ACE2 a cikin kwayoyin halitta na iya taimakawa wajen yaki da cutar.
Koyaya, wasu kungiyoyin masu sana'a da masu gyara jiki suna ba da shawarar cewa a koyaushe akwai ƙa'idodin rage ACE da ARB.
Wani bincike da aka yi a kan yanayin da ake ciki da kuma ci gaban da aka wallafa a ranar 11 ga watan Agusta, 2020 ya gano cewa "a yi amfani da ACE mai amfani da aka yi amfani da shi a ci gaba da muhimmanci wajen rage hadarin cututtukan da aka samu da kashi 34 cikin dari tare da sarrafawa".
Bugu da ƙari, "hadarin kamuwa da cutar huhu mai tsanani ya ragu a cikin marasa lafiya da aka yi amfani da ACE inhibitors da aka kara haɗarin kamuwa da cutar huhu, musamman waɗanda aka yi wa bugun jini kuma ba su da zuciya ɗaya.
Yin amfani da ACE inhibitors ya taimaka wajen magance cututtukan huhu na pneumonia da ke da alaƙa da cutar, ko da yake sakamakon ya kasance ƙasa da lafiya fiye da haɗarin kamuwa da cutar huhu.
An gano cewa cutar ACE2 (rhACE2) wani sabon magani ne ga cututtukan huhu masu tsanani, kuma an gano cewa yana iya magance cutar huhu da rashin iskar oxygen a cikin ƙananan kwayoyin halitta tare da lipoosaccharide- yana da tasiri a kan alamun rashin ƙarfi na numfashi.
Rayuwar rabin rai na ErhACe a cikin mutum na kimanin sa'o'i 10 ne, kuma aiki guda ɗaya na tsawon minti 30 ne, wanda ya fi tasiri na sa'o'i 24.
Wasu binciken sun nuna rhACE2 ya zama magani mai tabbacin gaske ga waɗanda ke da wani abu na farko na antibody antibody (RAS inhibitor) ko kuma an ba su don magance cututtukan cututtukan huhu masu tsanani.
BCOVID 19 apps su ne apps na wayar hannu da aka tsara don taimakawa wajen bin diddigin mutane a cikin sadarwa don 2019-20 coronavirus, misali batun gano mutane (ta hanyar sadarwa) da za su iya zama masu kamuwa da cutar.
An samar da shirye-shirye masu yawa kuma an samar da su, tare da tallafin gwamnati a wasu yankuna da wuraren da doka ta kafa.
An kirkiro wasu kayan aikin da za su iya gina haɗin haɗin kai na tsarin aiki.
An yi ta da hankali sosai, musamman game da tsarin da ke da nasaba da bin diddigin yanayin masu amfani da software.
Ƙananan shigar da batutuwa na sirri da kuma matakai kamar amfani da siginar Bluetooth don shiga batutuwa na sirri da kuma sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa hannu don tallafawa aikace-aikacen da aka sanya a cikin Bluetooth don aiki a kan Android da iOS.
A kasar Sin, gwamnatin kasar Sin, tare da kamfanin Ally, ta kirkiro wani app da ke ba da damar jama'a su duba ko suna tare da mutanen da suka kamu da cutar COVID-19.
Ana amfani da shi a birane fiye da 200 a kasar Sin. A Singapore, ana amfani da software mai suna Tires Togazer.
Kungiyar IT ce ta ci gaba da samar da wannan software kuma za ta ba da damar samunsa ga gwamnati nan ba da daɗewa ba. Kungiyar Arewacin Macedonia ta "Tsaya Coronavirus" Bluetooth ita ce babbar hanyar gano masu cutar da kuma ba da gaggawa ga hukumomin lafiya.
An samar da shirin ne ta hanyar ma'aikatar sadarwa da fasaha da ma'aikatar kiwon lafiya.
A ranar 14 ga watan Afrilu, 2020, an yi amfani da software don karɓar tabbaci daga Google Play Store da kuma Apple App Store.
A ranar 12 ga watan Afrilu, gwamnatin kasar ta sanar da cewa shirin na sharewa yana cikin ci gaba mafi kyau, kuma zai kasance a shirye ga masu amfani a cikin mako guda. Hakazalika, an shirya a Ireland da Faransa don "dakatar da COVID".
Kasashen Ostiraliya da New Zealand suna bin tsarin kula da marasa lafiya na Singapore da kuma yarjejeniyar Blustray. Rasha na son gabatar da shirin kula da marasa lafiya da aka gano suna da COVID-19 kuma suna zaune a Moscow, don tabbatar da cewa marasa lafiya ba za su bar gida ba.
Ross Anderson, injiniyan tsaro a Jami'ar Cambridge, ya nuna wasu yiwuwar samun matsala tare da tsarin tsarin, ciki har da, kuskure mai kyau da kuma rashin yiwuwar tasiri idan an iyakance aikin shirin ga ƙananan al'umma.
Da yake bayyana damuwa game da ɓacewar ko ɓarna na "Coronavirus" software, Apple ya sanya takunkumi kan nau'in ƙungiyoyi da ke ƙara coronavirus-kamar software a cikin Store. Ƙuntatawa kawai "sarrafawa" ne ko kuma a matsayin misali ga manyan ƙungiyoyi.
Google da Amazon sun yi aiki tare don yin irin wannan haramcin.
Masu kai hari na musamman sun yi ta nuna damuwa game da matsalolin da ke tattare da kula da lafiyar mutum ta amfani da shirin coronavirus, musamman game da ko an gina ingantaccen tsarin kula da tsarin kula da cutar coronavirus a lokaci guda lokacin da haɗarin ya ƙare.
Ƙungiyoyin duniya da kungiyoyi 100 sun bayyana cewa suna neman a hana wannan nau'in ƙwarewa.
Kungiyoyi sun bayyana sharuɗɗa guda takwas game da ayyukan gwamnati:
Dole ne daidaito ya zama "duka doka. Dole ne kuma daidai".
Dole ne a yi karin kulawa da kuma kulawa bayan cin abinci;
Dole ne a iyakance amfani da bayanai saboda dalilai na COVID-19;
Dole ne a kiyaye tsaro da kuma rashin sunansa kuma a tabbatar da cewa an kiyaye shi;
Dole ne mai saka idanu na dijital ya guji ƙara nuna bambanci da nuna bambanci;
Duk wani bayani da aka bayar ga wani ɓangare na uku dole ne a bayyana shi a cikin doka;
Dole ne jami'an tsaro su kasance a wurin don magance zalunci da kare hakkin 'yan ƙasa.
Ana buƙatar shiga ta hanyar da ta dace ta duk "masu ba da bashi", tare da masu ba da sabis na kiwon lafiya na jama'a da kuma kungiyoyi masu rauni. Kamfanin CCC ya ba da rahoton 'yan jarida ba tare da iyaka ba (Reporter von Grinsen) (RSF) kuma an ba su izinin shiga.
Shawarwarin da Google da Apple suka yi na nuna cewa suna fama da matsalolin ci gaba da saka idanu ta hanyar cire tsarin saka idanu daga tsarin sarrafa wayar hannu lokacin da ba a buƙatar hakan.
Wasu ƙasashe suna amfani da Intanet bisa tushen saka idanu na wuri maimakon shirye-shirye, cire su duka yana buƙatar saukar da software, da kuma ikon hana saka idanu.
A Isra'ila, an yarda da intanet mai kulawa.
Intanet ta dogara ne akan magance matsalar samun damar bayanai na wurare marasa kyau tare da matsalar ɓoye ɓoyewa.
Ko da yake, ba dole ba ne duk tsarin da cibiyar uwar garke su sami damar sarrafa bayanan wurin mutum; an gina wasu tsarin tsare sirri da ke amfani da cibiyar uwar garke kawai don sadarwa tare da juna (duba sashe na gaba).
A Koriya ta Kudu, an yi amfani da tsarin da ba a tsara shi ba don gudanar da sa ido kan sadarwa.
Maimakon amfani da software na musamman, tsarin ya tattara bayanan da ake saka idanu daga tushe daban-daban kamar bayanan da ake saka idanu na na'urorin hannu da bayanan katin da ake sarrafawa, kuma ya haɗa waɗannan don yin bayanin kula a cikin wasiƙun da aka rubuta ga waɗanda aka ɓoye.
Bugu da ƙari, don amfani da wannan bayanin don sanar da ɓoyayyun hanyoyin sadarwa, gwamnati ta kuma ba da wuraren da aka ba da bayanan ga jama'a, wasu abubuwa an ba su izinin yin amfani da su saboda canje-canje a dokokin bayanan sirri da suka faru bayan ɓarkewar MERS a wannan ƙasar.
Ana samun wannan bayanin a fili ta hanyar wasu shirye-shirye da kuma shafukan yanar gizo. Kasashe kamar Jamus sun kafa wanda ke amfani da duka cibiyoyin tattarawa da kuma tsarin tsare sirri.
A ranar 6 ga Afrilu, 2020, har yanzu ba a bayyana cikakken bayani ba.
Kula da tsare sirri na sadarwa yana da kyau a kafa, tare da babban tsari na bincike na wallafe-wallafe wanda ya fara zuwa aƙalla 2013. Wannan a ranar 7 ga Afrilu, 2020, fiye da kwamitin kwararru za su yi aiki don magance yanayin abokantaka, kamar amfani da Bluetooth Low Energy (BLE) na Bluetooth low energy.
Ko da yake, PEPP-PT wata dama ce ta tsarawa wadda ta ƙunshi duka hanyoyin da ke tattare da cibiyoyin sadarwa da kuma cibiyoyin sadarwa, kuma ba ta da wata yarjejeniya. Yarjejeniyar cibiyoyin sadarwa ta ƙunshi kulawa ta musamman ta musamman (DP-PPT/D-3t), lambar sadarwa ta wucin gadi (TCN), lambar sadarwa ta bazuwar (fka, CEN), yarjejeniya da kuma hanyar aiki na wayar salula ta sirri ta wayar salula (PACT) da sauransu.
A cikin waɗannan ladabi, ba a taɓa fitar da bayanan sirri daga na'urar ba, duk daidaitawa suna faruwa a cikin na'urar.
Ƙungiyoyin masu zaman kansu a MIT Media Lab suna aiki a kan "Hanyar Tsaro", wani dandamali don amfani da fasahar tsare sirri yayin tattara bayanai da kuma amfani da bayanan wuri ko hanyoyin da aka tsara don lura da yaduwar COVID-19.
Wani bincike da aka samo daga White Development, "Rogue's Walking Program: Protecting Personal Privacy in ......", ya fito ne a watan Maris na 2020. Wani irin wannan yanayi shi ne dandamali na Safeway da Enigma MPC, wani kamfanin da ke samar da fasahar keɓaɓɓu wanda aka kafa a asali ta MIT Data Lab.
Masu amfani da tsaro suna amfani da fasaha mai ƙarfi don ba masu amfani damar rarraba bayanai masu mahimmanci da na kiwon lafiya tare da sauran masu amfani da masu amfani, ba tare da jin kunya game da sirrin wannan bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyar TCN ta duniya ta kafa ta ƙungiyoyi waɗanda ke aiki kan abin da ke daidai da tsarin yarjejeniya mai kama da juna, tare da manufar rage haɗari da kuma ba da damar duniya don amfani da kuma musayar bayanai ta hanyar tsarin software don masu saka idanu da kuma faɗakarwa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta bayyana tushen* na yarjejeniyar Blue Terrace da aka yi amfani da ita ta hanyar shirin gwamnati.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa Android da iOS na wayar hannu, sun ƙaddamar da wani kamfen don saka idanu na haɗin kai, wanda suka yi imanin zai kare sirrin, bisa haɗin Bluetooth Low Energy da kuma kiyaye cryptography.
Sun kuma bayyana siffofi da kuma bayanan da ke cikin fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, an tsara tsarin don yin aiki a matakai uku:
Wannan aikin na taimakawa gwamnati ta samar da shirin kula da lafiyar masu kamuwa da cutar coronavirus
Matsayin wannan aikin da ke da alaƙa kai tsaye da ISO da Android da kuma shirin Apple shine a ɗauki taken don haɓaka da ci gaba da lura da matsala ta hanyar ƙaddamar da tsarin a cikin sabon tsarin sake dawowa, sannan kuma sake fashewa ta hanyar da ta dace lokacin da haɗarin ya ƙare.
Magungunan maye (kuma magungunan sake amfani da su don sake amfani, sake sabuntawa, sake amfani ko sake amfani da magani) suna nufin sake amfani da wani magani da aka yarda da shi don magance cututtuka ko yanayin kiwon lafiya daban-daban, wanda aka yi shi ne.
Wannan jerin bincike ne na kimiyya da ake neman a yanzu don samar da ingantacciyar magani ga COVID-19.
Sauran binciken sun hada da samar da allurar rigakafi da kuma canja wurin jini na mutanen da suka warke. SARS-CoV-2 ya ƙunshi kimanin sunadarai 66 da suka dace da magani, wanda ke da ...
Nazarin wannan shafin na samar da wani shiri na samar da maganin rigakafi mai tasiri akan furotin na COVID-19.
Abubuwan da aka fi sani da sunadarai na SARS-CoV-2 sun hada da popin a matsayin wani abu mai fita, RNA da ke ɗaure da RNA mai ƙwayoyin cuta. Hellae case, S protein, da ADP ribophosphate.
A, A, ET duk karatun tare da wasu daga cikin abubuwan da aka zaɓa an yi amfani da su mafi kyau sannan an gwada su zuwa kusan kashi tare da magungunan da suka fi ƙarfi kamar magungunan da aka yi amfani da su a cikin sauri.
Chlorine magani ne na maganin zazzabin cizon sauro wanda ake amfani da shi a kan wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxylchloroquine suna da alaƙa tsakanin magungunan huɗu da ake bincike a kansu a matsayin wani ɓangare na tallafin asibiti na gwaji.
Gwamnan New York, Andrew Cosmo, ya sanar da cewa jihar New York za ta fara gwajin chloroquine da hydroxylchloroquine a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin yin amfani da chlorine hydrochloride da chlorine phosphate a ƙarƙashin dokar ta baci ta gaggawa (EUA).
FAD ba ta amince da maganin ba, kuma EUA ta yarda da shi ne kawai don maganin gwaji ga marasa lafiya da suka kwanta amma ba za su iya samun magani a asibitin gwaji ba (a cikin gwajin gwaji).
CDC ta ce "amfani, magani, ko tsawon lokacin hydrochloroquine don karewa ko warkewa daga SARS-CoV-2" bai riga ya zama sananne ba.
Likitoci sun ce za su yi amfani da magani a lokacin da "babu wani zaɓi".
Wani bincike na Turkiyya a Istanbul na gudanar da wani karamin bincike kan amfani da chlorine a hade da zinc, bitamin A, bitamin C da kuma wani karamin bincike kan amfani da chlorine a hade da zinc, bitamin A, bitamin C da bitamin D.
Ya yi bincike mai zurfi a Jami'ar Duke da kuma Jami'ar Oxford.
Makarantar likitancin NYU ta Langon tana gudanar da gwaji kan aminci da tasirin kiyayewa daga amfani da hydroxychloroquine.
Gwaje-gwajen dakin gwaje-gwaje na kasar Sin a Wuhan da Shenzhen
A cikin kwanaki 4 da suka gabata, 35 daga cikin marasa lafiya a Shenzhen sun samu sakamako mara kyau, yayin da tsawon lokacin cutar ya kasance kwanaki 11 daga cikin marasa lafiya 45 da ba a karɓa ba.
A wani bincike da aka gudanar a Johannesburg a kan mutane 240 da ke fama da cutar huhu, an ba rabin su favipiravir kuma an ba rabin su umifenovir. (Lura: Waɗannan su ne magungunan ƙwayoyin cuta)
Hukumar Kula da Magunguna ta Italiya ta ba da hujja ga jama'a cewa tallafin magani bai isa ba.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don ambarinta, kuma za ta yi amfani da sojojin ta don isar da magungunan zuwa asibitocin jami'a, inda za a yi amfani da su wajen magance cutar COVID-19.
A cewar yanayin kudu maso yammacin kasar Sin, Shu Shu Shu Shu Abe ya sanar da Shugaba Trump cewa zai iya sayar da magungunan da ba su da tasiri sosai a cikin yanayin da cutar ta kamu da shi.
Yana iya zama mai lafiya ga mata masu ciki ko waɗanda suke so su yi ciki.
Maganin Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran Labaran
An tsara magunguna don hana kwayar cutar HIV ta shiga cikin kwayoyin halitta.
Wata ƙungiyar masu bincike a Jami'ar Colorado na kokarin canza magunguna don gano wani fili wanda ke rubuta wani kwayar halitta mai suna SARS-CoV-2 protein-protein enzyme. Akwai wasu ra'ayoyi a cikin ƙungiyar kimiyya game da tura albarkatun zuwa sabon magani musamman waɗanda aka haɓaka don HIV/AIDS.
Hukumar ta WHO ta haɗa da Lopenavir/Retinavir a cikin gwajin kwayoyin halitta a duniya.
Masana kimiyya na Gilead sun kirkiro kuma sun ci gaba da yin amfani da shi a matsayin magani ga cutar Ebola da kuma cutar sankarar mura. Masana kimiyya na Gilead sun gano cewa Remdesivir yana da aikin ƙwayar cuta a cikin vitro don magance cutar philo, pneumo, parasitic, da kuma coronavirus.
Matsalar maganin kwayar cuta ita ce, ci gaban rigakafi a cikin kwayoyin halitta yana haifar da ɓoyewar DNA zuwa wasu cututtuka masu haɗari da kuma cututtuka masu yaduwa.
Wasu karatun farko sun ba da shawarar cewa Remdesvir yana da ƙarfin rigakafi. Ga wasu rukunin gwaji na ci gaba, biyu na asibitin Cleveland; ɗaya ga mutanen da suka kamu da cutar a matsakaici, ɗayan kuma ga waɗanda suka kamu da cutar a tsanani.
Akwai gwaje-gwaje uku na asibiti don samun bitamin C a cikin jini ga mutanen da ke asibiti ko marasa lafiya saboda COVID-19; biyu na magani mai sarrafawa (Cene, Kennedy) da kuma guda mara sarrafawa (Italian).
Jihar New York ta fara gwajin cutar Azithromycin a ranar 24/3/2020.
Cibiyar Kula da Lafiya ta Duniya ta Japan (NCGM) ta shirya gwajin asibiti na alvesco na Taijin, cyclesonide, wani magani mai guba na corticosteroid don cutar numfashi, don magance marasa lafiya da ke da alamun farko na kamuwa da cutar coronavirus.
Hanyar angiotensin - gyaran enzymes 2, maganin Conagon 2 hanya ce ga marasa lafiya 200 don ganewa a cikin yanayin tsanani, a cikin asibitocin da aka yi a Denmark, Jamus da Austria za ku iya sanin yadda maganin zai yi aiki.
Masu bincike a Cibiyar Zuciyar Montreal, Kanada, suna duba rawar da colchicine collagen ke takawa wajen rage kumburi da cututtukan huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
Wannan gwaji da ake kira Colorona Colorona, yana bi da mutane 6,000 da suka kai shekaru 40 da haihuwa da suka kamu da cutar COVID-19 ko kuma suna da alamun rashin lafiya da ba sa bukatar zuwa asibiti.
Mata masu ciki ko masu shayarwa ko waɗanda ba su da wata hanyar yin zubar da ciki ba su dace ba.
Ana yin amfani da magungunan anticoagulant da yawa a Italiya.
Ana amfani da maganin anticoagulant na Maina a cikin magani na marasa lafiya, kuma ci gaba da ci gaba da gudanar da aikin likita na Italiya don kafa tsarin yadda za a yi amfani da shi.
An sanar da wata gwaji mai yawa a kan marasa lafiya 300 game da yadda ake amfani da sodium enoxaparin a cikin kariya da kuma amfani da miyagun ƙwayoyi a Italiya a ranar 14/4.
Tun lokacin da aka gano SARS-CoV-2 a matsayin cutar, an yi bincike sosai a kan yadda za a inganta maganin rigakafin da aka samu a lokacin da ake yaduwar cututtuka kamar MERS, SARS, da West Nile Virus.
Rebavirin: An ba da shawarar rebavirin a matsayin magani ga COVID-19 bisa ga tsarin nono na 7.
Amyfenovir: An ƙaddara amyfenovir don maganin COVID-19 a cikin tsarin nono na 7.
Wasu maganin rigakafi da aka gano a matsayin maganin ɓoye na COVID-19:
Tosilizmab (anti-IL-6): An yarda da shi ta Sin.
Ka kuma duba gwajin a Italiya da Sin. da Tocilizumab #COVID-19.
COVID-19 ya zama sanadiyar cutar coronavirus 2019 (COVID-19).
Ko da yake babu wani kwari da ya kammala gwajinsa na likita, akwai ƙoƙari da yawa a cikin ci gaba don bunkasa kwari.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta bayyana cewa ba ta yi hasashen cewa cutar SARS-CoV-2, wanda ke da cutar sankara, za ta kasance a cikin ƙasa da watanni 18 ba.
An zaɓi abubuwa biyar daga cikin binciken farko na binciken tsaro a watan Afrilu.
An gano COVID-19 a watan Disamba na shekarar 2020.
Yawancin yaduwar da aka samu a duniya a shekarar 2020, za su haifar da ayyukan zuba jari da bincike don bunkasa tsarin.
Yawancin magunguna masu amfani da ilimin halittu suna amfani da su don haɓaka tsarin da ya dace da SARS-CoV-2.
A watan Afrilu, an sanar da muhimman bukatun CEPI na ci gaba da bunkasa tsarin da ke tattare da saurin aiki, iya aiki, kayan aiki da kuma haɗin kai na duniya.
A watan Afrilu, masana kimiyya na CEPI sun bayyana cewa an yi bincike da ci gaba da fasahohi 10 na dandamali daban-daban a farkon shekarar 2020 don samar da ingantaccen tsarin yaki da COVID-19.
Akwai dandamali da yawa na ci gaba da ƙaddamar da binciken 1 na binciken Slammette wanda ya haɗa da:
DNA da RNA (mataki na 1 mai haɓaka da zaɓi: moderna, mRNA-1273)
An yi amfani da kwayoyin halitta masu amfani da kwayoyin halitta (Cansino Biologics), adenovirus (Adenovirus) na nau'in 5 na masu amfani da kwayoyin halitta.
A watan Afrilu, masana CEPI sun sanar da cewa an zaɓi abubuwa 115 a farkon matakan ci gaba, kuma an sanya su 78 a matsayin ayyukan aiki (79 bisa ga Cibiyar Milkin), da kuma wasu 37 da aka sanar, amma tare da rashin samun damar samun bayanai (wanda aka tsara a cikin tsare-tsaren ko zane-zane).
Mataki na 1-2 na gwaji na farko yana samar da lafiya na farko da kuma gwajin rigakafi, wanda shine gwaji na farko, magani marar lahani na hannu da kuma a gefe guda, yayin da ake tsara magani a cikin mafi ƙwarewa, tasiri.
Mataki na 3 na gwaji yana yawanci ya ƙunshi ƙarin masu ba da shawara, wanda ya ƙunshi rukuni na kulawa da kuma gwajin tasirin kwayoyin halitta don hana cutar yayin lura da sakamako masu illa na cin abinci.
Daga cikin nau'ikan 79 da aka zaɓa a cikin ci gaban aiki (wanda aka sanya su a farkon Afrilu 2020), 74 ba su da ƙimar kimantawa ta mutum (duk da haka suna cikin bincike)
A ranar 24/1/2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa za ta yi bincike don kwayar cutar da ke ɓoye na allurar da ta tsara ƙwayoyin cuta don motsa wani mai kiyayewa.
A ranar 24/1/2020 a Kanada, Cibiyar Halitta ta Duniya (VIDO-InterVac) ta Jami'ar Saskatchewan ta sanar da fara aikin Halitta, da nufin fara rarraba mutum a 2021.
An sanar da ayyukan ci gaban kwayar cutar a Cibiyar Kula da Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon Ciwon
A ranar 29/1/2020, kamfanin Janssen Pharmaceutical, Hanneke Schuitemakr, ya sanar da cewa sun fara amfani da shi wajen bunkasa wani tsari.
Jansum wani kamfani ne na ci gaban tsarin aiki tare da abokin aikinsa na fasaha, Vaxart.
A ranar 18/3/2020, New Biological Therapy ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka Piggott.
A ranar 8/2/020, dakin gwaje-gwaje na OncoGen a Romania ya kafa wani shafin da aka tsara tare da fasahar da ta yi kama da wadda aka yi amfani da ita wajen magance cutar kansa a cikin yara.
A ranar 25/3 darektan binciken ya bayyana cewa sun kammala sashi na karshe na tsarin tsarin kuma sun fara bincike.
A ranar 27/2/2020, wani kamfani na Generex, NuGenerex Immuno-Oncology, ya sanar da cewa sun fara aikin gina wani li-key peptde don yaki da COVID-19.
Sun so su yi wani zaɓi na gwaji wanda za a iya gwada shi a kan mutane "a cikin kwanaki 90".
A ranar 5/3/2020, Jami'ar Washington ta St. Louis ta sanar da aikinta na bunkasa tsarin.
A ranar 5/3/2020, rundunar binciken likitocin Majalisar Dinkin Duniya da rundunar soja a Fort Detrick da rundunar binciken Walter Reed a Silver Spring, duka biyu a yammacin Marylad, sun sanar da cewa suna aiki a kan wani rikici.
A ranar 10/3/2020, Biological Solutions ta sanar da cewa tana da alaƙa da Novavax.
A cikin ci gaba da samar da tsarin.
Manyan abokan hulɗa sun sanar da shirye-shiryen su na kammala aikin da kuma gwajin gwaji na 1 na asibiti a watan Maris na shekara ta 2020.
A ranar 21/3/2020, Ministan Lafiya na Indiya ya sanar da cewa za su yi aiki a kan raka'a 11, kuma ko da a cikin wani mataki mai sauri zai ɗauki aƙalla shekara ɗaya da rabi zuwa shekaru biyu don ci gaba da tsarin.
A ranar 12/3/2020, Medicago, wani kamfanin fasaha na rayuwa a Quebec City, ya sanar da ci gaban cutar coronavirus a matsayin wani karamin sashi na sashin tallafi na Cibiyoyin Nazarin Lafiya na Kanada.
Zaɓin tsari yana cikin binciken gwaji, tare da gwajin mutum da aka shirya a watan Yuli da 8 na 2020.
Kafin wannan makon, jaridar Guardian ta ruwaito cewa shugaban Majalisar Dinkin Duniya Donald Trump ya ba da "kudi mai yawa" don neman hanyar magance rikicin Covid-19, a kan rashin amincewar Jamus.
A ranar 17/3/2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka haɗin gwiwar mRNA-based synthesis.
Zaɓin mRNA-based BNT162 na yanzu yana cikin gwaji da gwaji na asibiti da ake sa ran zai fara a watan Afrilu na 2020.
A Italiya a ranar 17/3/2020, Kamfanin Kimiyya na Italiya, Takis Biotech Technology ya sanar da cewa sakamakon gwajin da ba a kammala ba zai kasance a watan Afrilu na 2020 kuma za a iya yin amfani da zaɓin ƙwayoyin halitta na ƙarshe a kan ɗan adam kyauta.
A Faransa a ranar 19 ga watan Maris na shekarar 2020, kungiyar CEPI ta sanar da cewa za ta ba da dala miliyan 4.9 ga wani rukuni na bincike na COVID-19 da ke tattare da cibiyoyin bincike na Pasteur da Thems Bioscience (Vienna da Austria) da Jami'ar Pittsburgh, duk da haka, CEPI ta ba da dala miliyan 29 don bunkasa COVID-19.
Sauran haɗin gwiwar CEPI don bunkasa tsarin COVID-19 sune Moderna da Curevac da Inovio da Novavax da Jami'ar Hong Kong da Jami'ar Oxford da Jami'ar Queensland
A ranar 20/3/2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'u na nau'ikan.
Masu binciken daga Imperial College London sun sanar da cewa za su ci gaba da samar da wani tsari na hana cutar COVID-19.
An kirkiro tsarin da aka zaɓa a cikin kwanaki 14 tare da aiwatar da tsare-tsaren a Sin.
A karshen watan Maris, gwamnatin Kanada ta ba da sanarwar bayar da dala miliyan 275 ga ayyukan bincike na maganin COVID-19, wanda ya haɗa da wasu takardun da aka zaɓa daga kamfanoni da jami'o'i na Kanada, kamar su Medicago da Jami'ar Saskatchewan.
A lokaci guda, gwamnatin Kanada ta bayyana cewa ta ba da dala miliyan 192 musamman don bunkasa cutar COVID-19, tare da shirye-shiryen kafa "bank of vaccines" da yawa na sababbin hanyoyin da za a iya amfani da su idan wani sabon annobar cutar ta coronavirus ta barke.
A ranar 2/4/2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun sanar da cewa Pittsburgh ta gudanar da gwajin cutar COVID-19 a cikin beraye, suna cewa "MNA asali rigakafin SARS-CoV-2 S1 ya haifar da amsa mai ƙarfi mai karewa [a cikin beraye] wanda ya fara bayyanawa makonni 2 bayan kariya.
A ranar 16 ga watan Afrilu 2020, Jami'ar Waterloo Pharmaceutical ta Kanada ta sanar da wani zane na DNA da aka zaɓa ta hanyar yin amfani da kwayoyin halitta.
Ta amfani da kwayoyin cuta, ana zana DNA don hana ƙanshin kwayoyin mutum daga samar da ƙwayoyin cuta marasa lahani kamar ƙwayoyin cuta, don ƙarfafa tsarin garkuwar jiki don samar da rigakafi ga SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Majalisar Dinkin Duniya, masana'antu da jami'o'i uku sun haɗa kayan aikin su don haɗa kwamfutar mai ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran.
Wasu ƙwayoyin cuta suna da sakamako daban-daban, kuma ana kiransu sakamako marar kyau.
Wannan yana nufin za su iya amfana daga cutar bayan an dakatar da cutar.
Wani babban ƙididdigar gaggawa a Ostiraliya na neman a yi wa ma'aikatan kiwon lafiya 4,170 rajista.
Ƙungiyoyin ci gaba na iya zama marasa lafiya ko tasiri.
Ƙungiyoyin farko na ƙayyade tasirin kwayoyin cutar COVID-19 suna amfani da samfurori a cikin dabbobi na musamman, misali, ƙwayoyin halitta na waje (ACE2), buƙatar matakan tsaro na 3 na rayuwa don magance ƙwayoyin cuta masu rai, da kuma gudanarwa ta duniya don tabbatar da matakan tsaro na gwaji.
Ba a gwada kwayoyin cutar SARS da MERS a cikin mutum ba.
A shekarar 2020, babu wani magani ko magani na SARS da aka nuna cewa yana da lafiya ko tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma bunkasa sababbin kwayoyin magani don magance SARS shine babban abin da gwamnatoci da jami'an kiwon lafiya suka fi so a duniya. Babu wani tabbataccen bayani game da MERS.
Lokacin da MERS ya zama sanannen cuta, an yi imanin cewa samun binciken SARS na iya samar da magani mai amfani don inganta haɓakar iska da kuma maganin cutar MERS-CoV.
A watan Maris na shekarar 2020, akwai wani nau'in DNA na MERS da ya kammala gwajin gwaji na farko a cikin mutane, da kuma wasu uku masu ci gaba, dukansu sun ƙunshi ƙwayoyin cuta masu ƙwayoyin cuta, biyu suna ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta (ChAdOx1-MERS da BVRS-GamVac), da kuma wani nau'in MVA-vectored (MVA-MERS-S).
Shafukan watsa labarai na yanar gizo sun wallafa wani labari na cewa an yi amfani da cutar a bayan COVID-19 wanda aka sani a baya.
An yi watsi da sababbin abubuwa saboda alamun da aka wallafa a shafukan sada zumunta game da rashin sababbin abubuwa don aikin kwayoyin halitta da kuma maye gurbin wasu nau'ikan coronavirus kamar SARS.
Cutar Coronavirus (COVID-19) cuta ce mai kumburi wadda ke haifar da alamun cututtukan cutar ta hanyar numfashi ta Coronavirus (SARS-CoV-2).
Alamomin da aka saba gani sun haɗa da hawan jiki, hawan jiki, da kuma numfashi.
Sauran alamun na iya zama gajiya, ciwon hanci, tari, ƙishirwa, rashin wari, da ciwon ciki.
Lokaci na bayyanar cututtuka na farko yana da kusan kwanaki biyar amma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Duk da yake yawancin cututtuka suna haifar da bayyanar cututtuka masu sauƙi, wasu suna haifar da ciwon huhu da kamuwa da cuta ta biyu.
A ranar 17 ga watan Afrilu 2020, an samu karin mutum miliyan 2.24 a kasashe 210 da yankuna, wanda ya haifar da mutuwar mutane sama da 153,000.
Fiye da mutane 568,000 sun warke. Kwayar cutar tana yadawa musamman tsakanin mutane a lokacin da suke da dangantaka ta kusa, sau da yawa ta hanyar ƙananan numfashi na numfashi daga yin tawaye, yin tawaye, da magana.
Yayin da ake samar da ƙananan saukad da a yayin numfashi, galibi suna fada ƙasa ko a saman fuska kuma suna kamuwa da cutar daga nesa.
Mutane kuma suna kamuwa da cutar ta wurin taɓa fuska marar tsabta, idanu, ƙashi, da baki.
Kwayar cutar na iya zama a kan fuska har tsawon sa'o'i 72.
Ana samun mafi yawan yaduwar cutar a cikin kwanaki uku na farko bayan bayyanar cututtuka na farko, ko da yake yaduwar za ta iya faruwa kafin bayyanar cututtuka ko kuma a cikin matakai na gaba. Hanyar ganewar asali ta yau da kullum ta hanyar yin amfani da rRT-PCR (rRT-PCR) a cikin ƙwayar cuta da kuma ƙwayar cuta.
Ana sa ran yin amfani da abin rufe fuska ga waɗanda ake zargin suna da cutar da kuma masu kula da su.
Shawarwarin likita game da amfani da abin rufe fuska daga mutane daban-daban, wasu gwamnatoci suna ba da shawara game da amfani da su, wasu suna ba da shawarar amfani da su, wasu kuma suna neman amfani da su.
A halin yanzu, babu wani magani ko magani na musamman na COVID-19.
An samu karuwar cutar a cikin gida a yawancin ƙasashe shida na WHO.
Masu kamuwa da cutar za su iya zama marasa bayyanar cututtuka ko kuma su nuna alamun cutar mura kamar zazzabi, kumburi, gajiya, da kuma rashin numfashi.
Alamomin gaggawa sun haɗa da wahalar numfashi, ciwon hanci ko matsa lamba, damuwa, rashin jin daɗi, da kuma launin toka na fuska ko baki: Ana ba da shawara ga likita kai tsaye idan akwai waɗannan alamun.
Sau da yawa, ba a lura da alamun numfashi na sama kamar kumburi, zazzabi ko ƙishirwa.
Alamun numfashi kamar su hawan jini, hawan jini, da kuma numfashi an lura da su a cikin kididdiga.
Wasu cututtuka na farko na nono sun kasance ne kawai a cikin matsanancin bugun jini da kuma bugun zuciya.
A wasu lokatai, cutar na iya haifar da ciwon jijiya, rauni a cikin gabobin biyu, da mutuwa.
Wannan shi ne abin da ake kira lokacin bayyanar cututtuka.
Kwanaki biyar zuwa shida na iya zama daga kwana biyu zuwa 14.
Saboda haka, a tsakanin kwanaki 11.5 na kamuwa da cutar, rahotanni sun nuna cewa ba duk waɗanda suka kamu da cutar ba ne ke ci gaba da bayyanar cututtukan.
Ba a san cikakken rawar da masu ɗaukar marasa bayyanar cututtuka ke takawa wajen watsa cutar ba, ko da yake akwai shaidar farko da ta nuna cewa suna iya haifar da yaduwar cutar.
A halin yanzu ba a san yawan mutanen da ke fama da cutar ba kuma ana gudanar da bincike a kansu, Cibiyoyin Kula da Cututtuka na Koriya (KCDC) sun ruwaito cewa kashi 20 cikin dari na wadanda suka kamu da cutar sun kasance marasa alamun cutar a lokacin da suke asibiti.
Hukumar lafiya ta duniya ta fara nazarin cututtukan da ba su da wata alama a yau da kullum: a cikin 1 / 4: 166 na kamuwa da cuta a wannan rana, 130 (% 78) sun kasance marasa alama a lokacin da aka raba.
Dukansu kwayoyin cuta da kuma kwayoyin cuta na iya ɗaukar manyan nau'ikan kwayar cuta.
Magana da ƙarfi yana haifar da ƙananan saukad da fiye da magana ta yau da kullun.
Wani bincike a Singapore ya gano cewa kokin da ba a rufe shi ba zai iya yin ƙananan ƙananan whale da aka kai ga tsawon mita 4.5 (15 ft).
Ko da yake ba a yawan samun kwayar cutar ta iska, kimiyya ta duniya ta nuna cewa za a iya samun iskar oxygen ko kuma iska mai iska a cikin hanyoyin da ke cikin ɗakunan mutane ta samar da samfurin RNA mai kyau na kwayar cutar.
Wasu ayyuka na likita kamar su shigar da iska da kuma yin bugun zuciya (CPR) na iya haifar da numfashi ya zama iska mai tsabta, wanda ke haifar da iska.
Yayin da ake zaton cewa ana iya yada shi ta fuska, an yi amfani da wannan tsoron. An fi jin tsoron cutar lokacin da mutane ke da alamun cutar; yayin da yaduwar za ta iya faruwa kafin bayyanar alamun, tsoro ya rage.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce a lokacin da ba a san yadda cutar za ta yi sauri ba, mutum zai iya kamuwa da mutane biyu zuwa uku.
A musamman, ana iya lura da kwayar cutar a rana ɗaya a kan kwali, a fiye da kwana uku a kan filastik (m polymer) da kuma polymer mai tsabta, kuma a fiye da sa'o'i hudu a kan 99% na jan ƙarfe.
Ko ta yaya, kaya masu nauyi suna dogara ne akan zafi da zafin jiki.
Sabulu da kuma tsabtace-kayan aiki suna da tasiri idan aka yi amfani da su ba daidai ba, sabulu yana lalata matakan ƙwayar cuta, yana tilasta su, kuma yana saki su a fata da sauran fuskoki.
Sauran magunguna, kamar su sinadarai masu tsabta da kuma maganin rigakafi (anti-inflammatory agents) ba su da tasiri sosai. A wani bincike a Hong Kong, an tattara samfurori daga takardar shaidar kwana biyu bayan an fara asibiti.
Mutum biyar cikin shida sun nuna cewa sun sami cutar a rana ta biyu, kuma mutum na shida ya nuna cewa sun sami cutar a rana ta biyu.
Cutar Coronavirus ta 2 (SAR-CoV-2) wani sabon cuta ne mai cutar shan numfashi, wanda aka fara ganowa daga cikin mutane uku da suka kamu da cutar huhu da ke da alaƙa da cutar shan numfashi mai tsanani a birnin Wuhan.
Dukkanin nau'ikan SARS-CoV-2 na faruwa ne daga kwayoyin cutar coronavirus a cikin yanayi.
A waje da jikin mutum, an kashe kwayar cutar ta sabulu na gida, wanda ke kashe ƙwayar mai kare ta. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Fushi ne mafi yawan kwayoyin da ke kamuwa da cutar COVID-19 saboda kwayar cutar ta shiga cikin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta ta hanyar ƙwayoyin cuta na angiotensin-transmuting enzyme 2 (ACE2), wanda shine mafi yawan nau'ikan ƙwayoyin ƙwayoyin cuta na huhu na alveolar type 2.
Kwayar cutar tana amfani da wani nau'i na sukari na musamman da ake kira "peplomer" don yin hulɗa da ACE2 da kuma yadda yake cikin ƙwayoyin halitta.
An gano ciwon zuciya mai tsanani a cikin kashi 12 cikin 100 na marasa lafiya da aka yi asibiti a birnin Vaun, Sin, kuma yana faruwa sau da yawa a cikin mummunan yanayin.
Yawan cututtukan cututtukan zuciya na cututtukan zuciya yana da girma, yana haifar da aiki mai tsanani na jijiyoyin jiki da kuma rashin lafiyar jiki, amma cututtukan zuciya na iya kasancewa da alaƙa da masu karɓa (ACE2) a zuciya.
Masu karɓar ACE2 suna da ƙayyadaddun aiki a zuciya kuma suna da tasiri a cikin aikin zuciya.
An samu karuwar jini mai yawa (31%) da kuma karuwar jini mai yawa (25%) a cikin marasa lafiya da ke ICU da ke da kamuwa da COVID-19 kuma yana iya kasancewa da alaƙa da rashin yiwuwar warkewa. Binciken mutanen da suka mutu saboda COVID-19 ya nuna cewa cutar alveolar alveolar da kuma kumburi na lymphoma suna yaduwa a cikin ƙirjin.
Ko da yake SARS-CoV-2 yana da wani abu da zai iya nuna ACE2 na ƙwayoyin epithelial na numfashi, marasa lafiya da ke fama da cutar COVID-19 suna da alamun kamuwa da cutar.
Musamman, an nuna cewa kwayoyin T na GM-CSF na asibiti suna da alaƙa da IL-6-secreting antibody na kamuwa da cuta da cutar huhu mai tsanani a cikin marasa lafiya na COVID-19.
An kuma bayyana masu rubutun kwayar cutar lymph a cikin binciken.
WHO ta wallafa wasu takardun shaida don gano cutar.
Hanyar da aka saba amfani da ita ita ce gwajin lokacin da ake yin rikicin polymerase chain reaction (rRT-PCR).
Ana yin bincike ne a kan samfurori na numfashi da aka samu daga karɓar ƙuƙwalwa da kuma ƙuƙwalwa; duk da haka, ana iya amfani da samfurori na ƙuƙwalwa ko kuma na huhu.
Sakamakon zai kasance a cikin sa'o'i biyu zuwa kwanaki biyu.
Ana iya yin amfani da gwajin jini, amma suna bukatar a ɗauki samfurori biyu na jini a makonni biyu kuma sakamakon zai kasance mai inganci.
Masana kimiyya na zamani sun iya ware wani nau'in kwayar cutar coronavirus kuma su yada kwayoyinta don haka dakunan gwaje-gwaje na duniya na iya samar da gwajin aikin polymerase chain reaction (PCR) da kansu don lura da kamuwa da cutar.
A ranar 4/4/2020, ana gudanar da gwajin rigakafi (wanda zai iya lura da kamuwa da cuta mai aiki idan mutum ya riga ya kamu da cutar) wanda ke ci gaba, amma ba a taɓa amfani da maganin rigakafi ba.
Kwarewar ƙwayoyin cuta da rarrabuwa sun nuna cewa suna da daidaito da kuma daidaito na kashi 60 zuwa 70 cikin ɗari.
FDA ta amince da gwajin farko na cibiyar kula da lafiya a Majalisar Dinkin Duniya a ranar 21/3/2020 don amfani a ƙarshen wannan watan. Dokokin gano cututtuka da asibitin Zhongnan na Jami'ar Wan ya wallafa sun ba da shawarar hanyoyin gano cututtuka bisa ga ka'idodin likita da haɗarin kamuwa da cuta.
Na'urar ta gilashin gilashi ta yi aiki tare da wata dutse, rashin daidaito da kuma jinkirin farashi a farkon kamuwa da cutar.
Rashin numfashi, hotunan radiation (ciwon huhu tare da maye gurbin alveolar cuta) da kuma taurin jiki na iya nuna ci gaba da cutar.
Ba a samun bayanai masu yawa game da cutar COVID-19 da kuma cutar da ake kira fashewar jini.
Mafi yawan asibitocin da aka samu a cikin labaran su ne:
Alamu: cututtukan huhu, cututtukan zuciya, kumburi da kuma kumburi.
Za a iya lura da nau'ikan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttuk
Ƙaramin ƙwayoyin cuta: ƙwayoyin cuta, ƙwayoyin cuta, ƙwayoyin cuta masu girma, ƙwayoyin cuta na tsakiya da lymph nodes da ƙwayoyin cuta masu girma.
Ƙarfin ƙwayar cuta mai ƙarfi: Ƙarfin ƙwayar cuta mai yawa (DAD) tare da ƙwayar cuta mai yawa.
DAD yana haifar da ciwon numfashi mai tsanani (ARDS) da rashin iskar oxygen a cikin jini.
Sodium dissolving: Sodium dissolving organs a cikin alveolar da kuma tsakiyar tsokoki.
Jini: Rashin ƙwayoyin cuta a cikin jini (DIC): karamin karamin karamin jini.
Hanyoyin hana kamuwa da cutar sun hada da kasancewa a gida, yin tafiya a wurare masu kyau, wanke hannu da sabulu da ruwa na tsawon dakika 20, yin numfashi mai kyau da kuma guje wa rasa idanu da hanci da kuma bakuna da hannayensu.
CDC ta bada shawarar rufe bakinka da hanci da kayan shafawa lokacin da kake shan wahala ko shan wahala, kuma ta bada shawarar yin amfani da kayan shafawa idan kayan shafawa ba su samuwa.
Ana bada shawara a yi wanka a hannu bayan duk wani cocaine ko sinadaran.
CDC ta ba da shawarar yin amfani da takardar rufe fuska a wuraren jama'a, don hana motsi ga marasa bayyanar cututtuka. Manufofin tsare-tsaren nesa da zamantakewa don rage haɗuwa da mutane masu fama da cututtuka zuwa manyan kungiyoyi shine rufe makarantu da wuraren aiki, dakatar da tafiya da kuma hana manyan tarurruka.
Tsarin nesa ya haɗa da cewa mutane su kasance aƙalla mita 6 (1.8m) daga juna.
Babu wani magani da aka gano da zai iya taimakawa wajen dakile COVID-19. Kamar yadda ba a yi hasashen cewa za a samu ci gaba ba har zuwa farkon 2021, wani muhimmin ɓangare na gudanar da COVID-19 shi ne ƙoƙarin rage ƙarancin annobar, wanda ake kira "gwada na ƙuƙwalwa".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na tsawon dakika 20, musamman bayan sun shiga bayan gida ko kuma idan hannuwansu sun kasance marasa tsabta, kafin cin abinci da bayan sun shafe hanci, cocaine ko sinadarin.
WHO ta ba da shawarar yin amfani da kayan tsabtace hannu na giya aƙalla kashi 60 cikin ɗari na giya, amma kawai idan babu ruwa da sabulu. Ga yankunan da ba a samun kayan tsabtace hannu, WHO ta ba da dokoki biyu don samar da gida.
A cikin waɗannan dokoki, an ƙara aikin antibacterial na ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da kwayoyin cuta daga barasa; wannan "ba abu ne mai aiki ba ne don maganin rigakafin hannu".
An ƙara glycerin a matsayin mai narkewa.
Ana kula da mutane da kulawa mai taimako, wanda zai iya haɗa da maganin ruwa, taimakon oxygen, da kuma taimakon wasu gabobin da ke dauke da cutar.
Hukumar ta CDC ta ba da shawarar cewa waɗanda ake zargin suna dauke da cutar su yi amfani da abin rufe fuska mai sauƙi.
Ana amfani da ECMO don gano matsalar rage numfashi, amma amfanin yana cikin bincike.
Ana sa ran tsabtace mutum da rayuwa mai kyau da kuma kiyaye abinci don inganta rigakafi.
Maganin tallafi na iya zama da amfani ga mutanen da ke da alamun bayyanar cututtuka a farkon lokacin kamuwa da cutar. WHO da Hukumar Lafiya ta Duniya sun ba da shawarwarin likita don kula da mutanen da ke asibiti saboda COVID-19.
Masu kula da lafiya da masana kimiyyar huhu na Majalisar Dinkin Duniya sun tattara shawarwari don maganin rigakafin cutar daga kayan kyauta, IBCC.
A watan Afrilu na shekarar 2020, babu wani magani na musamman ga COVID-19.
Don bayyanar cututtuka, wasu masu sana'a na likita sun bada shawarar yin amfani da paracetamol a kan ibuprofen a matsayin layi na farko.
Ya kamata a yi la'akari da yadda za a rage haɗarin kamuwa da cutar, musamman a wuraren kiwon lafiya inda yin ayyuka zai iya haifar da cutar sankara, kamar shigar da iska ko kuma canja wurin iska.
Don kula da lafiyar masu sana'a da ke kula da mutane da ke fama da COVID-19, CDC ta ba da shawarar sanya masu cutar a cikin ɗakin kadaici (AIIR) da kuma amfani da siginar siginar sigina, siginar sadarwa da kuma siginar siginar siginar iska. CDC na shirin kafa ƙa'ida don amfani da kayan adana mutum (PPE) a lokacin annobar.
Abubuwan da aka ba da shawarar: PPE, masks ko fuska masu numfashi, masu kare ido, da kuma kayan aikin likita. Lokacin da aka samu, an amince da masu numfashi (maimakon fuska).
An yi amfani da N95 air conditioners don yin amfani da su a wuraren masana'antu amma FDA ta ba da izinin amfani da masks a ƙarƙashin Dokar Izinin Amfani da Gaggawa (EUA).
An tsara su don kare su daga abubuwa masu rai kamar su gas, amma ba su da tasiri a kan wani abu na musamman na halitta wanda ke ba da tabbacin amfani da su ba.
Lokacin da ba a samun masks ba, CDC ta ba da shawarar yin amfani da masks, ko kuma masks na gida a matsayin kayan ƙarshe.
Yawancin cututtukan COVID-19 ba su da ƙarfi don buƙatar iska ko juyawa, amma akwai wasu da suka buƙata.
Ana gudanar da bincike sosai a kan irin taimakon numfashi ga mutanen da ke fama da COVID-19 da ke tattare da numfashi mai sauƙi ga mutanen da ke asibiti, tare da wasu shaidu cewa ana iya kawar da numfashi mai amfani da iska mai iska mai iska mai iska ko kuma iska mai iska mai kyau.
Ba a san ko kowanne daga cikin waɗannan kwayoyin yana da amfani iri ɗaya ga mutanen da ke da cututtuka masu tsanani ba.
Wasu likitoci sun amince da yin amfani da iska mai saurin canzawa idan akwai, saboda wannan hanya tana iyakance yaduwar sinadarin aerosol fiye da na huhu. Matsalar ta fi muni fiye da tsofaffi (waɗanda suka wuce shekaru 60, musamman waɗanda suka wuce shekaru 80).
Yawancin ƙasashe masu tasowa ba su da asibitoci masu zaman kansu don kowane mai haƙuri wanda ke iyakance ikon tsarin kiwon lafiya na sarrafa ƙaruwar yawan masu cutar coronavirus da ke da wuya da ke buƙatar zama a asibiti.
Wani gwaji na kimiyya a cikin nono ya gano cewa kashi 5 cikin 100 na marasa lafiya sun yarda su kasance a cikin kulawa, kashi 2.3 cikin 100 suna buƙatar taimakon likitan iska, kuma kashi 1.4 cikin 100 sun mutu.
A Sin, kusan kashi 30 cikin dari na mutanen da ke asibiti a sakamakon COVID-19 za a yi musu asibiti a ICU.
Kayan aikin iska suna da matukar rikitarwa saboda ci gaban alamun damuwa na numfashi mai tsanani (ARDS) na COVID-19 da kuma aiki mai wuya na oxygenation.
Masu sauya iska suna da ikon sarrafa matsa lamba kuma suna buƙatar babban PEEP don haɓaka isar da iskar oxygen yayin da rage haɗarin iska mai haɗari da ke tattare da lalata iska zuwa huhu.
Ƙarfin PEEP bazai samu a cikin yanayin iska na tsofaffi ba.
Bincike na hanyoyin ci gaba ya fara a watan Janairun 2020, kuma akwai magungunan rigakafin cutar a cikin dakin gwaje-gwaje.
Magungunan rigakafi na iya zama mafi inganci.
Ko da yake sababbin magunguna suna bukatar lokaci har zuwa 2021, an yarda da magunguna da yawa don wasu amfani ko kuma a cikin gwaji na ci gaba.
Ana iya gwada maganin rigakafi a cikin mutane a cikin cututtuka masu tsanani.
WHO ta ba da shawarar cewa masu ba da kai su yi aiki tuƙuru a gwajin lafiya da tasiri na maganin. FDA ta ba da izinin lokaci don dawo da jini a matsayin magani na gwaji a cikin yanayin da rayuwar mutum ke cikin haɗari.
Wannan ba shi da kwarewa a binciken likita da ake bukata don nuna tasiri da lafiya ga cutar.
A watan Fabrairun 2020, Sine ya kirkiro wani aikace-aikacen wayar hannu don rage yaduwar cutar.
Masu amfani da takardu sun nemi su rubuta sunayensu da lambar ID.
Aikace-aikacen yana da ikon gano "tausayi na kusa" ta amfani da bayanan kula da mai haƙuri da kuma haɗarin kamuwa da cutar.
Kowane mai amfani zai iya bincika yanayin wasu masu amfani uku.
Idan an gano wani babban haɗari, to, ba wai kawai shirin yana ba da shawarar zama a gida ba, amma yana sanar da hukuma ta gida. Ana amfani da bayanai masu yawa game da bayanan wayar hannu, fasahar fuska, gano wuri na wayar salula ta zamani don gano masu cutar da kuma waɗanda suka tuntube su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba jami'an tsaro damar aiwatar da bayanan wayar hannu na mutanen da za su iya kamuwa da cutar coronavirus.
An yi amfani da wannan hanyar don tilasta yin amfani da keɓewa da kuma kare waɗanda za su iya kasancewa da dangantaka da mutanen da suka kamu.
A watan Maris na shekarar 2020, kamfanin dillancin labarai na Deutsche Telekom ya fitar da wani software na wayar hannu wanda ke tattara bayanan wuri tare da darektan gwamnatin tarayya ta Jamus, Robert Koch Institute for Research and Prevention of the Virus.
Rasha ta samar da fasahar fuska don gano wadanda ke yin rigakafin.
Hukumar kula da lafiyar yankin Italiya ta Gillio Galleria ta sanar da shi cewa, kashi 40 cikin dari na 'yan kasar na ci gaba da shan wahala daga rashin lafiyarsu".
Gwamnatin Jamus ta bayyana cewa an yi amfani da sa'o'i 48 a karshen mako na Haik'us, inda aka samu mutane sama da 42,000.
Shugaban Estonia Kristi Kulliveld ya kuma bayyana wayar duniya a matsayin wata hanyar da za ta iya magance yaduwar cutar coronavirus.
Daga cikin su, mutane suna fama da baƙin ciki sakamakon keɓewa, ƙuntataccen tafiya, rashin lafiyar magani ko tsoron kamuwa da cutar.
Babies ya bayyana abin da Roy O'Connor ya ce "fiye da ɗaya rashin daidaituwa na zamantakewa, kadaici, rashin lafiyar jiki, baƙin ciki, da kuma rikice-rikice na tattalin arziki suna da cikakkiyar raƙuman ruwa don cutar da lafiyar jiki da lafiya.
Wannan yana nufin cewa cutar tana da matsakaici tare da wasu alamomi ko babu alamomi, kamar sauran cututtukan numfashi kamar zazzabi.
A matsakaici, yanayin zai warke cikin makonni biyu, yayin da a cikin matsananciyar yanayi, zai ɗauki makonni uku zuwa shida kafin ya warke.
Mata masu juna biyu suna da mafi yawan haɗarin kamuwa da cutar COVID-19 mai tsanani wanda aka samo wannan bayani daga wasu ƙwayoyin cuta masu kama da SARS da MERS, amma akwai bayanai kadan game da COVID-19.
A cikin irin wannan yanayin, COVID-19 na iya zama alamar rashin ƙarfi mai tsanani na C (ARDS) wanda ke haifar da wahalar numfashi, rashin iskar oxygen ko kuma jinkirin aiki a cikin wani sashi.
Matsalolin da ke tattare da COVID-19 sun hada da rashin aiki, jini da kuma cutar zuciya, koda da hanta.
Ana ganin an yi amfani da Procerombin (wani furotin da ke cikin ƙwayar ƙwayar cuta) a kashi 6% na waɗanda aka kwantar da su zuwa asibiti tare da COVID-19, yayin da an lura da rashin aikin koda a kashi 4% na matakinsa.
Kimanin kashi 20 zuwa 30% na mutanen da suka kamu da cutar COVID-19 sun sami maganin maganin maganin.
A cewar wannan rahoton, matsakaicin lokaci tsakanin bayyanar cututtuka na farko da mutuwa a rana ta goma, ya rage tare da biyar masu rarraba.
Koyaya, ana kula da marasa lafiya zuwa ICU kuma suna da matsakaicin lokaci na kwana bakwai a cikin rabin mutuwa da zama.
A cikin nazarin yanayin da aka yi a baya, matsakaicin lokacin bayyanar alamun farko na mutuwa ya kasance kwanaki 14, tare da matakan kwanaki shida zuwa 41.
A cikin wani bincike na Hukumar Lafiya ta Kasa (NHC), mace-mace ta mace-mace ta kasance 2.8% yayin da mace-mace ta kasance 1.7%.
Wani gwajin nazarin canji na post-mortem na C ya nuna cewa yaduwar alveolar da aka samu a jikin mutum na alveolar a cikin jini na dabbobi ya haifar da mummunar cututtukan sellular fibromyxide a cikin jini.
An lura da waƙar ƙwayoyin cuta a cikin ƙwayoyin cuta na Nemosites a cikin rabin 30s.
Jininsa na Thorax yana nuna alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
A cikin kashi 11.8 cikin dari na mutuwar da aka samu a cikin rahoton Hukumar Lafiya ta Tsakiya ta Duniya, an lura da cutar zuciya ta hanyar yawan sunadarai ko kuma bugun zuciya.
A cewar rahoton Majalisar Dinkin Duniya na watan Mayu, kashi 89 cikin 100 na wadanda aka kwantar da su a asibiti sun kasance wadanda suka riga sun kamu da cutar. Kasancewa da shiri game da samun magani da tattalin arzikin zamantakewar yankin suna da tasiri iri ɗaya akan mutuwa.
Yawan mutuwar zai iya canzawa dangane da yanayin saboda bambancin yankuna, amma kuma saboda wahalar ilimin lissafi.
Yawan matsakaici na iya zama dalili na yawan adadin mutuwar.
Koyaya, gaskiyar ita ce, mutuwar ta kasance sakamakon kamuwa da cutar a baya kuma yawan mutuwar yanzu ba a iya kwatanta su ba.
Masu shan sigari suna da kashi 1.4 cikin dari na yawan kamuwa da cutar fiye da talakawa da ke fama da cutar COVID-19 kuma kusan kashi 2.4 cikin dari ne na mutanen da ke bukatar kulawa ta musamman fiye da waɗanda ba sa shan sigari.
Asibitin gwamnati na Hong Kong ya gano wani magani wanda ke da karfin jini na kimanin 20 zuwa 30 ga wasu mutane da suka warke daga cutar, da kuma wasu gabobin da suka lalace.
Wannan zai iya sa a yi la'akari da muhimmancin yin la'akari da lafiyar da za a samu a baya don warkewa.
A watan Mayu na shekarar 2020, ba a san ko mutanen da suka kamu da cutar sun samu rigakafi mai tsawo a cikin mutanen da suka warke daga cutar ba.
Ana ganin cewa ana yin rigakafi a kan halayyar wasu ƙwayoyin cuta, amma an samu wasu waɗanda suka warke daga COVID-19 sakamakon gwajin gwajin cutar coronavirus da aka bayyana a cikin kwanaki na gaba.
Ana ganin cewa waɗannan cututtukan suna daɗa muni idan aka yi amfani da su a tsawon lokaci fiye da idan aka yi amfani da su a kai a kai.
An bayyana cewa kwayar cutar ta samo asali ne daga dabba, wato, cutar Spilver.
Ba a san asalin cutar ba, amma a watan Disamba na shekarar 2020 cutar ta zama cikakkiyar hanyar watsawa daga mutum zuwa mutum.
An wallafa wani bincike kan mutane 41 da suka kamu da cutar COVID-19 a watan Janairu na shekarar 2020 a Lancet, inda aka fara nuna alamun bayyanar cututtuka a ranar 1 ga watan Janairu na shekarar 2019.
WHO ta fitar da rahoton cewa ba a ganin wata alama ba a ranar 8 ga watan Janairun 2019.
Ana amfani da wasu ma'auni don ƙididdige yanayin mutuwar.
Wadannan lambobi sun bambanta dangane da yankin da lokacin da aka yi amfani da su, kuma suna shafar yawan gwajin, ingancin tsarin kiwon lafiya, zaɓin magani, lokacin da cutar ta fara yaduwa da kuma halaye na al'umma kamar shekaru, jima'i, kiwon lafiya a gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar U07.1 don mutuwar marasa lafiya na ICD mai cutar yellow ball don mutuwar a cikin dakin gwaje-gwaje kuma ta ba da lambar U07.1 don mutuwar a cikin likita ko na zamani na COVID-19 ba tare da ciwon dakin gwaje-gwaje na SARS-CoV-2 ba.
A cewar masanin ilimin lissafi na Jami'ar Johns Hopkins, "Johns Hopins", yawan mutuwar mutane a duniya yana da kashi 6.9 cikin dari (153,822/2,240,191) a ranar 17 ga Afrilu 2020.
Yawan ya bambanta daga yanki zuwa yanki, wasu ma'auni kamar CFR, wanda ke nuna yawan mutanen da aka gano sun mutu saboda cutar, da kuma IFR, wanda ke nuna yawan mutanen da aka gano (ko ba a gano ba) sun mutu saboda cutar.
Waɗannan masanan lissafi ba sa yin amfani da lokaci don yin bincike game da al'ummar da ke da cutar yayin yanke shawara game da shari'o'in.
Duk da yake ba dukan mutanen da ke da cutar ba ne ke da maganin rigakafi, kasancewa da maganin rigakafi na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar cutar a Italiya, Castiglione d'Adda, wani karamin kauye na mutane 4,600, mutane 80 (kashi 1.7) sun mutu.
A Gangelt, cutar ta yadu ta hanyar bikin Carnival, ta yadu a tsakanin matasa, ta haifar da ƙananan adadin mutuwar, kuma ba duk mutuwar COVID-19 ne aka rarraba a cikin wannan ba.
Bugu da ƙari, har yanzu tsarin kiwon lafiya na Jamus bai yi nasara ba.
A Netherlands, ana samun maganin rigakafi a kashi 3 cikin 100, wanda aka samo daga masu ba da jini.
69 (0.004% na yawan jama'a) sun tabbatar da cewa sun mutu saboda COVID-19.
Sakamakon cutar da kuma yawan mutuwar ta bambanta ga maza da mata.
Mutuwa ta fi girma a cikin maza, a cewar wani bincike da aka yi a China da Italiya.
Mafi yawan tsoro ga maza a cikin shekaru 50 ne.
A kasar Sin, yawan mutuwar maza ya kai kashi 2.8 cikin dari, mata kuma kashi 1.7 cikin dari.
Ba a san ainihin dalilin bambancin jinsi ba, amma al'ada da kuma hali na halitta* na iya zama dalili.
Bisa ga ilimin kimiyya, rashin yawan shan taba a cikin mata da kuma karuwar rashin lafiyar co-morbidity a cikin maza, kamar hawan jini a cikin matasan mata, na iya haifar da yawan mutuwar da ya fi girma a cikin maza.
A Turai, kashi 57 cikin 100 na mutanen da suka kamu da cutar sun kasance maza, kuma kashi 72 cikin 100 na mutanen da suka mutu daga COVID-19 sun kasance maza.
A watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta gano bayanan da suka shafi jinsi na COVID-19 ba.
Bincike ya nuna cewa cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttan.
Matasan ma'aikatan kiwon lafiya da ma'aikatan aikin jinya suna da matsayi mafi girma, kuma suna da kyakkyawan damar yin fama da cutar.
Hukumar lafiya ta duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa za a sake suna cutar da sunan "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO alama ce ta cutar coronavirus, VI alama ce ta cutar, kuma 19 alama ce ta lokacin da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi sunan ne ta hanyar kauce wa nuna wani yanki na musamman (misali China) ......
WHO ta yi amfani da "COVID-19 virus" a cikin tattaunawa ta jama'a.
Ba abin mamaki ba ne cewa ana kiran cutar "coronavirus" ko kuma cutar.
A lokacin da cutar ta fara yaduwa a Wuhan, China, an kira cutar da cutar "Coronavirus" da "Coronavirus Wuhan".
A watan Janairun 2020, WHO ta ba da shawarar cewa 2019-nCov da 2019-Coronaviruses suna da ƙarfi a matsayin sunaye na dindindin na cutar da kwayar cuta dangane da jagorar 2015 game da amfani da wuri a cikin cutar da sunayen cututtuka.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda girman shinge a cikin tsarin gyaran gyare-gyare na kasar Sin, wasu masana'antun gine-gine na dijital suna ba da mahimmancin kiwon lafiya ga buga abubuwa kamar ƙurar ƙura da sassan na'urar iska.
Alal misali, lokacin da wani asibitin Italiya ya nemi kayan numfashi na gaggawa, kuma masu hulɗa ba su iya samun su a cikin lokaci ba kamar yadda aka buƙata, an sake fara aikin gida don dawo da wasu daga cikin su kuma an yi amfani da su don neman 100 na bukatar numfashi a cikin dare.
Tun farkon farkon COVID-19, an yi ta yin la'akari da ka'idoji, jita-jita, da kuma rashin gaskiya game da asalin, auna, tsarawa, magani ko wasu fannoni na cutar, kuma an yi ta yaduwa cikin sauri ta hanyar yanar gizo.
Mutane suna iya watsa cutar zuwa wasu dabbobi.
Binciken kimiyya ya kasa gano shaidar karuwar cutar a cikin alade, shanu, da kaji.
Babu wani magani ko magani da aka amince da shi don magance cutar.
Binciken duniya kan kwayoyin cutar COVID-19 da magunguna ana gudanar da su ne ta hanyar kungiyoyin gwamnati, kungiyoyin ilimi da kuma masana'antu.
A watan Agusta, Hukumar Lafiya ta Duniya ta fara nazarin gwajin 'SOLIDARITY Trial' don tantance tasirin maganin maganin maganin maganin kwayar cuta guda hudu da ke da alkawuran rashin tasiri.
Babu wani tsari da ake samu, amma bangarori daban-daban suna aiki don samar da samfurin da aka zaɓa.
A baya, an yi amfani da aikin da aka yi a kan SAES-CoV saboda SARS-CoV da SARS-CoV-2 suna amfani da kwayar ACE2 don shiga cikin kwayoyin mutum.
An yi bincike a kan wasu abubuwa uku da suka faru.
Na farko, ana yin bincike don samar da kwayar cutar guda ɗaya ga kowace cuta.
Ana amfani da irin wannan kwayar cutar da ke da cutar ta mutuwa ko kuma ta mutuwa don amsawa da sauri ga tsarin rigakafin mutum ga sabon kamuwa da COVID-19.
Dabara ta biyu, ta hanyar yin amfani da kwayoyin halitta don yin amfani da kwayoyin halitta da ke sa tsarin garkuwar jiki ya zama mai saurin kamuwa da cutar.
A cikin SARS-CoV-2, wannan binciken ya mai da hankali kan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin kwayar ACE2.
Dabarar ta uku, ita ce, nucleic acid na ƙwayoyin cuta (DNA ko RNA ƙwayoyin cuta, sabon hanyar yin ƙwayoyin cuta).
Gwajin kwayar halitta a cikin kowane ɗayan waɗannan dabarun yana buƙatar gwada aminci da tasiri. A ranar 16 ga Maris, 2020, an fara gwajin farko na kwayar halitta a kan masu sa kai hudu na Seattle.
Anadrol yana dauke da wani nau'i na kwayoyin halitta mara lahani da aka samo daga kwayar cutar, Anadrol dependent enhancement an bayar da shawarar a matsayin babbar matsala ga ci gaban kwayoyin cutar 2-SARS-CoV, amma wannan yana da mahimmanci (ba a sani ba).
An gudanar da gwaje-gwaje na asibiti sama da 300 a watan Afrilu na 2020.
An yi bincike a kan gwaje-gwaje bakwai da aka amince da su don magance cutar zazzabin cizon sauro, kuma an yi bincike a kan huɗu da suka shafi hydrochloricillin ko chloricillin.
An yi niyyar cewa yawancin binciken da ake yi a kasar Sin zai kasance kan maganin da aka yi amfani da shi, tare da gwaji tara na Phase III akan Redisvir a wasu ƙasashe don samun rahoto a ƙarshen Afrilu.
Ci gaban cibiyoyin likita don nazarin motsi na COVID-19 da kuma takardun magani na ci gaba, kamar yadda a cikin Afrilu 2020. Akwai wasu magungunan rigakafin cutar da aka tantance don magance COVID-19. Daga cikinsu akwai Remedicivir da Hydrochloricine, Lopinvir/Retinavir da Lopinavir/Retinavir da aka haɗa don beta-receptors a jiki.
Akwai tabbaci na wucin gadi na tasirin da Remdesvir ke yi, kamar yadda a ranar 5 ga watan 2020.
An ga ci gaban cibiyar kiwon lafiya a cikin marasa lafiya da aka warkar da motsin zuciyarmu ta hanyar amfani da rimdesvir.
An gudanar da gwaji na uku na asibitin lafiya a Amurka, China da Italiya. An yi amfani da chloroquine a maganin zazzabin cizon sauro a China a shekarar 2020 tare da muhimman sakamako na farko.
Duk da haka, akwai dangantaka da yin nazari a kan binciken.
Gwamnatin Korea da kuma hukumar kula da lafiya ta kasar Sin sun bada shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Nazarin Kwayar cuta ta Wuhan, yayin da ta ba da shawarar cin abinci na kowace rana na gram guda, ta lura cewa jinkirin cin abinci na biyu a cikin abinci yana da haɗari da kisa.
A ranar 28 ga Mayu, 2020, FDA ta sanar da cewa akwai gaggawa a yi amfani da hydrochloride da chloroquine a cikin yanke shawara mai kyau game da lafiyar likitanci ga mutanen da ke dauke da COVID-19.
Bayanai na farko sun nuna cewa abinci mai yawa na ribavirin yana da muhimmanci ga SARS-CoV-2 vitro.
An ba da shawarar yin karin rarrabuwa a cikin In vivo bayan an nuna rashin ƙarancin ƙarancin SARS-CoV-2. Nazarin ya nuna cewa furotin na farko da aka shirya ta hanyar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta 2 (TMPRSS2) shine tushen shiga cikin SARS-CoV-2 ta hanyar hulɗa da mai karɓar ACE2.
Gwaje-gwaje na chloroquine da hydroxychloroquine tare da kwayoyin cuta ko kuma ba tare da maganin ba sun ƙuntata cewa al'ummar likita sun hana su yarda da irin waɗannan magunguna ba tare da bincike mai zurfi ba. Oseltamivir ba ya hana SARS-CoV-2 kuma ba shi da wani sanannen aiki a cikin maganin COVID-19.
Fitar da sinadarin cytokine na iya zama matsala a cikin matakan COVID-19 na gaba.
Akwai hujja cewa hydroxychloroquine na iya samun maganin maganin saurin cytokine. Tocilizumab an ƙayyade shi a cikin tsarin kulawa na Hukumar Lafiya ta Duniya bayan an kammala karamin bincike.
Wannan wani gwaji ne na gwaji biyu na kasa da kasa a Italiya, inda sakamakon ya nuna cewa mutane suna da cutar mai tsanani.
A hade da gwajin jini don gano matsalar cytokine, wannan yana nufin amsawa ga ci gaba, wanda zai iya zama sanadin mutuwa a wasu mutane masu cutar.
Ciwon cytokine -6 mai karɓa mai karɓa ya amince da FDA a cikin gaggawa tare da binciken da aka yi kafin a dakatar da shi don magance alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
A wannan yanayin, babu wata hujja ta bazuwar ko kuma ta sarrafawa da ta nuna cewa tocilizumab magani ne mai tasiri ga CRS.
Ana amfani da maganin rigakafi da aka tsabtace da kuma gina jiki da aka tattara ta hanyar tsarin rigakafin waɗanda suka warke daga COVID-19 ga waɗanda za a yi wa allurar rigakafi a matsayin hanyar da ba ta da ƙarancin haƙuri.
An gwada wannan aikin don SARS ba tare da samun cikakkiyar sakamako ba.
Ana yin amfani da maganin kwayar cutar a matsayin tsarin da ake tsammani na aikin da maganin antibacterial na iya sarrafa rigakafin cutar SARS-CoV-2.
Sauran hanyoyin, duk da haka, kamar su antibody na dogara da cytotoxicity ko aikin hana kwayar cuta na iya zama da amfani.
Sauran hanyoyin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin
Abubuwan da ake samarwa na tarin jini na jini na jini, wanda ya ƙunshi gina jiki na jini na marasa lafiya da suka warke da kuma maganin rigakafi na musamman na cutar wanda za a iya ƙarawa don saurin yaduwa.
Cutar coronavirus ita ce wata cuta da ke nuna alamun cutar.
Li Wenliang, likita ne a cibiyar asibitin Wuhan, wanda daga bisani ya kamu da COVID-19 kuma ya mutu bayan da aka san cewa cutar ta yadu.
